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SOMMARIO 
Pseudomonas aeruginosa è un patogeno opportunista che provoca una vasta 
gamma di infezioni nell’uomo. È noto che l’incidenza delle infezioni da P. 
aeruginosa è maggiore in persone che presentano elevati livelli di glucosio nel 
sangue, a causa della capacità del batterio di utilizzare il glucosio in eccesso come 
nutriente per la crescita. Pertanto, bloccare l’attività di proteine coinvolte nel 
trasporto o nell’utilizzazione del glucosio da parte del batterio potrebbe essere 
una buona strategia per lo sviluppo di farmaci anti-pseudomonas. 
Per valutare questa ipotesi, abbiamo costruito una serie di mutanti singoli e 
multipli difettivi nel trasporto del glucosio nel ceppo PAO1 di P. aeruginosa e li 
abbiamo analizzati per fenotipi correlati alla virulenza in saggi in vitro e in vivo, 
in due differenti modelli di infezione. In particolare, sono stati deleti i geni 
codificanti per i trasportatori della membrana interna Glt, GntP e Kgut, che 
mediano l’ingresso del glucosio e dei suoi derivati ossidati gluconato e 2-
ketogluconato. Un triplo mutante privo dei suddetti trasportatori si è rivelato 
incapace di crescere su glucosio come unica fonte di carbonio (mutante GUN, 
Glucose Uptake Null). 
Più di 500 geni, che controllano sia funzioni metaboliche che la virulenza, sono 
espressi in modo differenziale nel mutante GUN rispetto al ceppo parentale. 
Coerentemente con i dati dell’analisi trascrittomica, i saggi di virulenza in vitro 
hanno mostrato che il mutante GUN si comporta diversamente dal ceppo 
parentale, avendo una ridotta capacità di formare biofilm e una maggiore 
secrezione di proteasi, piocianina e pioverdina. Inoltre, questo mutante ha una 
produzione alterata delle molecole segnale che attivano il sistema del quorum 
sensing. È interessante notare che il profilo trascrizionale e la maggior parte dei 
tratti fenotipici analizzati differiscono tra il mutante GUN e il ceppo parentale 
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indipendentemente dalla presenza del glucosio, suggerendo che uno (o più) dei 
trasportatori deleti abbia una funzione addizionale non correlata al trasporto del 
glucosio. 
Infine, alcuni mutanti hanno mostrato un diverso grado di virulenza in saggi di 
infezione negli ospiti modello Caenorhabditis elegans e Galleria mellonella. In 
particolare, mentre in C. elegans la virulenza dei mutanti è risultata simile a 
quella del ceppo parentale PAO1, i mutanti deleti del gene kguT, che codifica per 
il trasportatore del 2-ketogluconato, sono meno virulenti di PAO1 in G. 
mellonella. L’attenuazione è particolarmente significativa per il doppio mutante 
ΔgntP ΔkguT e per il mutante GUN. Questo risultato suggerisce che l’efficacia 
antibatterica di composti che bloccano l’utilizzo del glucosio da parte di P. 
aeruginosa potrebbe presumibilmente variare a seconda della capacità del 
patogeno di adattarsi allo specifico contesto nutrizionale dell’ospite infettato. 
Una maggiore conoscenza delle interazioni metaboliche che avvengono tra 
patogeno ed ospite nel sito d’infezione diventa quindi sempre più necessaria per 
poter sviluppare terapie antibatteriche efficaci. 
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ABSTRACT 
Pseudomonas aeruginosa is an opportunistic pathogen causing a wide range of 
infections in humans. Pathologies leading to hyperglycaemia have been 
associated with augmented risk of developing serious P. aeruginosa infections 
due to the ability of the bacterium to utilize glucose as carbon source for the 
growth. Therefore, preventing the import of glucose might be a good strategy to 
develop anti-pseudomonas drugs. 
To address this hypothesis, a collection of single and multiple glucose uptake 
defective mutants was generated in P. aeruginosa PAO1 and tested for virulence-
related phenotypes in in vitro assays and in vivo, in two different infection 
models. In particular, we engineered mutants in genes encoding inner membrane 
(IM) proteins involved in the internalization of glucose and its oxidized 
derivatives gluconate and 2-ketogluconate, i.e. the Glt, GntP and KguT 
transporters. A triple mutant lacking these transporters was demonstrated to be 
completely unable to grow on glucose as sole carbon source (Glucose Uptake 
Null mutant, GUN). 
The transcriptomic analysis revealed a strong divergence in the GUN 
transcriptional profile relative to the parental strain, with more than 500 
differentially expressed genes, controlling both metabolic functions and 
virulence traits. Consistent with the transcriptomic data, the GUN mutant showed 
a pleiotropic phenotype in the in vitro assays, with a reduction in biofilm 
formation and an increased secretion of proteases, pyocyanin and pyoverdine. 
Furthermore, the production of quorum sensing signal molecules was altered in 
this mutant. Interestingly, the gene expression profile and most phenotypic traits 
differ between GUN and the parental strain irrespective of the presence of 
glucose, suggesting a possible additional role for the deleted transporter(s). 
 4 
 
Finally, the in vivo assays demonstrated that while the virulence of all mutants in 
the Caenorhabditis elegans infection model was essentially comparable to that 
of the wild type strain, all mutants lacking kguT (i.e. the 2-ketogluconate 
transporter gene) and especially the double ΔgntP ΔkguT and GUN mutants, 
were attenuated in the Galleria mellonella model. This suggests that targeting 
glucose metabolism with specific drugs may alter P. aeruginosa pathogenicity 
depending on the ability of this pathogen to adapt to the specific nutritional 
context encountered at the site of infection. Therefore, a deeper knowledge of 
host-pathogen metabolic transactions is pivotal to develop effective antibacterial 
strategies based on hampering bacterial metabolic functions. 
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AIM OF THE THESIS 
The aim of this thesis is to assess whether affecting the import of glucose may 
influence the expression of virulence traits in P. aeruginosa, thus validating 
glucose uptake pathway as a possible new target for anti-pseudomonas 
therapies. 
Metabolic genes have been repeatedly identified among those contributing to the 
in vivo virulence of the opportunistic pathogen P. aeruginosa and are considered 
interesting targets for novel anti-pseudomonas drugs. In this regard, genes 
involved in glucose uptake deserve consideration. Indeed, pathologies leading to 
hyperglycaemia have been demonstrated to promote bacterial infections by 
stimulating the growth of human pathogens such as P. aeruginosa. This 
bacterium can utilize glucose as unique carbon source for the growth by 
importing it through either a phosphorylative route or a periplasmic oxidative 
pathway generating gluconate and 2-ketogluconate (2-KG). Different works have 
shown that the regulation of glucose catabolic genes, and in particular of 2-KG 
import, is tightly linked to that of toxA, the gene encoding the key virulence factor 
exotoxin A, establishing a connection between glucose and virulence. 
The above general goal has been pursued through the fulfilment of the following 
specific objectives: 
1. Generation of single and multiple P. aeruginosa PAO1 mutants in genes 
encoding outer membrane (OM) and inner membrane (IM) glucose 
transporters. Specific aims: i) to obtain mutant strains with specific defects in 
glucose transport for the phenotypic characterization; ii) to assess whether 
other unknown glucose transporters may supply the absence of the known 
ones. 
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2. Gene expression profiling of a P. aeruginosa mutant lacking all glucose 
transporters in comparison with the parental PAO1 strain and validation by 
RT-qPCR and in vitro phenotypic assays of transcriptomic data in 
presence/absence of glucose. Specific aims: i) identification of 
genes/pathways responding to glucose in P. aeruginosa; ii) identification of 
genes, if any, specifically responding to the lack of glucose transporters. 
3. Evaluation of mutants’ virulence in the Caenorhabditis elegans nematode 
and the Galleria mellonella insect infection models. Specific aims: to assess 
whether the lack of glucose transporter(s) affects virulence in different 
infection models. Besides being a prerequisite for validating glucose uptake 
pathway as a possible new target for anti-pseudomonas therapies, this 
analysis would contribute to shed light on P. aeruginosa metabolic state 
during the infection of these widely used non-mammalian models. 
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PART I  
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STATE OF THE ART 
1. Pseudomonas aeruginosa: a versatile opportunistic pathogen 
The genus Pseudomonas represents a large group belonging to the γ-
proteobacteria class comprising more than 200 species isolated from various 
environmental sources. Indeed, members of this genus inhabit soil and aqueous 
environments, associate with plants in the rhizosphere as commensal but can also 
behave as pathogens of mammals, insects and plants (Singh et al. 2016). 
Pseudomonas aeruginosa is a prototypical Pseudomonas species considering its 
impressive ability to colonize the most disparate environments and hosts as 
different as plants, nematodes, insects and mammals. It is considered one of the 
major opportunistic pathogen for humans, as it can cause severe infections in 
subjects in which the physiological barriers against infection have been 
compromised. Indeed, P. aeruginosa is one of the most prevalent nosocomial 
pathogens and its infections are more prevalent among people with compromised 
host defences such as AIDS patients or neutropenic patients undergoing 
chemotherapy, but also patients with cystic fibrosis (CF) or severe burns (Lyczak 
et al. 2000; Gellatly & Hancock 2013). P. aeruginosa infections are linked to 
remarkable morbidity and mortality due to the ability of the bacterium to adapt 
to environmental changes and nutritional sources, to produce a wide range of 
virulence factors and to develop antibiotic resistance. Indeed, P. aeruginosa has 
been enclosed among “superbugs”, namely bacteria endowed with intrinsic 
resistance to a variety of antibiotics, like aminoglycosides, fluoroquinolones and 
β-lactams (Poole 2011). The intrinsic mechanisms of P. aeruginosa resistance 
are largely due to the low permeability of its outer membrane and the presence 
of multiple efflux pumps (Breidenstein et al. 2011). Moreover, other mechanisms 
exploited by P. aeruginosa to increase the resistance rate are: i) the acquisition 
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of inheritable traits by horizontal genetic transfer; ii) adaptive resistance induced 
by sub-inhibitory concentrations of antibiotics or altered metabolic states, 
conditions commonly encountered in P. aeruginosa biofilms during chronic 
infections (Fernández et al. 2011). 
The genome of P. aeruginosa PAO1 reference strain was the first to be sequenced 
among those of pseudomonads. With a size of 6.3 Mb, the PAO1 genome was 
the largest of the sequenced bacterial genomes at that time (Stover et al. 2000). 
Consistent with the capability of P. aeruginosa to exploit a variety of nutrients 
in disparate environmental niches, functional assignments of the predicted ORF 
revealed that 10% of the P. aeruginosa PAO1 genome (i.e. about 500 genes) 
encodes for proteins involved in the transport of nutrients. In particular, P. 
aeruginosa has a broad array of transporters for mono-, di-, and tricarboxylic 
acids, whereas the sugar transporters are quite scarce (Stover et al. 2000). 
1.1. The arsenal of P. aeruginosa virulence factors 
The remarkable ability of P. aeruginosa to invade and colonize the human host 
is owed to the high number of virulence factors it synthesizes. This pathogen 
produces both cell-associated (pili, flagella, lectins, glycocalyx, 
lipopolysaccharide and biofilm) and extracellular (proteases, haemolysins, 
pyocyanin, siderophores, exotoxin A, T3SS effectors) virulence factors that 
participate in the three stages of the infection: i) bacterial adhesion and 
colonization; ii) tissue invasion; iii) systemic dissemination (Strateva & Mitov 
2011). A summary of the main P. aeruginosa virulence factors and their 
contribution to the pathogenesis is listed in Table 1. 
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Table 1. P. aeruginosa virulence factors and respective role in the pathogenesis 
 
 
The adhesion and colonization phase requires a break in first-line physical and 
immunological barriers and is mostly dependent on cell-associated virulence 
factors, such as: 
• Type IV pili and flagella: cell surface appendages mediating bacterial 
colonization thanks to their ability to adhere to epithelial cells (Farinha et al. 
From Strateva & Mitov 2011. 
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1994; Feldman et al. 1998). Type IV pili are pilin protein fibres that, besides 
binding to specific galactose, mannose and sialic acid-containing receptors 
on epithelial cells, are required for cell-to-cell interactions in biofilm 
microcolonies and twitching motility (O’Toole & Kolter 1998; Skariyachan 
et al. 2018). Twitching is a propulsion mechanism that P. aeruginosa exerts 
to reach and colonize the surface of abiotic substrates, like catheters. Flagella 
are complex organelles, composed of flagellin subunits, necessary for 
chemotaxis and motility. They mediate both single-cell swimming motility 
and swarming, a multicellular coordinated movement of a bacterial 
population across a semisolid surface contributing to early stages of P. 
aeruginosa biofilm (Shrout et al. 2006). 
• Lectins: sugar-binding proteins interacting with carbohydrates located on 
host cell surfaces. P. aeruginosa produces two soluble lectins, LecA and 
LecB, which specifically bind to galactose and fucose, respectively. Besides 
their role in adhesion, lectins have a cytotoxic effect in lung epithelial cells 
and contribute to biofilm development (Chemani et al. 2009; Grishin et al. 
2015). P. aeruginosa strains with mutations in lecA and lecB form thinner 
and less structured biofilms (Grishin et al. 2015). However, the specific 
function of lectins on the formation of a correct biofilm architecture remains 
unclear. 
• Glycocalyx: extracellular polysaccharidic matrix, composed of uronic acids 
and carbohydrates, protecting P. aeruginosa from phagocytosis and acting as 
a barrier against cationic antibiotics, such as aminoglycosides, due to its 
polyanionic nature (Nikaido 1994). 
• Lipopolysaccharide (LPS): carbohydrate-lipid complex forming the outer 
leaflet of gram-negative bacteria. In gram-negative bacteria, the LPS is 
composed of the lipid A, a polysaccharide core region and the O-antigen. The 
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major contribution to P. aeruginosa pathogenicity is exerted by lipid A and 
O-antigen. Lipid A is composed of a di-glucosamine biphosphate backbone 
anchored to the outer membrane by six or seven fatty acyl chains. It elicits 
the production of pro-inflammatory mediators by interaction with Toll-like 
receptor 4 (TLR 4) on the surface of immune cells (Akira et al. 2006). Linked 
to the lipid A moiety by the LPS core, the O-antigen is a variable repeating 
polysaccharidic region that shows immunogenicity. P. aeruginosa produces 
two different forms of O-antigen: A-band, a homopolymer of D-rhamnose 
triggering a weak antibody response, and B-band, a heteropolymer eliciting a 
strong antibody response that is the basis for serogroup specificity (King et 
al. 2009).  
• Biofilm: complex of bacterial microcolonies embedded in a matrix named 
Extracellular Polymeric Substance (EPS) comprising three major 
exopolysaccharides (alginate, Pel and Psl), extracellular DNA (eDNA) and 
proteins (type IV pili and flagella). The physical structure and chemical 
properties of P. aeruginosa biofilm determine its protective role from the 
entry of antibiotics and the attack by immune cells (Skariyachan et al. 2018). 
Alginate, an exopolysaccharide composed of mannuronic and glucuronic acid 
repeats, enhances P. aeruginosa surface adhesion and promotes the 
conversion from non-mucoid to mucoid phenotype (Hay et al. 2009). Pel, a 
glucose-rich polysaccharide, and Psl, pentasaccharide consisting of D-
glucose, D-mannose and L-rhamnose repeats, function as structural scaffolds 
to maintain biofilm integrity (Colvin et al. 2012). Extracellular DNA 
increases aminoglycosides resistance and acts as a nutrient source during 
starvation and as a “skeleton” by interacting with Psl to form Psl-eDNA fibres 
that allow bacterial adherence and growth (Chiang et al. 2013; Wang et al. 
2015). 
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P. aeruginosa invasion of host tissues depends upon the secretion of extracellular 
enzymes and toxins interfering with host physical barriers, immune defences or 
cellular functions. The main secreted virulence factors are: 
• Proteases: P. aeruginosa produces several extracellular proteases, such as 
elastases (LasA and LasB), alkaline protease and protease IV. The two 
elastases work synergistically to destroy elastin-containing human lung 
tissues (Van Delden & Iglewski 1998). LasB is a zinc metalloprotease able 
to degrade not only actin but also fibrin, fibronectin and collagen. LasA is a 
serine protease that enhances LasB activity by cleaving glycine-glycine 
bonds within elastin. Alkaline protease is a zinc metalloprotease degrading 
fibronectin and several components of host immune system (Laarman et al. 
2012). Protease IV is a serine protease that can cleave complement proteins, 
immunoglobulins, fibrinogen and degrade the corneal epithelium (Engel et 
al. 1998). 
• Haemolysins: two haemolysins are produced by P. aeruginosa, rhamnolipids 
and phospholipase C (PLC). Rhamnolipids are amphipathic molecules, 
composed of L-rhamnose containing glycolipids, promoting swarming 
motility and the maintenance of biofilm architecture (Caiazza et al. 2005; 
Davey et al. 2003). It was observed that rhamnolipids contribute to create 
interior cavities in the biofilm structure to permit the flow of water and 
nutrients (Chrzanowski et al. 2012). This haemolysin was also identified in 
the sputum of cystic fibrosis patients and can block the ciliary activity of 
human lung epithelium (Read et al. 1992). PLC especially hydrolyses 
phospholipids containing quaternary ammonium groups (e.g., 
phosphatidylcoline), which are major components of eukaryotic membranes 
but rarely found in prokaryotes (Berka & Vasil 1982). 
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• Pyocyanin (PYO): a blue pigment, belonging to the phenazine family, 
produced by P. aeruginosa secondary metabolism. It is a redox active 
compound that can serve as mobile electron carrier to modulate the 
intracellular redox state in conditions of electron acceptors restriction, such 
as oxygen limitation during stationary phase (Price-Whelan et al. 2007). PYO 
is essential for full virulence in different infection models, ranging from 
insects and nematodes to mammals (Lau et al. 2004). The presence of PYO 
in the lung epithelium strongly contributes to the severity of P. aeruginosa 
respiratory infections in CF patients by exposing epithelial cells to oxidative 
stress and stimulating the production of proinflammatory mediators. (Rada & 
Leto 2013). P. aeruginosa possesses two redundant operons, phz1 and phz2, 
implicated in PYO biosynthesis (Mavrodi et al. 2001). These two operons 
share 99% identity but have distinct promoter regions. The transcription of 
phz1 is induced by LasR, RhlR and PqsR, whereas only PqsR has a positive 
role in phz2 expression (Whiteley et al. 1999; Déziel et al. 2004; Recinos et 
al. 2012). 
• Pyoverdine (PVD): major siderophore of P. aeruginosa synthesized under 
conditions of iron starvation to sequester ferric iron from the environment for 
bacterial growth. PVD induces the production of virulence factors, such as 
exotoxin A, protease IV and PVD itself, and is important for biofilm 
development in vitro (Lamont et al. 2002; Visca et al. 2007). Moreover, the 
expression of PVD synthetic genes was demonstrated to be high during lung 
systemic infections and in the sputum of CF patients (Handfield et al. 2000; 
Haas et al. 1991). 
• Exotoxin A (ETA): enzyme transferring the ADP-ribose moiety of NAD to 
the eukaryotic elongation factor 2 (eEF-2), leading to cessation of protein 
synthesis and cell death. P. aeruginosa isolates from different sites of 
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infection produced ETA (Hamood, Griswold, et al. 1996). ETA synthesis by 
P. aeruginosa is fine-tuned by positive and negative effectors and 
environmental conditions (Hamood et al. 2004). The expression of the toxA 
gene for ETA is induced by the iron starvation sigma factor PvdS and 
repressed by Fe2+ and the ferric-uptake regulator Fur (Hamood et al. 2004). 
Moreover, toxA expression is controlled by a pair of effectors, namely PtxR 
and PtxS, involved in the regulation of ketogluconate metabolism (see details 
in Section 4.4; Daddaoua et al. 2012). 
• T3SS effectors: four exoenzymes (ExoS, ExoU, ExoT, ExoY) are secreted by 
the type III secretion system (T3SS), which is responsible for the direct 
injection of P. aeruginosa toxins into the host cell (Hauser 2009). ExoS and 
ExoU are the most potent exotoxins, whereas ExoT and ExoY have minor 
roles in cytotoxicity. ExoS is a bifunctional toxin with GTPase activating 
protein and ADP-rybosiltransferase activities that interferes with actin 
cytoskeletal organization and eukaryotic DNA synthesis, causing cell death 
(Pederson & Barbieri 1998). ExoU is a phospholipase causing rapid death of 
eukaryotic cells due to disruption of plasma membrane integrity. ExoT has 
the same function as ExoU, but only the 0.2% of ExoU activity. ExoY is an 
adenylate cyclase with uncertain significance in infection. 
The systemic dissemination is a poorly characterized stage of P. aeruginosa 
pathogenesis supposed to be mediated by the same cell-associated and secreted 
virulence factors implicated in the localized infection (Strateva & Mitov 2011). 
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1.2. The P. aeruginosa quorum sensing network 
The expression of most P. aeruginosa virulence factors is modulated by a cell-
to-cell communication system known as Quorum Sensing (QS). This system is 
common in both gram-positive and gram-negative bacteria and is based on the 
production of small diffusible molecules called autoinducers. The level of these 
signal molecules rises along with the increase of bacterial population until it 
reaches a threshold concentration (the “quorum”) that permits the interaction of 
these molecules with their cognate transcriptional regulator. In this way, the 
regulators can activate or repress the expression of their target genes. 
P. aeruginosa possesses a sophisticated QS network, consisting of four systems 
(las, rhl, pqs, and iqs) and depending on the interaction of different regulators 
with distinct classes of autoinducers (Fig. 1; Lee & Zhang 2015). 
 
 
Fig. 1. The P. aeruginosa quorum sensing network. The four QS systems, with their respective 
autoinducers and transcriptional regulators, are represented with different colours. The main targets 
controlled by each regulator are indicated in dashed squares. Arrows, positive regulation.  
Modified from Lee & Zhang 2015. 
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The production of N-3-oxododecanoyl-homoserine lactone (OdDHL), by the 
autoinducer synthase LasI, mediates the activation of the las system. The 
interaction of OdDHL with its cognate regulator LasR induces the expression of 
virulence genes and lasI, thus creating a positive feedback loop (Seed et al. 1995). 
LasR positively regulates the expression of LasA and LasB elastases, alkaline 
protease and exotoxin A (Smith & Iglewski 2003). It was demonstrated that the 
OdDHL signal is necessary for normal biofilm differentiation (Davies et al. 
1998). 
As for the las system, the autoinducer of the rhl system is also an homoserine 
lactone, namely the N-butanoyl-homoserine lactone (BHL), synthetized by RhlI. 
The BHL signal molecule binds to its cognate regulator RhlR to activate the 
expression of rhlAB, phz and lecAB genes for the synthesis of rhamnolipids, 
pyocyanin and lectins, respectively (Brint & Ohman 1995). In addition, the RhlR-
BHL complex is required for the full activation of the lasB promoter and induces 
the expression of rhlI, forming a second positive feedback loop (Brint & Ohman 
1995; Ochsner & Reiser 1995). 
P. aeruginosa expresses a third QS system, termed pqs, responding to a signal 
molecule chemically different from those of las and rhl systems. This molecule 
is termed Pseudomonas Quinolone Signal (PQS) and is structurally defined as 2-
heptyl-3-hydroxy-4-quinolone. The PQS cognate regulator is PqsR, that 
positively regulates the expression of the pqsABCDE operon, for the production 
of the PQS precursor HHQ (4-hydroxy-2-heptyl-quinoline), and the pqsH gene 
for the conversion of HHQ to PQS (Cao et al. 2001). Mutants with a defective 
pqs system show a decreased production of virulence factors such as pyocyanin, 
elastases, lectins and rhamnolipids (Cao et al. 2001). 
The autoinducer of the fourth QS system is IQS (Integrated QS signal), 
structurally identified as 2-2-hydroxyphenyl-thiazole-4-carbaldehyde. This 
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system is relevant under phosphate starvation and its disruption was 
demonstrated to cause a decrease in the production of BHL, PQS and virulence 
factors such as pyocyanin, rhamnolipids and elastases (Lee et al. 2013). 
The four QS circuits are interconnected and hierarchically organized. The las 
system resides at the top of the signalling cascade, with the LasR-odDHL 
complex positively regulating the expression of rhlR, rhlI, pqsR and pqsH (Pesci 
et al. 1997; Deziel et al. 2004). Also the iqs system was demonstrated to be 
regulated by las when bacteria grow in rich medium (Lee et al. 2013). The pqs 
system indirectly enhances the expression of rhl-related virulence traits by 
inducing rhlI expression, forming a bridge between las and rhl circuits 
(McKnight et al. 2000). However, exceptions in this hierarchy occur. It was 
found that RhlR can induce the synthesis of las-controlled virulence factors and 
PQS in a ΔlasR mutant, indicating that a compensatory activation of the rhl 
system can override the QS hierarchy to maintain the expression of virulence 
genes when the las circuit is affected (Dekimpe & Deziel 2009). This is the 
situation often encountered during chronic infections of the CF lung, with P. 
aeruginosa isolates that may lose the las system but keep the RhlR-dependent 
regulation of QS virulence factors (Bjarnsholt et al. 2010). Furthermore, the 
timing in the expression of las and rhl systems was demonstrated to depend on 
the growth medium, with rhl activated earlier than las under certain conditions 
(Duan & Surette 2007). This suggests that the QS regulatory systems have a 
dynamic hierarchy to allow a precise and prompt expression of P. aeruginosa 
virulence genes in response to environmental changes. 
1.3. Regulation of quorum sensing by environmental cues 
The P. aeruginosa quorum sensing (QS) network is well integrated into global 
regulatory circuits, so that signals additional to cell density can be sensed by this 
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pathogen to regulate the production of virulence effectors. Indeed, the expression 
of QS systems in P. aeruginosa is influenced by a variety of metabolic and 
environmental signals, as well as by human host factors (Fig. 2; Venturi 2006; 
Lee & Zhang 2015). 
 
 
Regulators of the stringent response, a conserved regulatory mechanism 
coordinating bacterial adaptation to nutrient starvation, differently affect the 
induction of QS systems. The overproduction of DksA, a regulator that increases 
the activity of the stringent response signal (p)ppGpp (penta- and tetra-
phosphorylated guanosine), inhibits the rhlI expression and the translation of 
Fig. 2. Regulation of P. aeruginosa quorum sensing network by environmental cues and host 
factors. The four QS systems are represented in violet rectangles. Light blue circles highlight the 
factors mediating QS network regulation in response to extracellular signal, indicated in the upper 
part of the figure. Arrows, positive regulation. Perpendicular lines, negative regulation. 
The regulation mechanisms are elucidated in the text. Modified from Lee & Zhang 2015. 
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LasB elastase and rhamnolipids encoding genes (Branny et al. 2001; Jude et al. 
2003). On the contrary, the overproduction of the (p)ppGpp synthesizing protein 
RelA promotes a cell-density independent and premature transcription of lasR 
and rhlR, as well as elastase activity (van Delden et al. 2001). Accordingly, a 
(p)ppGpp deficient strain shows a significant downregulation of las and rhl 
systems, in line with a decrease in elastase and rhamnolipids production 
(Schafhauser et al. 2014). 
The RpoS starvation sigma factor is also involved in the regulation of QS genes. 
RpoS represses rhlI transcription in early log phase, with a concomitant reduction 
in BHL levels and in the expression of the rhl-dependent phz and hcn operons for 
the biosynthesis of pyocyanin and hydrogen cyanide, respectively (Whiteley et 
al. 2000). Transcriptomic analysis revealed that RpoS influences the expression 
of many QS-controlled genes, suggesting that this sigma factor may act as a 
global regulator of QS network at the onset of stationary phase (Schuster et al. 
2004). Some QS-dependent genes are induced by RpoS (lecA, coxAB), whereas 
others are repressed (aprA, phz and hcn operons). 
Another alternative sigma factor, RpoN, involved in nitrogen metabolism and 
assimilation under nitrogen limiting conditions, negatively regulates lasRI and 
rhlRI expression in a nutrient-rich medium (Heurlier et al. 2003). On the other 
hand, this sigma factor act as a positive regulator of rhlI transcription when P. 
aeruginosa was grown in minimal medium supplemented with glucose 
(Thompson et al. 2003). 
Phosphate deprivation stimulates the expression of the pqs system, promoting the 
formation of PQS-Fe3+ toxic complexes that elicit a rapid mortality in C. elegans 
(Zaborin et al. 2009). Moreover, the iqs system can partly take over the activity 
of las under phosphate-limiting conditions by inducing rhl and pqs systems (Lee 
et al. 2013). The PhoB/PhoR two-component system, which activates the cell 
 21 
 
response to phosphate starvation, was found to mediate this induction (Zaborin 
et al. 2009; Lee et al. 2013). 
Although the expression of QS-related virulence factors (proteases, exotoxin A) 
is triggered in iron-limiting environments, a direct connection between iron 
deprivation and the expression of QS genes has not been found so far. However, 
iron starvation indirectly increases PQS levels by triggering the Fur-dependent 
de-repression of PrrF1 and PrrF2, two small RNAs inhibiting the degradation of 
the PQS precursor anthranilate (Oglesby et al. 2008). PQS molecules can 
function as iron trap at the P. aeruginosa cell surface to facilitate the siderophore- 
dependent iron uptake (Diggle et al. 2007). 
Oxygen limitation stimulates the synthesis of hydrogen cyanide (HCN), a potent 
inhibitor of the aerobic respiratory chain in many organisms. It was found that 
LasR and RhlR cooperate with ANR, a global regulator of the anaerobic response 
in P. aeruginosa, to induce the expression of the hcnABC cyanide biosynthetic 
operon (Pessi & Haas 2000). 
The expression of QS-dependent genes changes also in response to human 
factors. As an example, the bind of interferon-γ cytokine to OprF, the major P. 
aeruginosa outer membrane protein, activates rhlI expression and the production 
of PA-I lectin and pyocyanin (Wu et al. 2005). This could be a strategy adopted 
by P. aeruginosa to counteract the activation of host immune response upon 
pathogen recognition. Different human peptides may also impact on P. 
aeruginosa QS. For instance, the opioid peptide dynorphin, normally found at 
high concentrations in intestinal tissues upon stress, is able to penetrate P. 
aeruginosa cells in a mouse model of infection (Zaborina et al. 2007). The 
recognition of dynorphin by P. aeruginosa was found to induce the expression 
of the pqs system and pyocyanin synthetic genes (Zaborina et al. 2007). 
Moreover, the C-type natriuretic peptide (CNP), produced by endothelial cells to 
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regulate body fluid homeostasis and blood pressure, triggers the cAMP-
dependent activation of Vfr, a P. aeruginosa transcriptional factor positively 
regulating lasR transcription and the expression of a variety of virulence 
determinants, including exotoxin A (Blier et al. 2011). Finally, it was proved that 
the phagocytic antimicrobial peptide LL-37 promotes the synthesis of PQS and 
QS-related virulence factors, such as phenazines, hydrogen cyanide, elastase and 
rhamnolipids (Strempel et al. 2013). 
2. Caenorhabditis elegans and Galleria mellonella as model hosts 
to study P. aeruginosa infections 
Invertebrates can be used as model hosts to investigate bacterial pathogenesis and 
have several advantages over mammalian models (Glavis-Bloom et al. 2012). 
Indeed, invertebrates are much cheaper and easier to maintain, as they do not 
require special lab equipment, and no ethical approval is necessary for their use. 
Additionally, the small size and short lifespan make them ideal for high-
throughput studies. Despite not presenting an adaptive immune system, 
invertebrates have a relatively advanced innate immune response sharing many 
similarities to that of mammals. A certain conservation was especially observed 
in the innate immune mechanisms of insects and mammals (Ganz & Lehrer 1994; 
Hoffmann 1995; Kopp & Medzhitov 1999). 
The recognition of a pathogen by the host innate immune system is mediated by 
a set of proteins, termed pattern-recognition receptors (PRRs), which can directly 
identify invariant molecule structures shared by most of bacteria (pathogen-
associated molecular patterns or PAMPs). Interestingly, it was observed that the 
Toll family of PRRs are crucial for the activation of innate host defence in both 
mammals and insects (Kopp & Medzhitov 1999). These receptors induce a 
signal-transduction pathway to activate the expression of defence-related genes 
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that is well conserved from insects to mammals (Kopp & Medzhitov 1999). A 
certain similarity was also found in the type of defence effectors produced to kill 
pathogens. For example, the antimicrobial peptides class of defensins is shared 
between insects and mammals (Ganz & Lehrer 1994). 
As already mentioned in Section 1, P. aeruginosa is not only an opportunistic 
pathogen for mammals but it can also naturally infect invertebrates such as 
insects and nematodes. The relevance of using invertebrates as P. aeruginosa 
infection model arises from the possibility to screen libraries of mutants and, 
consequently, to study the contribution to pathogenesis of essentially all P. 
aeruginosa genes. Therefore, invertebrates might function as preliminary in vivo 
virulence screening systems to restrict the number of P. aeruginosa mutants to 
be tested in mammals. 
In the next two sections, I provide a brief introduction to the invertebrate models 
I used for the P. aeruginosa infection assays: the Caenorhabditis elegans 
nematode and the Galleria mellonella insect larvae. 
2.1. The Caenorhabditis elegans model 
The C. elegans soil-living nematode is well suited for experimental studies, 
considering its small size (adults are ~1 mm), rapid life cycle (~3.5 days at 20 
°C), short lifespan (~ 2 weeks) and transparent body. In addition, its genome was 
fully sequenced and it is possible to generate mutant strains (Waterston et al. 
1993). Moreover, RNA interference was established to be a powerful system of 
genetic silencing in C. elegans, thanks to the possibility to deliver double-
stranded interfering RNA to the nematode by feeding (Fire et al. 1998). C. 
elegans is particularly suitable to study bacterial infections because it naturally 
feeds on microorganisms and is susceptible to a variety of bacteria that are 
pathogenic also for mammals (Tan & Ausubel 2000). 
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P. aeruginosa was demonstrated to kill this nematode by two distinct modes 
according to the growth conditions. In low salt media, the highly virulent P. 
aeruginosa PA14 strain is able to colonize and accumulate in the nematode 
intestine, causing the death over 2-3 days ("slow killing"; Tan et al. 1999). The 
infectious process entails: i) severe distension of the intestinal lumen, with a 
consequent reduction in the volume of intestinal epithelial cells; ii) accumulation 
of an unidentified extracellular matrix in the intestinal lumen; iii) synthesis of 
outer membrane vesicles by P. aeruginosa; iv) abnormal autophagy in the 
intestinal cells (Irazoqui et al. 2010). By contrast, when grown in high salt media, 
P. aeruginosa PA14 kills the nematodes within 4-24 hours by the production of 
diffusible toxins, such as phenazines ("fast killing"; Mahajan-Miklos et al. 1999). 
It was demonstrated that phenazines exert their toxic activity through the in vivo 
generation of oxidative stress (Mahajan-Miklos et al. 1999). 
A transposon mutant library generated in PA14 strain was screened for 
attenuation of virulence in C. elegans to gain insights into the genetic basis 
underlying the pathogenesis of this bacterium (Feinbaum et al. 2012). The screen 
revealed that the major contributors to virulence appear to be genes implicated in 
the regulation of virulence effectors expression (lasR, rhlR, gacA, gacS) and 
nutrient assimilation (aru, glnK). Curiously, only a small subset of the virulence 
genes identified in the screening contribute to the infection also in mammalian 
hosts. This is probably due to discrepancies in both physico-chemical 
characteristics (temperature, pH, nutrient availability) and components 
participating in the immune response. 
The defence mechanisms that C. elegans induces upon pathogen recognition have 
not been completely understood. Although a Toll-receptor homolog, tol-1, is 
present in C. elegans genome, the genes encoding crucial components of the Toll 
signalling pathway of mammalian innate immunity seem to be absent. 
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Nevertheless, the expression of many immune response genes was found to be 
controlled by the PMK-1 p38 mitogen-activated protein kinase (MAPK), the 
terminal MAPK of the defence activating cascade that is present also in mammals 
(Troemel et al. 2006). The immune effectors induced by PMK-1 include 
defensin-like antimicrobial peptides, lysozyme and C-type lectins, proteins that 
bind sugar moieties on the surface of pathogens and stimulate phagocytosis. 
2.2. The Galleria mellonella model 
G. mellonella, or greater wax moth, is an insect of the Pyralidae family 
increasingly proposed as a new model to study bacterial infections. It is the larval 
stage of the wax moth that is used as animal model and the last instar larvae 
before pupation are those specifically employed for the infection assays. Like C. 
elegans, G. mellonella larvae are inexpensive, easy to be stored and have the 
advantage that they survive at 37 °C, allowing the investigation of temperature-
dependent microbial virulence factors, whereas C. elegans cultivation 
temperature spans from 15 to 25 °C. Larvae infection is performed by 
intrahemocoelic injection in one of the pseudopods. While this infection mode is 
too labour-intensive to allow the utilization of Galleria in high throughput 
screenings, it has the advantage that a controlled number of bacteria can be 
inoculated in each larva; this gives the opportunity to estimate the half-maximum 
lethal dose (LD50), a parameter commonly used to evaluate bacterial virulence 
(Ramarao et al. 2012). On the other hand, substantial limitations to this model 
are that its genome has not yet been sequenced and strategies to generate mutants 
have not been developed. Another problem is that the larvae are usually 
purchased from independent breeders who sell them as pet food. This implies that 
breeding conditions and larvae maintenance can influence the susceptibility to 
infections. 
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G. mellonella is sensitive to a wide range of gram-positive and gram-negative 
pathogens, such as P. aeruginosa (Tsai et al. 2016). Notably, the susceptibility 
of these larvae to P. aeruginosa infections is particularly high, with an LD50 of 
fewer than 10 bacteria observed for the PA14 strain (Jander et al. 2000; Miyata 
et al. 2003). The infectious process entails the bacterial dissemination into the 
larvae hemolymph, typically causing death by septicemia in less than 24 h. 
The possibility to perform the infection assays at 37°C led to investigate whether 
the P. aeruginosa virulence factors implicated in G. mellonella killing were also 
relevant in mammalian infections. Nevertheless, ambiguous results have been 
reported so far. A significant positive correlation between the virulence of PA14 
mutants in G. mellonella and in a burn mouse model was observed (Jander et al. 
2000). In contrast, the pathogenic capacity of P. aeruginosa strains, isolated from 
either diseased patients or the environment, resulted highly variable between G. 
mellonella and a murine airway model (Hilker et al. 2015). Interestingly, the G. 
mellonella model was found to be convenient to study the involvement of type 
III secretion system (T3SS) in P. aeruginosa pathogenesis (Miyata et al. 2003). 
The in vivo virulence of PA14 mutants in genes encoding T3SS effectors 
indicated that none of them is essential for G. mellonella killing, but the 
simultaneous inactivation of ExoT and ExoU is necessary to obtain a highly 
attenuated killing phenotype. A high level of correlation was observed between 
the results obtained in Galleria and those found in cytopathology assays 
performed with a mammalian tissue culture system. 
G. mellonella larvae appear to be also useful as animal model to test the in vivo 
efficacy of novel antimicrobial agents. As an example, this model was 
successfully exploited to demonstrate the efficacy of double and triple antibiotic 
combination therapies against a multidrug-resistant strain of P. aeruginosa 
(Krezdorn et al. 2014). A pre-screening with G. mellonella would reduce the 
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number of antibacterial candidates to be tested in mammalian models, with a 
significant reduction of times, costs and ethical issues. 
Compared to other invertebrates, insects have an advanced innate immune system 
similar to that of mammals and consisting of both a cellular and a humoral 
response. The cellular response is mediated by phagocytic cells, termed 
hemocytes, located within the hemolymph. G. mellonella has 6 different types of 
hemocytes involved in bacterial encapsulation and phagocytosis (Table 2; Tsai 
et al. 2016). 
Table 2. Elements of cellular and humoral immune responses in G. mellonella 
 
 Modified from Tsai et al. 2016. 
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The humoral response depends on the activity of soluble effector molecules that 
recognize, immobilize and kill pathogens. In G. mellonella, the humoral response 
relies on the production of opsonins and antimicrobial peptides, and on 
melanization (Table 2; Tsai et al. 2016). As mammalian pattern recognition 
receptors, opsonins recognize and bind to conserved bacterial structures, making 
them visible to the immune system. Apolipophorin-III (apoLp-III), the major 
opsonin of Galleria, specifically binds the bacterial lipopolysaccharide and 
lipoteichoic acid, stimulating the hemolymph antimicrobial activity (Niere et al. 
1999). Another recognized bacterial component is peptidoglycan, which is bound 
by peptidoglycan recognition proteins (PGRPs) through a conserved domain 
homologous to T4 phage lysozyme. 
G. mellonella produces 18 known or putative antimicrobial peptides (AMPs), 
including lysozyme, cecropins, moricins and defensins. Lysozyme disrupts cell 
wall peptidoglycan by cleaving the β-1, 4 bond between N-acetylglucosamine 
and N-acetylmuramic acid. Cecropins and moricins are amphipathic peptides 
able to create pores in the cytoplasmic membrane of both gram-positive and 
gram-negative bacteria, resulting in ion leakage. Defensins are cationic peptides 
causing the formation of voltage-dependent ion channels in the cytoplasmic 
membrane and triggering ion leakage and cell lysis. 
Melanization represents the synthesis and deposition of melanin around invading 
pathogens to promote their encapsulation and opsonisation. This process starts 
with the formation of black dots on the larvae surface and leads to complete 
browning before larvae death (Fig. 3). 
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Melanin formation depends on the activity of phenoloxidase (PO), that is 
produced as the inactive form pro-phenoloxidase (Pro-PO) in hemocytes. The 
activation of Pro-PO to PO by cleavage occurs upon pathogen recognition and 
catalyses the conversion of phenols to quinines, which non-enzymatically 
polymerize to form melanin at the site of infection. 
3. Glucose homeostasis and bacterial infections 
Hyperglycaemia is a pathological disruption of glycaemic control systems 
causing an abnormal increase in glucose blood concentration. Indeed, 
hyperglycaemia was defined as a blood glucose concentration ≥ 7 mM, compared 
to 4-5.5 mM of healthy individuals (Baker et al. 2006). Pathologies leading to 
hyperglycaemia, such as diabetes mellitus (DM), are associated with an increased 
probability to develop serious bacterial infections and, indeed, patients with 
diabetes have a 4.4 higher risk of bloodstream infection than non-diabetics 
(Stoeckle et al. 2008). This enhanced susceptibility to bacterial infections is 
related with both immunity dysfunction due to hyperglycaemia and the glucose-
stimulating effect on the growth of bacterial pathogens such as P. aeruginosa and 
S. aureus (Baker et al. 2006). 
Fig. 3. The stages of G. mellonella melanisation upon bacterial infection. Modified from Tsai et al. 
2016. 
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Hyperglycaemia can impair the innate immune system by interfering with the 
activity of polymorphonuclear neutrophils (PMNs) (Geerlings & Hoepelman 
1999; Peleg et al. 2007). All the steps of PMNs functioning, i.e. adherence to the 
site of infection, transmigration through the vessels, phagocytosis and microbial 
killing, are affected in diabetic patients (Delamaire et al. 1997; Geerlings & 
Hoepelman 1999). In particular, it was demonstrated that superoxide production 
by PMNs is reduced in diabetics, due to the diversion of NADPH into the polyol 
pathway, a process converting the excess of glucose into sorbitol (Mazade & 
Edwards 2001). Moreover, a consequence of hyperglycaemia is the formation of 
excessive advanced glycation end products (AGEs), a group non-enzymatically 
and irreversibly glycated macromolecules interfering with neutrophil functions. 
Indeed, AGE albumin was able to inhibit neutrophils trans-endothelial migration 
and S. aureus-mediated production of reactive oxygen species (Collison et al. 
2002). 
On the other hand, infections are a major cause of stress-induced hyperglycaemia. 
The release of cytokines during the inflammatory process caused by infection 
results in failure of insulin to repress hepatic gluconeogenesis, thus increasing 
blood glucose levels (McCowen et al. 2001). In this way, a vicious circle between 
inflammation and hyperglycaemia is established. 
3.1. Common infections in hyperglycaemic subjects 
The most recurring bacterial infections in diabetic patients are in order: urinary 
tract infections (UTIs), respiratory infections, soft tissue infections and 
bacteraemia (Peleg et al. 2007; Burekovic et al. 2014). 
The most common bacterial pathogens isolated in the urine of diabetic subjects 
with UTI are E. coli and other Enterobacteriaceae (Klebsiella spp, Proteus spp 
and Enterobacter spp) and Enterococci (Peleg et al. 2007). Moreover, this 
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patients are more prone to have resistant pathogens as cause of their UTI, due to 
the frequent antibiotic treatments to which they are subjected and the increased 
incidence of hospital-acquired UTIs (Nitzan et al. 2015). 
Hyperglycaemia is associated with augmented risk of contracting community 
acquired pneumonia (CAP; Baker et al. 2006). There is a wide spectrum of 
bacteria implicated in CAP, with an over-representation of S. aureus and gram-
negative pathogens (Baker et al. 2006). Patients with chronic obstructive 
pulmonary disease (COPD) have increased presence of gram-negative pathogens 
in their sputum when blood glucose levels raise (Loukides & Polyzogopoulos 
1996). Together with S. aureus, P. aeruginosa is the major responsible for lung 
infections in hyperglycaemic subjects, thanks to its ability to use the excess of 
glucose in airway secretions for the growth (see details in Section 3.2). 
Diabetic foot ulcer and necrotizing fasciitis are the most frequent soft-tissue 
infections in diabetics. Aerobic gram-positive cocci (especially S. aureus) are the 
predominant microorganisms in diabetic foot infections, but patients with chronic 
wounds may be also infected by gram-negative rods like P. aeruginosa (Lipsky 
et al. 2006). Both polymicrobial and monomicrobial infections are related to 
necrotizing fasciitis, with gram-positive (Streptococcus, Staphylococcus, 
Clostridium) and gram-negative (Vibrio) species involved (Iacopi et al. 2015). 
Community-acquired bacteraemia caused by E. coli and other enterobacteria has 
higher incidence and poorer outcome in diabetic patients, when compared with 
non-diabetic individuals (Thomsen et al. 2005). Diabetes is also a major risk for 
community-acquired pneumococcal bacteraemia (Thomsen et al. 2004). 
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3.2. Hyperglycaemia exacerbates P. aeruginosa lung infections 
The apical surface of airway epithelia is covered by a layer of fluid, the Airway 
Surface Liquid (ASL), that is normally maintained sterile thanks to the activity 
of antimicrobials and innate immune components, and to mucociliary clearance 
(Bartlett et al. 2008). The ASL contains also factors necessary for bacterial 
growth, such as proteins, lipids and sugars, that are cleared from this layer when 
in excess. In particular, it was observed that glucose deprivation from the ASL is 
pivotal to safeguard the sterility of the airways (Pezzulo et al. 2011). Indeed, 
glucose levels in the ASL of healthy subjects are maintained very low (~ 0.4 mM; 
12 times lower than glucose blood concentration), in spite of a big trans-epithelial 
gradient for the passive transport of glucose from blood to ASL (Baker et al. 
2007). The restriction of ASL glucose concentration is mediated by: i) the 
epithelial tight junctions, which are poorly permeable to glucose; ii) glucose 
metabolism in the epithelial cells; iii) the presence of apical and basolateral 
facilitative glucose transporters (GLUTs) permitting the passive movement of 
glucose across cell membranes to maintain glucose homeostasis (Fig. 4A; Baker 
& Baines 2018). 
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Both hyperglycaemia and airway inflammation promote the disruption of airway 
glucose homeostasis, increasing the levels of glucose in the ASL (Fig. 4B). 
Diabetes elevates the glucose trans-epithelial gradient in the airways, leading to 
an ASL glucose concentration of about 1.2 mM (Baker et al. 2007). In cystic 
fibrosis (CF) patients, who have chronic lung inflammation, glucose in the ASL 
reaches a concentration of 2 mM (Baker et al. 2007). The reason for this 
phenomenon is the increase in paracellular glucose diffusion across the airway 
epithelium into ASL, due to the altered expression of epithelial tight junction 
Fig. 4. Glucose homeostasis is essential for airways sterility. A. In healthy subjects, ASL glucose 
levels are very low (~ 0,4 mM) thanks to functional epithelial tight junctions, epithelial glucose 
metabolism and glucose transporters (GLUTs). This limits the growth of bacteria in the ASL (orange 
and blue circles). B. Airway glucose homeostasis can be disrupted by hyperglycaemia, which 
increases the glucose gradient towards ASL, and inflammation, which enhances the permeability of 
tight junctions. The resulting higher glucose levels in the ASL stimulates the growth of bacteria able 
to use glucose as carbon source (orange circles). From Baker & Baines 2018. 
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proteins (Garnett et al. 2013). The high ASL glucose concentration was 
demonstrated to stimulate the growth of respiratory pathogens, such as P. 
aeruginosa, able to use glucose as carbon source for growth (Garnett et al. 2013). 
P. aeruginosa proliferation triggers the production of virulence factors that can 
damage the airway epithelium, thus enhancing the inflammatory response and 
the paracellular glucose movement into the ASL (Garnett et al. 2013). In this 
way, a vicious circle among bacterial proliferation, inflammation and glucose 
flux into the ASL is established. 
P. aeruginosa pulmonary infections are particularly severe in people that are 
subjected to both airway inflammation and hyperglycaemia. This is the case of 
cystic fibrosis related diabetes (CFRD) patients. CFRD is the most common 
comorbidity in CF subjects, with an incidence 20% in adolescents and 40-50% 
in adults (Moran et al. 2009). Survival is significantly affected in people with 
CFRD, with fewer than 25% surviving to an age of 30, compared to 60% of non-
diabetic CF patients (Finkelstein et al. 1988). One of the main reasons for the 
greater mortality of CFRD subjects is the accelerated decline in lung function 
(Koch et al. 2001). It was proved that ASL glucose levels are further elevated to 
4 mM in people with CFRD (Baker et al. 2007). This additional perturbation in 
airway glucose homeostasis exacerbates the aforementioned vicious circle in 
CRFD airways, contributing to the worse outcome of bacterial lung infections 
observed in these patients. 
The glucose-dependent stimulation of P. aeruginosa lung proliferation was also 
shown in murine models of hyperglycaemia, CF and CFRD (Gill et al. 2016; 
Hunt et al. 2014). P. aeruginosa burden is clearly higher in the lungs of 
hyperglycaemic mice, which have significantly greater airway glucose, and in 
non-diabetic CF mice (Fig. 5; Hunt et al. 2014). Diabetic CF mice showed a 
minor bacterial clearance from their lung compared to both hyperglycaemic and 
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CF mice, leading to a further increase in P. aeruginosa load (Fig. 5; Hunt et al. 
2014). 
 
 
The increased proliferation of P. aeruginosa in the lungs of diabetic mice is a 
direct consequence of its ability to metabolize the excessive ASL glucose, since 
it was not observed in some mutant strains in which glucose uptake and 
utilization genes were deleted (see Section 4.4; Pezzulo et al. 2011; Gill et al. 
2016). 
 
 
 
Fig. 5. P. aeruginosa clearance from mice lungs. Lung homogenate colony-forming units (CFUs) 
recovered 18 h after P. aeruginosa PAO1 infection of wt mice, hyperglycaemic mice (wt+stz), cystic 
fibrosis mice (cf) and diabetic CF mice (cf+stz). The dashed line indicates the clearance threshold, 
based on 3-times the standard deviation above the mean value obtained in wt mice. 
*P < 0.05, **P < 0.01. From Hunt et al. 2014. 
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4. P. aeruginosa glucose metabolism 
4.1. Metabolic versatility and hierarchical management of carbon 
sources in P. aeruginosa 
Pseudomonas spp. usually inhabit environmental niches characterized by a 
restricted presence of sugars. This is probably the reason why the bacteria of this 
genus can metabolize a very limited number of sugars (glucose, glycerol, 
mannitol and fructose), despite their huge metabolic versatility, which allows 
them to use many different compounds as carbon and energy sources. However, 
metabolic versatility must be fine-tuned to guarantee a rapid adaptation to the 
frequently changed environmental conditions and optimize the ecological fitness. 
In this respect, bacteria adopt a regulatory process, named Carbon Catabolite 
Repression (CCR), to preferentially use the carbon source providing the most 
efficient growth and to concurrently inhibit the uptake and catabolism of all the 
other exploitable compounds. Therefore, CCR leads to a hierarchy in the 
consumption of the different carbon sources.  
The regulatory factor operating CCR in P. aeruginosa is the Crc protein. Crc is 
an RNA-binding protein that inhibits the expression of genes for the uptake and 
catabolism of the non-preferred carbon sources by associating to their mRNAs 
and preventing the formation of a productive translation initiation complex (Rojo 
2010; Fig. 6a). The CrcZ small RNA regulates Crc availability. Indeed, this 
sRNA contains five Crc binding sites and is able to sequester the regulator in 
conditions that produce low or no CCR (Rojo 2010; Fig. 6b). 
crcZ expression is directly activated by the CbrA/CbrB two-component system 
(TCS) and the RpoN sigma factor (Sonnleitner et al. 2009). The CbrA/B TCS is 
required for the expression of genes involved in the utilization of several carbon 
and nitrogen sources, including mannitol, glucose, arginine, histidine and proline 
 37 
 
(Nishijyo et al. 2001). It was suggested that this TCS works co-ordinately with 
the NtrB-NtrC TCS, which regulates amino acids catabolism, to balance the 
carbon-nitrogen ratio in the cell (Nishijyo et al. 2001; Li & Lu 2007). However, 
the specific signals inducing the autophosphorylation of the CbrA sensor are 
currently unknown. 
 
 
Fig. 6. Regulation of CCR in P. aeruginosa. (a) Activity of the Crc protein. Crc binds at specific sites 
of target mRNAs close to the AUG translation start site, interfering with the formation of a productive 
translation initiation complex. (b) Crc regulation by the CrcZ sRNA. CrcZ contains five Crc-binding 
sites in its structure and can sequester Crc under conditions that generate low or no CCR. CrcZ levels 
depend on the CbrA/B two-component system, according to the carbon sources present in the medium. 
From Rojo 2010.  
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CrcZ sRNA was exploited as a bioindicator of CCR. A chromosomal crcZ-gfp 
fusion was created to monitor the contribution of different carbon sources to CCR 
(Fig 7; Valentini et al. 2014). The stronger is the activation of CCR, the lower is 
the expression of crcZ and thus fluorescence. As expected, C4 dicarboxylates 
(fumarate, malate and succinate), the preferred carbon source for P. aeruginosa, 
are the stronger inducer of CCR. In contrast, glucose causes an intermediate 
induction of CCR, being used less efficiently than C4 dicarboxylates, but more 
efficiently than other sugars (mannitol) and amino acids. 
 
Fig. 7. Carbon source dependent activation of crcZ in P. aeruginosa. The expression of the crcZ-
gfp fusion was monitored in P. aeruginosa PAO1 grown to mid-log phase in minimal medium, 
supplemented with the indicated carbon sources, or in LB medium. Fluorescence values are relative 
to crcZ-gfp expression in the presence of oxaloacetate (OAA). From Valentini et al. 2014. 
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4.2. Glucose metabolism in P. aeruginosa 
Glucose metabolism was first clarified in P. putida as a three-pronged metabolic 
process converting glucose to 6-phosphogluconate (6-PG; del Castillo et al. 
2007). All the key enzymes for the synthesis of 6-PG from glucose are also 
present in P. aeruginosa, with a very high sequence conservation ranging from 
70% to 95% similarity (del Castillo et al. 2007). A schematic representation of 
glucose metabolism in Pseudomonas spp. is depicted in Fig. 8. 
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Glucose can cross the outer membrane (OM) barrier through the OprB and OprB2 
selective porins. OprB does not strictly function as a glucose-selective porin, but 
Fig. 8. Glucose metabolism in Pseudomonas spp. The genes for glucose uptake and catabolism, 
indicated in italics, are: gcd, glucose dehydrogenase; gad, gluconate dehydrogenase; gntP, gluconate 
permease; kguT, 2-ketogluconate transporter; glk, glucokinase; gnuK, gluconokinase; 
kguK, 2-ketogluconate kinase; zwf, glucose-6-P-dehydrogenase; kguD, 2-ketogluconate reductase; 
pgi, glucose-6-P-isomerase; fbp, fructose diphosphatase; fda, fructose diphosphate aldolase; 
edd, phosphogluconate dehydratase; eda, 2-keto-3-deoxy gluconate aldolase. 
OM, outer membrane; IM, inner membrane; PG, periplasmic space. From del Castillo et al. 2007. 
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has a broad specificity, facilitating the diffusion of several carbohydrates, 
including mannitol, glycerol and fructose (Wylie & Worobec 1995). Even though 
at a quite reduced rate, OprB null-mutants still retain the capability to transport 
glucose, suggesting that glucose can non-specifically diffuse across the OM 
through other porins (Wylie & Worobec 1995). A second porin, OprB2, appears 
to be implicated in glucose transport across the OM. This porin has the same size 
and is 95% identical to OprB (Chevalier et al. 2017). 
Unlike most bacteria, the intake of glucose in Pseudomonas spp. is not dependent 
on the phosphotransferase system, a multiprotein phosphorelay coupling the 
transport of carbohydrates across the inner membrane (IM) with their 
concomitant phosphorylation. Instead, once crossed the OM, periplasmic glucose 
can be internalized into the cytoplasm and metabolized to 6-phosphogluconate 
by two distinct pathways: the phosphorylative and oxidative routes of glucose 
uptake (Fig. 8; Udaondo et al. 2018).  
In the phosphorylative pathway, glucose is directly transported as free sugar 
across the IM by Glt, an ABC transporter consisting of three components: the 
permease, encoded by gltF and gltG, the ATP-binding protein, encoded by gltK, 
and the periplasmic binding protein, encoded by gltB (Adewoye & Worobec 
2000). Once reached the cytoplasm, glucose is phosphorylated by glucokinase 
(GlK) to give glucose-6-phosphate (G6P). Next, the NADP-dependent glucose-
6-phosphate dehydrogenase (Zwf) converts G6P to 6-phosphogluconolactone, 
which is then transformed to 6-phosphogluconate by the 6-
phosphogluconolactonase (Pgl) (Ma et al. 1998; Hager et al. 2000). 
On the other hand, in the oxidative pathway, periplasmic glucose is oxidized to 
gluconate by the membrane-bound glucose dehydrogenase (Gcd), which uses 
pyrroloquinoline quinone (PQQ) as cofactor (Midgley & Dawes 1973). At this 
stage, gluconate can be transported into the cytoplasm or further oxidized in the 
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periplasm to 2-ketogluconate (2-KG). Gluconate internalization is mediated by 
the GntP gluconate permease, a predicted gluconate:H+ symporter, whereas its 
oxidation to 2-KG depends on the activity of the Gad gluconate dehydrogenase, 
a membrane-bound enzyme supposed to use FAD as cofactor (Roberts et al. 
1973). In turn, 2-KG can enter the cytoplasm through the KguT ketogluconate 
transporter, a putative anion:cation symporter (Swanson et al. 2000). Once in the 
cytoplasm, gluconate and 2-KG are respectively phosphorylated to 6-
phosphogluconate and 2-keto-6-phosphogluconate by gluconate kinase (GnuK) 
and 2-ketogluconate kinase (KguK) (Swanson et al. 2000). Finally, 2-keto-6-
phosphogluconate is reduced by the NADP-dependent KguD reductase to give 
6-phosphogluconate (Swanson et al. 2000). 
Then, the convergent product of glucose metabolism, 6-phospogluconate (6-PG), 
enters the Entner-Doudoroff (ED) pathway, a series of reactions alternate to 
glycolysis (Lessie & Phibbs 1984). Indeed, P. aeruginosa lacks the glycolytic 
phosphofructokinase and thus exploits the ED route to obtain glyceraldehyde-3-
phosphate (G3P) and pyruvate from 6-PG by a two-step reaction. At first, the 6-
phosphogluconate dehydratase (Edd) transforms 6-PG to 2-keto-3-deoxy-6-
phosphogluconate (KDPG), which is then hydrolysed to produce G3P and 
pyruvate by the KDPG aldolase (Eda). While pyruvate is decarboxylated to 
acetyl-CoA and enters the Krebs cycle, G3P may be converted to pyruvate, by 
lower glycolytic pathway, or recycled to 6-PG via gluconeogenic enzymes (Fda 
fructose diphosphate aldolase, Fbp fructose diphosphatase and Pgi 
phosphoglucoisomerase). This cyclic ED pathway helps in the generation of 
more reducing power in terms of NADPH cofactor. 
Metabolic flux analysis in P. aeruginosa under high glucose concentrations 
revealed that the carbon flow through the oxidative route is 10-fold higher that 
that entering by the Glt uptake system (Midgley & Dawes 1973). 
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4.3. Genetic organization and transcriptional regulation of glucose 
metabolic genes in P. aeruginosa 
P. aeruginosa glucose metabolism genes are highly organized, with the genes 
belonging to the distinct catabolic segments arranged in operons under the control 
of different regulators, namely HexR, PtxS, GntR, and the GltR/GtrS two-
component system (Fig. 9; Udaondo et al. 2018). 
 
 
Concerning the genomic organization of glucose uptake and catabolic genes, it 
can be observed that: 
• The kgu genes for 2-ketogluconate uptake and catabolism are organized in an 
operon immediately downstream ptxS, the gene coding for the transcriptional 
Fig. 9. Genetic organization of glucose metabolic genes in P. aeruginosa. Glucose metabolic 
genes are divided in four blocks according to their respective regulators, indicated above each block. 
The black arrows on genes represent the promoter. Only the promoters relevant for the thesis are 
reported. The regulation of each block is detailed in the text. Modified from Udaondo et al. 2018. 
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regulator of this metabolic branch (Swanson et al. 2000; Daddaoua et al. 
2012). The other operon regulated by PtxS is gad, encoding gluconate 
dehydrogenase and located next to the kgu genes (Daddaoua et al. 2012). The 
expression of kgu and gad is also controlled by another transcriptional 
regulator, ptxR, located next to and transcribed divergently from ptxS 
(Hamood et al. 1996). 
• The gntR gene, coding for the transcriptional regulator of gluconate metabolic 
branch, is divergently transcribed from gluconokinase gnuK, which is located 
adjacent to gluconate permease gntP (Daddaoua et al. 2017). The three genes 
are transcribed as monocistronic units. 
• The Entner-Doudoroff genes edd and eda do not belong to the same operon. 
Indeed, edd is located between glyceraldehyde 3-phosphate dehydrogenase 
gap-1 and the glk operon, comprising glucokinase glk, and the genes for the 
GltR/GtrS TCS. The gtrS gene precedes the oprB operon, encompassing the 
genes for the OprB porin and the Glt transporter. The eda gene is part of an 
operon also including glucose-6-phosphate dehydrogenase zwf and 6-
phosphogluconolactonase pgl. The gene for the HexR regulator is 
immediately upstream this operon and transcribed in opposite direction. 
Besides being highly organized, glucose catabolic segments are also tightly 
regulated by the concerted action of HexR, PtxS, GntR and the GltR/GtrS two-
component system (TCS), which guarantee a simultaneous induction of all 
glucose metabolic routes. Interestingly, glucose is not the effector molecule of 
any of these systems, which differentially respond to distinct pathway 
intermediates. Thus, the activation of glucose metabolism requires the initial 
degradation of glucose. 
A comprehensive scheme of glucose metabolism regulators, with an indication 
of their effectors and target genes, is depicted in Fig. 10. 
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The HexR regulator belongs to the RpiR family and was demonstrated to 
negatively regulate the expression of zwf/pgl/eda and edd/glk/gltR/gtrS operons, 
as well as of gap-1 gene, in P. putida (Daddaoua et al. 2009). The HexR-mediated 
regulatory mechanism seems to be highly conserved in pseudomonads, 
considering that the physical organization of these genes is maintained within 
Pseudomonas (del Castillo et al. 2007). HexR operator sites were identified in 
zwf, edd and gap-1 promoters and led to the identification of the 5’-TTG-N7/8-
ACAA-3’ consensus sequence (Daddaoua et al. 2009). Binding of the Entner-
Doudoroff intermediate 2-keto-3-deoxy-6-phosphogluconate (KDPG) to DNA-
bound HexR triggers the dissociation of the regulator, enabling transcriptional 
activation (Daddaoua et al. 2009). 
Fig. 10. The regulatory network of P. aeruginosa glucose metabolism. The regulators involved in 
glucose metabolism are indicated in the circles with different colours. The respective target genes are 
represented in the rectangles with the same colour code. The – and + symbols indicate repression or 
activation of gene expression respectively. The effector molecules are placed above the regulatory 
network, with the dashed arrows pointing the regulator(s) they bind. 
KDPG, 2-keto-3-deoxy-6-phosphogluconate; 6-PG, 6-phosphogluconate; 2-KG, 2-ketogluconate. 
Modified from Udaondo et al. 2018. 
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PtxS is a repressor of the LacI family that binds to the palindromic sequence 5’-
TGAAACCGGTTTCA-3’ immediately downstream of the transcriptional start 
sites of kgu and gad operons in P. aeruginosa (Daddaoua et al. 2012). Besides 
controlling the expression these operons, PtxS was demonstrated to regulate its 
own expression in P. putida (Daddaoua et al. 2010). Interestingly, in P. 
aeruginosa PtxS post-transcriptionally regulates PtxR, a transcriptional activator 
of kgu/gad operons and toxA, the exotoxin A coding gene (Hamood et al. 1996; 
Daddaoua et al. 2012). It was proved that 2-ketogluconate is the effector molecule 
releasing PtxS-dependent repression (Daddaoua et al. 2012). 
GntR is a transcriptional repressor of both its own and gntP expression 
(Daddaoua et al. 2017). This regulator binds directly to the consensus sequence 
5’-AC-N-AAG-N-TAGCGCT-3’ in gntR and gntP promoters. The release of 
promoter-bound GntR is induced by gluconate and 6-phosphogluconate, the 
allosteric inducers of this repressor. GntR was demonstrated to be a paralogous 
of PtxS, with 23% sequence identity (Daddaoua et al. 2017). 
The GltR/GtrS TCS regulates the expression of several genes involved in glucose 
metabolism: gap-1, edd and those belonging to oprB and glk operons (Daddaoua 
et al. 2014). GtrS is the transmembrane sensor kinase, endowed with a 
periplasmic ligand binding domain specifically recognizing 2-ketogluconate and 
6-phosphogluconate. The binding of these effector molecules to GtrS triggers its 
autophosphorylation and the transphosphorylation of GltR response regulator. 
GltR acts as a transcriptional repressor of the aforementioned genes, and it is 
released from DNA upon phopsphorylation. The analysis of GltR operator sites 
determined the consensus sequence as 5’-tgGTTTTTc-3’ (Daddaoua et al. 2014). 
Most importantly, GltR was demonstrated to regulate also toxA expression (see 
details in Section 4.4). 
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An overview of this complex regulatory network suggests that there are two key 
metabolites implicated in the induction of glucose metabolism: 2-ketogluconate 
(effector of PtxS and GltR/GtrS) and 6-phosphogluconate (effector of GntR and 
GltR/GtrS). Moreover, the presence of the GltR/GtrS TCS among the regulators 
broadens the transcriptional response also to extracytosolic signals. 
4.4. Involvement of glucose metabolic genes in P. aeruginosa virulence 
As previously mentioned in Section 3.2, a link between glucose metabolism and 
colonization of the respiratory tract by P. aeruginosa has been established. 
Indeed, studies in hyperglycaemic mice revealed that deletions of glucose 
metabolic genes cause a clear reduction of P. aeruginosa lung proliferation. This 
decrease was observed for mutants defective in genes involved in glucose 
transport (oprB and gltK), catabolism (glk, edd) and belonging to its regulatory 
network (gtrS) (Pezzulo et al. 2011; Gill et al. 2016). 
Besides their growth-promoting role, glucose metabolic genes were found to 
participate in the expression of P. aeruginosa virulence factors. For example, the 
GtrS sensor kinase was discovered to be relevant for P. aeruginosa dissemination 
in a mouse infection model by modulating the expression of type III secretion 
system (T3SS) in response to host cells (O’Callaghan et al. 2012). In particular, 
the GtrS/GltR-dependent induction of OprB leads to the production of pyruvate 
metabolic intermediates that activate the Anr-NarL anaerobic pathway; NarL, in 
turn, promotes the activation of ExsA, the positive transcriptional regulator of 
T3SS. 
Furthermore, a direct connection between glucose assimilation and exotoxin A 
production was established. Indeed, both GltR/GtrS TCS and PtxS were shown 
to regulate toxA expression, albeit through different mechanisms. The GltR 
response regulator is able to bind PtoxA promoter in the proximity of the 
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transcriptional start site and probably inhibits toxA transcription by interfering 
with RNA polymerase recruitment (Daddaoua et al. 2014). In contrast, PtxS 
indirectly controls exotoxin A biosynthesis by affecting the activity of PtxR 
transcriptional activator. Interestingly, 2-ketogluconate is the allosteric inducer 
of both PtxS and GltR/GtrS TCS, supporting the relevance of this glucose 
metabolism intermediate in the expression of exotoxin A. 
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RESULTS AND DISCUSSION 
5. Generation of P. aeruginosa mutants with deletions of glucose 
uptake genes 
A panel of single and multiple mutants of P. aeruginosa PAO1 lacking genes 
implicated in glucose uptake were constructed by gene replacement (see Raneri 
et al., Supplementary Methods for details). The single mutants carry the 
untagged deletion of the genes for the outer membrane (OM) OprB porin, its 
paralogue PA2291 (encoding the OprB2 porin), the inner membrane (IM) GntP 
gluconate permease and the KguT ketogluconate transporter (Raneri et al., Fig. 
1a and 1b). These mutations were combined to create strains lacking the glucose 
porins (ΔoprB ΔPA2291) or the transporters involved in the oxidative route of 
glucose uptake (ΔgntP ΔkguT). Despite various attempts, it was impossible to 
obtain a mutant lacking gltK, the gene coding for the ATP-binding subunit of Glt 
IM glucose transporter, whereas we could obtain the deletion of a portion of gltK 
(234 out of the 386 codons) together with gltG and gltF, i.e. the permease 
subunits encoding genes (Raneri et al., Fig. 1b). The resulting Δglt mutation was 
inserted in both PAO1 and the ΔgntP ΔkguT double mutant to generate a strain 
devoid of the GntP, KguT and Glt IM glucose transporters. 
6. Growth of OM and IM mutants on different carbon sources 
The mutants were analysed for the ability to grow in minimal medium in the 
presence of glucose or gluconate as sole carbon sources, in order to investigate 
whether the deleted transporters are essential for the transport of such molecules. 
As a control, growth in succinate was also analysed. Indeed, succinate 
internalization was demonstrated to specifically rely on the Dct dicarboxylates 
transport systems (Valentini et al. 2011). The optical density of PAO1 wild type 
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(PAO1) and mutant strains was monitored for 7 h, to analyse their growth curves, 
and after 24 h of incubation.  
▪ OM mutants 
We found that the deletion of either one or both OprB and OprB2 glucose porins 
did not affect growth on glucose, which was comparable to that of PAO1 (Raneri 
et al., Fig. 2a and Supplementary Fig. S1). These results indicate that other 
porins may facilitate glucose entry into the periplasm. In agreement with this 
observation, gluconate entry can be promoted by the OprD porin, which allows 
also the diffusion of basic amino acids and imipenem (Huang & Hancock 1993). 
Moreover, since the OprF non-specific porin has a predominant role in the 
internalization of sugar larger than disaccharides in P. aeruginosa (Bellido et al. 
1992), it cannot be ruled out that it may also permit the passage of glucose in the 
absence of glucose-specific porins.  
It has been recently published that the growth of a PAO1 ΔoprB mutant in 
minimal medium supplemented with glucose is limited when compared to that of 
the wild type strain (Gill et al. 2016). This discrepancy with our results can be 
ascribed to a differential expression of genes encoding alternate OM glucose 
transporters in different PAO1 sublines (Klockgether et al. 2010). Interestingly, 
a hotspot of mutation in PAO1 genomes is the mexT gene, which codes for a 
repressor of OprD expression (Ochs et al. 1999). 
▪ IM mutants 
Concerning the mutants lacking IM transporters, the ΔgntP and ΔkguT single 
mutants reached comparable optical density as PAO1 after 24 h of incubation in 
all tested media (Raneri et al., Fig. 2b), although the ΔgntP strain showed a 
longer lag phase in glucose and gluconate and slower growth rate in the latter 
medium (Raneri et al., Table 1 and Supplementary Fig S1). These two mutants 
were also evaluated for growth with 2- ketogluconate (2-KG) as unique carbon 
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source to discriminate the GntP and KguT roles in the uptake of gluconate and 2-
KG. Unlike ΔgntP, the ΔkguT strain did not grow with 2-KG as sole carbon 
source (Raneri et al., Fig. 2c), confirming that 2-KG internalization is performed 
only by the KguT transporter (Swanson et al. 2000). The combination of ΔgntP 
and ΔkguT mutations resulted in a double mutant totally unable to use gluconate 
as unique carbon source (Raneri et al., Fig. 2b and Supplementary Fig. S1). 
The ΔgntP ΔkguT double mutant had also restricted growth on glucose, as ΔgntP 
ΔkguT cultures had a slower growth rate and reached the half of the optical 
density of PAO1 cultures grown in the same conditions for 24 h (Raneri et al., 
Table 1, Fig. 2b and Supplementary Fig. S1). In contrast, the Δglt mutant was 
able to grow on glucose as PAO1 (Raneri et al., Table1 and Fig. 2b). Finally, 
the deletion of the IM transporters in the Δglt ΔgntP ΔkguT triple mutant 
completely prevents growth on glucose or gluconate as sole carbon source 
(Raneri et al., Fig 2b and Supplementary Fig. S1). Being this mutant unable to 
use glucose for growth, it was renamed GUN, i.e. Glucose Uptake-Null. 
These data demonstrate that Glt, GntP and KguT are the unique transporters that 
can accomplish the passage of glucose across the IM in PAO1, with GntP and 
KguT specifically involved in the transport of gluconate and 2-ketogluconate (2-
KG), respectively. In the conditions of temperature and aeration of our assay, the 
oxidative route can entirely overcome the inability to perform glucose uptake by 
the phosphorylative route. In contrast, glucose transport by Glt cannot offset the 
lack of both gluconate and 2-KG transporters. This could be due to periplasmic 
glucose oxidation, which would convert glucose in molecules (i.e. gluconate and 
2-KG) that cannot be transported by Glt. 
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7. The lack of glucose transporters deeply impacts P. aeruginosa 
gene expression profile 
The availability of the GUN mutant allowed to examine how preventing glucose 
uptake might affect P. aeruginosa physiology through the analysis of the global 
transcription profile of this mutant strain in comparison with PAO1.  
RNASeq samples were collected 10 and 60 min after the supplementation of 
0.4% glucose to PAO1 and GUN cultures grown up to mid-log phase (OD600 ~ 
0.4) in M9 minimal medium supplemented with casamino acids (CAA), which 
can be used by P. aeruginosa as unique carbon source. It should be noted that 
casamino acids stock solution used for medium preparation is devoid of glucose 
(Raneri et al., Supplementary Fig. S2). Moreover, the growth of PAO1 and 
GUN strains in M9-CAA supplemented with glucose and of PAO1 in either 
presence or absence of glucose is comparable for the timespan of the experiment, 
with the mutant having a slightly lower growth rate (Raneri et al., 
Supplementary Fig. S3; Fig. 11). 
During my PhD training, I focused on the transcriptomic analysis of the 60 min 
condition, whose results were validated by RT-qPCR and phenotypic assays. The 
data are illustrated in the attached article and will be briefly presented and 
discussed in this section. The transcriptomic data of the 10 min condition will be 
illustrated in a separate section (Section 11). 
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We expected to identify as differentially expressed genes those responding to the 
presence of glucose, or its metabolites, and possibly other genes specifically 
responding to the lack of IM glucose transporters. The transcriptional analysis of 
PAO1 grown as described above (namely in M9 minimal medium supplemented 
with casamino acids) without glucose supplementation was included to 
discriminate between these two categories. Genes with at least two-fold 
differential expression (i.e. with a log2FC ≥ 1 or ≤ -1) and an adjusted P value ≥ 
0.05 were considered as differentially expressed in the evaluation of RNASeq 
results. For a subset of differentially expressed genes, RT-qPCR was performed 
to validate transcriptomic data (Raneri et al., Fig. 3b). 
Only 28 genes were identified as differentially expressed (DEGs) in PAO1 60 
min upon glucose addition (PAO1+ vs. PAO1; Raneri et al., Fig. 3a), with 24 
up-regulated and 4 down-regulated genes. On the contrary, when the PAO1+ 
transcriptome was compared to that of the GUN mutant grown in the same 
conditions, we found 514 DEGs (GUN+ vs. PAO1+; Raneri et al., Fig. 3a), with 
256 up-regulated and 258 down-regulated genes. Interestingly, a comparable and 
high number of DEGs (549) was identified in the comparison of GUN 
Fig. 11. Growth of PAO1 and GUN cultures 
in the RNASeq experiment. Generation time 
of PAO1 and GUN cultures in the 60 min of 
incubation with glucose 0.4% (w/v). Bars 
represent average (n=2) with SD. Empty bars, 
no glucose added; grey bars, culture 
supplemented with glucose. 
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transcriptional profile with that of PAO1 grown in absence of glucose (GUN+ 
vs. PAO1; Raneri et al., Fig. 3a). 
As expected, glucose addition to PAO1 cultures increased the expression of 
genes implicated in glucose uptake and metabolism (Raneri et al., 
Supplementary Tables S2 and S3). On the other hand, down-regulated DEGs 
included genes coding for components of amino acid or dipeptide ABC 
transporters (Raneri et al., Supplementary Table S3). 
Genes related to energy and carbon metabolism were enriched among those 
down-regulated in the GUN mutant relative to PAO1 grown in either presence or 
absence of glucose (Raneri et al., Table 2). In particular, the expression of genes 
implicated in oxidative phosphorylation was lower in the mutant, which appears 
to undergo a reorganization of the electron transport chain (Raneri et al., 
Supplementary Table S2). In addition, genes encoding components of the 
denitrification process, i.e. the dissimilatory nitrate respiration performed by P. 
aeruginosa to grow under anaerobic conditions (Arai 2011), were also down-
regulated in GUN (Raneri et al., Supplementary Tables S2). The perturbation 
of energy metabolism affected also the production of NAD(H) cofactors. Indeed, 
genes for NAD biosynthesis and for NADH dehydrogenase, which regenerates 
NAD+ in the electron transport chain, had lower expression in the mutant relative 
to PAO1 (Raneri et al., Supplementary Table S2). To confirm this observation, 
total NAD(H) was measured in PAO1 and GUN mid-log cultures grown in 
minimal medium with casamino acids and with or without glucose (Raneri et al., 
Fig. 3c). In line with transcriptomic data, the NAD(H) cellular content was 
significantly reduced in the GUN mutant compared to PAO1 grown in absence 
of glucose, suggesting that the lack of glucose transporters may perturb the 
cellular redox balance. As for carbon metabolism, the mutant showed a decreased 
expression of genes required for the degradation of glucose and some amino acids 
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(Raneri et al., Supplementary Table S2). Notably, genes for arginine and 
histidine utilization were significantly down-regulated in GUN (Raneri et al., 
Fig. 3b and Supplementary Tables S2). The stress condition of the GUN 
mutant was also suggested by the lower expression of genes typically associated 
with growth like those coding for ribosomal proteins, for the enzymes required 
for purine biosynthesis and for RNA polymerase subunits (Raneri et al., 
Supplementary Table S2). Indeed, the genes coding for the housekeeping 
(rpoD) and starvation (rpoS) sigma factors were down- and up-regulated in the 
mutant, respectively (Raneri et al., Table 3). Interestingly, quorum sensing-
dependent virulence genes involved in the synthesis of elastases, alkaline 
protease, rhamnolipids, pyocyanin and lectins were also up-regulated in the GUN 
mutant (Raneri et al., Supplementary Table S2). In addition, the mutant showed 
increased expression of genes coding for type I and type II secretion systems, 
respectively mediating the transport of alkaline protease and elastases outside the 
cell (Strateva & Mitov 2011), for multidrug efflux systems and for the synthesis 
and secretion of pyoverdine (Raneri et al., Supplementary Table S2). 
Overall, PAO1 transcriptional response to glucose is consistent with the results 
of a transcriptomic analysis performed in P. putida grown on glucose, which 
showed an up-regulation of genes mediating glucose transport and catabolism 
and a down-regulation of few genes involved in the uptake and utilization of 
alternative carbon sources (del Castillo et al. 2007). Lower expression of genes 
related to amino acids uptake in the presence of glucose could be a result of 
catabolite repression, since P. aeruginosa was demonstrated to preferentially use 
glucose over amino acids as growth substrate (Section 4.1; Valentini et al. 2014). 
The comparison of PAO1 and GUN transcriptomes suggests that a nutritional 
dysregulation occurs in the mutant. While lower expression of glucose catabolic 
genes in the GUN mutant was predictable, the strong repression of genes for 
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arginine and histidine degradation is unexpected because it does not occur in 
PAO1 growing without glucose although both strains rely only on casamino acids 
for their growth. Since the GUN mutant can grow on both arginine and histidine 
as unique carbon source as the wild type strain (data not shown), it may be 
hypothesized that PAO1 and GUN use the amino acids in the medium in a 
different order and/or at a different rate, leading to their exhaustion in the culture 
medium, and thus to the shutoff of genes encoding functions involved in their 
metabolism, at different times. Repression of genes linked to energy metabolism 
most likely depends on the nutrient shortage experienced by the GUN mutant 
under the tested conditions. This was supported by the higher expression in the 
mutant of genes for the aa3 terminal oxidase (coxAB, coIII; Raneri et al., Fig. 3b 
and Supplementary Table S2), which is known to be induced upon carbon 
starvation (Kawakami et al. 2010). The mutant appeared also to have an altered 
redox state, reflected by lower NAD(H) pool. The over-expression in the mutant 
of nap genes (Raneri et al., Fig. 3b and Supplementary Table S2), encoding 
the periplasmic nitrate reductase, may be related to redox imbalance. Indeed, Nap 
reductase was found to mediate redox balancing of Rhodobacter sphaeroides by 
using nitrate as an ancillary oxidant to dissipate excess reductant (Gavira et al. 
2002). 
8. The GUN mutant has altered production of quorum sensing 
autoinducers and defective biofilm formation 
Up-regulation of genes belonging to the quorum sensing (QS) regulatory network 
was observed in the GUN mutant relative to PAO1, regardless of the presence of 
glucose, in the RNASeq experiment. In particular, the expression of lasR and 
rhlR genes for QS regulators was found to be induced in the GUN strain, together 
with that of virulence genes controlled by LasR and RhlR (Raneri et al., Fig. 3b 
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and Supplementary Table S2). Nevertheless, the lasI and rhlI genes, implicated 
in the synthesis of las and rhl autoinducers, were not identified as differentially 
expressed in the transcriptomic analysis, although their expression is known to 
be positively regulated by LasR and RhlR, respectively (Seed et al. 1995; 
Ochsner & Reiser 1995). 
To gain insight into the organization of QS network in the GUN mutant, the 
production of 3OC12-HSL and C4-HSL (the signal molecules of las and rhl 
systems, respectively) was estimated in PAO1 and GUN cultures grown in 
minimal medium supplemented with casamino acids in presence or absence of 
glucose. Moreover, since biofilm formation depends on QS network (Gellatly & 
Hancock 2013; Skariyachan et al. 2018), we also measured the ability of the GUN 
strain to grow in a biofilm. These experiments were performed by our 
collaborators G. Rampioni and L. Leoni (Università degli Studi Roma Tre). We 
observed that the levels of 3OC12-HSL and C4-HSL autoinducers were 
respectively increased and not significantly changed in GUN relative to PAO1, 
irrespective of glucose presence (Raneri et al., Fig. 4a). 
Enhanced production of 3OC12-HSL in the GUN mutant is consistent with the 
higher expression of lasR and genes controlled by this QS regulator, such as lasA, 
lasB and aprA (Raneri et al., Fig. 3b and Supplementary Table S2). As 
indicated in Sections 1.2 and 1.3, both metabolic and environmental stress were 
found to modify the P. aeruginosa QS network, causing distortions in the 
hierarchical organization of QS systems and in the connection of las and rhl 
autoinducer synthases expression to that of their respective regulators (Duan & 
Surette 2007). Therefore, the metabolic dysregulation of the GUN mutant 
suggested by its transcription profile may explain its altered QS. 
Biofilm formation in the GUN mutant was estimated by means of crystal violet 
assay in polystyrene 96-well microplates and by laser scanning confocal 
microscopy (LSCM) on glass slides. Both assays were conducted in minimal 
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medium supplemented with casamino acids, in either presence or absence of 
glucose, and revealed that biofilm formation was reduced in the GUN mutant 
relative to PAO1 (Raneri et al., Fig. 4b). As observed for QS perturbation, 
reduced biofilm formation by the GUN mutant did not depend on the mutant’s 
inability to use glucose, as no reduction in biofilm formation was observed with 
PAO1 growing without glucose. 
9. Analysis of virulence-related phenotypes in P. aeruginosa 
glucose uptake mutants 
As mentioned in Section 7, transcriptomic analysis revealed the up-regulation of 
several genes coding for virulence determinants in the GUN mutant. To validate 
these data, in vitro assays for virulence-related phenotypic traits were applied to 
the glucose uptake defective mutants. In particular, we assessed: i) the production 
of pyocyanin, pyoverdine, rhamnolipids and extracellular proteases; ii) the ability 
to grow in microaerophilic and anaerobic conditions. Since their importance in 
P. aeruginosa pathogenicity (Kipnis et al. 2006), swimming and twitching 
motilities were also investigated, although genes involved in flagella and pili 
biosynthesis were not differentially expressed in the GUN mutant according to 
RNASeq data. 
▪ Production of pyocyanin, pyoverdine and rhamnolipids 
Pyocyanin (PYO), pyoverdine (PVD) and rhamnolipids secretion was estimated 
in cultures grown in LD broth up to the stationary phase because in our hands, in 
minimal medium, the production of these two molecules was low making 
unreliable the results of the assays. Glucose is present at low levels in LD 
medium, with a concentration ranging from 10 to 40 µM in different batches 
(Raneri et al., Supplementary Fig. S2). The production of PYO and, to a lesser 
extent, PVD was higher in all strains lacking the KguT ketogluconate transporter, 
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i.e. the ΔkguT, ΔgntP ΔkguT and GUN mutants (Raneri et al., Fig. 5a and 5b). 
We speculated that PYO and PVD synthesis might be promoted by the 
accumulation of 2-ketogluconate (2-KG) in the periplasm or by the absence of 
this molecule from the cytoplasm. However, the addition of 2-KG to the medium 
did not result in a further increase of PYO and PVD levels in any strain, rejecting 
the former hypothesis (Fig. 12). Since 2-KG is the allosteric inducer of PtxS 
repressor, we also hypothesized that this molecule could act as a signal to 
modulate the expression of genes involved in PYO and PVD production or 
secretion through a PtxS-dependent regulation. Nevertheless, PYO and PVD 
levels were unaffected between PAO1 and a ΔptxS isogenic mutant (Fig. 12). 
 
 
Fig. 12. Pyocyanin and pyoverdine secretion upon 2-ketogluconate addition. Pyocyanin (left 
panel) and pyoverdine (right panel) were measured in the supernatants of PAO1, ΔkguT and ΔptxS 
cultures grown 24 h at 37° C in LD not supplemented (empty boxes) or supplemented with 1 mM 2-
ketogluconate (2-KG; coloured boxes), as described in Raneri et al., Supplementary Methods. 
Values are normalized for the A600 of the cultures and expressed relative to PAO1 without 2-KG. The 
median (line) is reported inside the boxes (n≥5). The whiskers represent the minimum and maximum 
value observed. Significance was estimated with one-way Anova and Tukey post-hoc analysis 
(*, P<0.05; ***, P<0.001). 
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PYO can be used as mobile electron carrier for P. aeruginosa, accepting or 
donating electrons to maintain redox homeostasis (Price-Whelan et al. 2006). 
Thus, it is possible that increased pyocyanin production may be linked to 
perturbed redox homeostasis, which was actually observed for the GUN mutant 
(see Section 7). On the other hand, the synthesis of pyoverdine siderophore may 
be linked to a dysregulated iron metabolism. This appears to occur in the GUN 
mutant due to a reorganization of the electron transport chain, which would entail 
the synthesis of heme-containing proteins leading to iron starvation. Accordingly, 
the expression of the pvdS iron starvation sigma factor was found to be increased 
in the GUN mutant (Raneri et al., Table 3). 
Rhamnolipids secretion was detected on plates containing the cationic surfactant 
CTAB and methylene blue (MB) to allow their visualization. The ion-pairing of 
negatively charged rhamnolipids, whenever produced, with positively charged 
MB and CTAB leads to the formation of a dark blue halo surrounding the spotted 
colony due to methylene blue precipitation. The diameter of this halo, which 
reflects the amount of secreted rhamnolipids, was slightly increased in all strains 
lacking kguT and in ΔgntP, whereas the single deletion of glt had no impact on 
the synthesis of this virulence factor (Raneri et al., Supplementary Fig. S4a). 
▪ Production of extracellular proteases 
Proteases secretion was qualitatively estimated by performing a casein diffusion 
plate assay. In this experiment, the supernatants of cultures of PAO1 and mutant 
strains, grown in minimal medium supplemented with casamino acids in either 
absence or presence of glucose, were spotted onto casein-agar plates. The 
secretion of proteases is indicated by the formation of a white precipitate, as a 
result of the hydrolysis of soluble casein to the insoluble para-casein derivative 
(Lawrence & Creamer 1969). Since such precipitation can also spontaneously 
occur at acidic pH, we measured the pH of culture supernatants and we found 
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that it was around 6.5 for all strains irrespective on glucose presence or absence 
(data not shown). All strains produced a similar level of proteases when grown 
without glucose supplementation (a condition in which the growth of all cultures 
stopped approximately at OD600 0.8), whereas glucose addition to the cultures 
inhibited proteases secretion in the single mutants, but not in the ΔgntP ΔkguT 
and GUN strains (Raneri et al., Supplementary Fig. S4b), suggesting that 
protease secretion may be a response to nutritional starvation. 
▪ Growth in microaerophilic and anaerobic conditions 
The growth in anaerobiosis was performed by spotting cultures on LD-agar plates 
supplemented with nitrate, which were incubated in both anaerobic and aerobic 
conditions. As for the microaerophilic growth, cultures were inoculated in LD 
rich medium or in minimal medium supplemented with casamino acids in 96-
well microplates overlaid with paraffin oil, to prevent evaporation, and incubated 
without stirring to restrict oxygen influx. No difference between PAO1 and 
mutant strains was detected in either assays (Raneri et al., Supplementary Fig. 
S4c and S4d). 
▪ Swimming and twitching motilities 
Swimming and twitching motilities were analysed in minimal medium-agar 
plates supplemented with LD 5%, in the presence of glucose, gluconate or 
succinate. As for the twitching assay, cultures were spotted at the interface 
between the solidified nutrient medium and the petri dish bottom and their ability 
to spread across this interstitial space was monitored by measuring the diameter 
of growth halo. On the other hand, the growth halo deriving from dispersal of 
bacterial cultures inside semi-solid agar plates was evaluated in the swimming 
assay. A slightly reduced twitching zone was observed for the ΔkguT and ΔgntP 
ΔkguT mutants on gluconate and for GUN on both glucose and gluconate (Fig. 
13A). Swimming was inhibited for ΔgntP ΔkguT on gluconate and for GUN on 
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both glucose and gluconate, a result due to poor growth of these strains in such 
conditions (Fig. 13B). Furthermore, in glucose and, to a minor extent, in 
gluconate swimming plates all strains showed autolysis, a phenotype which has 
been linked to membrane disruption due to oxidative stress (Hazan et al. 2016). 
 
 
Fig. 13. Twitching and swimming motilities of glucose uptake defective mutants. A. Diameters 
of PAO1 and mutants’ twitching zones (TZ) in the indicated carbon sources, normalized for the TZ 
diameter of PAO1 in glucose. Bars represent average (n=3) with standard deviation. Significance was 
estimated with one-way Anova and Tukey post-hoc analysis (**, P<0.01; ***, P<0.001).  
B. Swimming motility of PAO1 and mutant strains with the indicated carbon sources. The 
experiment was performed three times in different days with similar results. In both panels, ΔΔ 
indicates the PAO1 ΔgntP ΔkguT strain. 
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10. Virulence degree of glucose uptake defective mutants in    
Caenorhabditis elegans and Galleria mellonella 
We investigated the virulence of glucose uptake mutants in two host models 
largely used to study P. aeruginosa infections, i.e. the Caenorhabditis elegans 
nematode and the Galleria mellonella insect larvae. 
▪ Caenorhabditis elegans infections 
The experiments in C. elegans were performed by our collaborators I. Bianconi 
and O. Jousson (Università degli Studi di Trento), whereas I did the experiments 
with G. mellonella. In the C. elegans slow-killing assay, nematodes are fed on P. 
aeruginosa cells, which proliferate within an extracellular matrix in the nematode 
gut lumen, thus colonizing the intestinal tract and killing the nematodes over 
several days at 20 °C (Tan et al. 1999). The virulence of ΔgntP, Δglt and GUN 
mutants was comparable to that of PAO1, whereas the ΔkguT and ΔgntP ΔkguT 
mutants were slightly, but significantly more virulent than PAO1 (Raneri et al., 
Supplementary Fig. 5). The higher virulence of ΔkguT and ΔgntP ΔkguT 
mutants in C. elegans may be related to enhanced pyocyanin secretion. As 
discussed in Section 9, the in vitro production of this virulence factor, which is 
relevant for P. aeruginosa pathogenicity in C. elegans (Mahajan-Miklos et al. 
1999), is increased in all strains lacking kguT. Curiously, despite the GUN strain 
produces more pyocyanin and other virulence determinants in vitro, its 
pathogenic potential was comparable to that of PAO1 in C. elegans. This may be 
ascribed to a metabolic stress restricting the ability of this mutant to thrive in the 
nematode nutritional context. Indeed, also genes related to metabolic functions 
play a role in C. elegans infections by P. aeruginosa (Feinbaum et al. 2012). 
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▪ Galleria mellonella infections 
As G. mellonella normally feed on honey, high levels of sugars are generally 
present in larvae. Indeed, it was estimated that the total amount of free glucose, 
fructose and sucrose ranges from 0.05 to 0.4 mg/ml in G. mellonella hemolymph 
(Wyatt et al. 1956). A preliminary estimation of glucose concentration in the 
hemolymph was therefore necessary to properly evaluate the results of the 
infection assays. Interestingly, glucose levels in G. mellonella larvae were 
significantly lower than the previous estimation (mean value 11.2 µM, 
corresponding to 2.0 µg/ml; Raneri et al., Supplementary Fig. S2), probably 
because the larvae were starved for 24/48 h before being infected by P. 
aeruginosa. In the G. mellonella infection assay, P. aeruginosa is directly 
injected in larvae hemolymph and systemically disseminates via circulation, 
causing an acute infection that kills the larvae in 18-42 h at 37 °C (Ramarao et 
al. 2012). The ΔgntP ΔkguT and GUN mutants resulted significantly less virulent 
that PAO1 and the other mutants (Raneri et al., Fig. 6a). Indeed, the mortality 
rate of larvae injected with ΔgntP ΔkguT and GUN strains was clearly lower than 
those observed for PAO1 and the other mutants at 24 h post infection (h.p.i; less 
than 40% for the two attenuated mutants, vs. > 70% for the other strains). 
Moreover, a slight but significant decrease in the virulence was also observed for 
ΔkguT up to 22 h.p.i. To assess whether virulence decrease in G. mellonella was 
due to in larva growth defects, we titred hemolymph bacteria at 16 h.p.i. Indeed, 
the hemolymph bacterial burden was significantly reduced for all the tested 
mutants compared to PAO1 (Raneri et al., Fig. 6b). In addition, parental PAO1 
and all mutants lacking kguT were investigated for their ability to induce the 
innate immune response of G. mellonella. To this end, phenoloxidase (PO) 
activity in the hemolymph of larvae infected with a lethal dose of PAO1 and 
mutant strains was measured (Raneri et al., Fig. 6c). PO production was 
significantly induced upon infection of the larvae with all the bacterial strains 
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compared to those mock-infected (i.e. injected with sterile physiological 
solution). Moreover, PO levels were significantly lower in larvae infected with 
the ΔgntP ΔkguT or GUN mutants relative to those infected with PAO1 or the 
ΔkguT strains. 
Differential adaptation of P. aeruginosa to the specific nutritional context of the 
two different hosts may explain the divergent effect exerted by the mutations in 
glucose uptake genes (and in particular by kguT deletion) on the pathogenicity. 
It is likely that C. elegans localized gut infection and G. mellonella systemic one 
pose two distinct nutritional contexts to infecting bacteria, with the latter having 
greater amount of sugars and amino acids (McGhee 2007; Wyatt et al. 1956). The 
contribution of metabolic functions to the infection process of P. aeruginosa and 
other pathogens is very relevant (de Lorenzo 2014 and 2015). For example, the 
Entner-Doudoroff pathway for sugar consumption contributes to the 
pathogenicity of L. pneumophila and V. cholerae under oxidative stress 
conditions (Harada et al. 2010; Patra et al. 2012). Moreover, the inactivation of 
NAD biosynthesis regulation affects P. aeruginosa metabolism and 
pathogenicity (Okon et al. 2017). Interestingly, a whole-genome screening for 
multi-host P. aeruginosa virulence genes identified a mutant lacking the crc 
gene, encoding the global regulator of catabolite repression, as one of the few 
attenuated in both non-mammalian systems and in a murine model of pneumonia 
(Dubern et al. 2015). 
11. Preliminary analysis of PAO1 and GUN transcriptional 
profiles in early exponential cultures 
As mentioned in Section 7, samples for RNASeq were collected also at an early 
time point (10 min) after the supplementation with 0.4% glucose to PAO1 and 
GUN cultures at OD600 ~ 0.4. Also in this case, a multiple comparison between 
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the transcriptomes of PAO1 growing with and without glucose and of GUN 
growing with glucose was performed. 78 DEGs were identified in PAO1 upon 
glucose addition (PAO1+ vs. PAO1; Fig. 14), with 44 up-regulated and 43 down-
regulated genes. As for GUN transcription profile, we found 483 DEGs (243 and 
240 genes up- and down-regulated, respectively) compared to PAO1 with 
glucose (GUN+ vs. PAO1+; Fig. 14) and 1022 DEGs (521 and 501 up- and 
down-regulated, respectively) with respect to PAO1 without glucose 
supplementation (GUN+ vs. PAO1; Fig 14). 
 
 
DEGs were analysed to identify enriched functional categories. As expected, 
glucose addition to PAO1 cultures resulted in an increased expression of genes 
involved in glucose uptake and metabolism (Supplementary Table S6). Up-
regulated DEGs included also genes related to virulence such as mexA and oprM, 
two components of the MexAB-OprM antibiotic efflux system (Li et al. 1995), 
Fig. 14. Venn-diagrams of differentially expressed genes (DEGs). The diagrams represent the 
number of under- (left panel) and over- (right panel) expressed genes between GUN+ and PAO1+, 
GUN+ and PAO1, PAO1+ and PAO1, as indicated. +, RNA extracted from cultures supplemented 
with glucose. 
Down-regulated DEGs Up-regulated DEGs 
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and suhB, a regulator of multiple virulence factors playing an essential role in P. 
aeruginosa pathogenesis (Li et al. 2013) (Supplementary Table S6). On the 
contrary, genes involved in amino acids uptake (aat) and metabolism (dad) were 
identified among those less expressed in PAO1 upon glucose addition 
(Supplementary Table S6). In addition, genes coding for the ATP-dependent 
protease AsrA and heat-shock proteins induced by this protease (ibpA, clpB, 
dnaK, grpE and hslVU) were identified among those down-regulated in PAO1 
with glucose (Supplementary Table S6). AsrA-dependent activation of the heat 
shock response was found to occur in response to lethal tobramycin 
concentrations in P. aeruginosa (Kindrachuk et al. 2011). 
Differentially expressed genes (DEGs) identified in the GUN mutant relative to 
PAO1 belong to several functional categories (Table 3). 
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Table 3. Enriched functional categories among DEGs 
GUN+ vs. PAO1+ GUN+ vs. PAO1 
Down-regulated DEGs1 
Polyamine catabolism (16) Polyamine catabolism (19) 
Propanoate metabolism (5) Propanoate metabolism (9) 
Ala, Asp, Glu2 metabolism (4) Val, Leu, Ile2 degradation (9) 
Val, Leu, Ile2 degradation (7) Butanoate metabolism (10) 
Carbon metabolism (16) Carbon metabolism (19) 
Geraniol degradation (6) Dycarboxylate metabolism (9) 
Aromatic compounds catabolism (5) ABC transporters (33) 
Butanoate metabolism (6) Ala, Asp, Glu2 metabolism (3) 
ABC transporters (22) Geraniol degradation (6) 
Arginine and proline metabolism (8) Aromatic compounds catabolism (6) 
Metabolic pathways (70) Triptophan metabolism (3) 
  Arginine and proline metabolism (10) 
Up-regulated DEGs1 
Ribosome (23) Ribosome (40) 
Oxidative phosphorylation (22) Oxidative phosphorylation (23) 
Phenazine biosynthesis (7) Fatty acid biosynthesis (12) 
Fatty acid biosynthesis (8)   
The expression of genes implicated in the metabolism of glucose, amino acids, 
polyamines, short-chain fatty acids (propanoate and butanoate), acyclic terpenes 
(geraniol) and aromatic compounds was decreased in the GUN mutant compared 
to PAO1, irrespective glucose presence or absence (Supplementary Table S5). 
1Categories are ordered according to increased adjusted probability value. The number of DEGs 
belonging to each category is indicated in brackets. 
2Ala, alanine; Asp, aspartic acid; Glu, glutamic acid; Val, valine; Leu, leucine; Ile, isoleucine. 
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Down-regulation in the mutant of genes coding for ABC transporters and 
transcriptional factors mediating the uptake and utilization of amino acids and 
polyamines was also found (Supplementary Tables S5 and S7). Up-regulated 
DEGs in GUN relative to PAO1 were enriched in genes involved in oxidative 
phosphorylation, such as the atp operon for the ATP synthase complex and the 
genes encoding the cbb3-1 (cco1), cbb3-2 (cco2) and bo3 (cyoAB) terminal 
oxidases of the electron transport chain (Supplementary Table S5). In addition, 
genes coding for ribosomal proteins, RNA polymerase subunits and required for 
fatty acid biosynthesis were over-expressed in the mutant (Supplementary 
Table S5). Finally, the GUN mutant showed an increased expression of several 
genes encoding QS-dependent virulence factors, such as elastases (lasAB), 
rhamnolipids (rhlAB), lectins (lecAB), phenazines (phz), and hydrogen cyanide 
(hcn) (Supplementary Table S5), a result somewhat unexpected given the low 
cell density of the cultures at the early time point, but in line with the altered QS 
network observed in the mutant at 60 min. 
Albeit still preliminary and requiring validation, we can make some preliminary 
considerations about the GUN and PAO1 global transcription profiles at the early 
time point after glucose addition (10 min), also in the light of the previously 
presented results about the transcriptomes of the two strains at a later time point 
(60 min after glucose addition). 
At both time points, glucose effect on PAO1 transcriptional profile is limited and 
shows the up-regulation of glucose metabolic genes and down-regulation of 
genes required for the utilization of amino acids. As mentioned in Section 7, 
glucose may repress the expression of genes involved in amino acids metabolism 
as a result of catabolite repression, considering that P. aeruginosa preferentially 
uses glucose over amino acids as carbon source for growth (Section 4.1; Valentini 
et al. 2014). 
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In contrast, the differential expression of both virulence-related genes (mexA, 
oprM and suhB) and AsrA-dependent genes in PAO1 with glucose is transient, 
as it was no longer observed 60 min after glucose addition. However, the latter 
genes have a decreased expression in the GUN mutant with respect to PAO1 at 
both time points, suggesting that the lack of glucose uptake systems may interfere 
with AsrA regulatory network. 
About 400 genes are differentially expressed between GUN and PAO1 at both 
time points irrespective of glucose. 117 of these genes are conserved between 10 
and 60 min conditions but only 45 share the same regulation at the two time 
points, a third of which encodes for virulence-related traits. On the other hand, a 
large fraction of the genes showing opposite regulation between 10 and 60 min 
codes for ribosomal proteins and components of the electron transport chain. 
Therefore, we can conclude that the lack of glucose transporters deeply affects 
P. aeruginosa gene expression at both 10 and 60 min after glucose addition, albeit 
with significant differences between the two time points that probably depend on 
the metabolic state of the GUN mutant. 
On the contrary, only 43 DEGs were exclusively identified in the GUN strain 
when compared to PAO1 with glucose, whereas 529 genes resulted differentially 
expressed only in the comparison between GUN and PAO1 without glucose. This 
difference was not observed at 60 min, as in that case a similar number of genes 
(121 and 144 genes, respectively) was found in the two comparisons. 
It is tempting to speculate that the accumulation of a great amount of glucose 
(and/or its derivatives gluconate and 2-KG) in the periplasm of the GUN mutant 
may be sensed as a signal to activate energy metabolism and, more in general, 
functions related with fast growth. In fact, significantly higher expression of 
genes implicated in oxidative phosphorylation and coding for ribosomal proteins 
is observed in the GUN mutant. 
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CONCLUSIONS AND FUTURE PERSPECTIVES 
In this Ph.D. thesis I describe the generation and characterization of a panel of 
single and multiple P. aeruginosa PAO1 mutants carrying untagged deletions of 
genes coding for IM proteins implicated in the uptake of glucose and its oxidative 
derivatives gluconate and 2-ketogluconate (2-KG). On the whole, my results 
show that Glt, GntP and KguT transporters are the only involved in the 
internalization of glucose, with GntP and KguT specifically required for the 
transport of gluconate and 2-KG, respectively. 
The analysis of wild type PAO1 and GUN transcriptomes 60 min upon glucose 
addition revealed that PAO1 transcriptional response to glucose is limited, 
whereas the mutant has a deeply altered gene expression relative to PAO1, with 
a high number of differentially expressed genes belonging to various pathways. 
Functional classification of differentially expresses genes (DEGs) indicated that 
the GUN mutant undergoes a complex metabolic dysregulation leading to 
nutritional disorders and interfering with energy metabolism and quorum 
sensing. Furthermore, the expression of several virulence genes is increased in 
this strain compared to parental PAO1. Interestingly, most of DEGs showed 
altered expression in the mutant even with respect to PAO1 grown in the absence 
of glucose, a result that was validated by RT-qPCR experiments. 
Phenotypic assays confirmed the transcriptomic data and depicted a pleiotropic 
phenotype for the GUN mutant, with lower NAD(H) content, altered quorum 
sensing, decreased biofilm formation and enhanced secretion of virulence factors 
such as pyocyanin, pyoverdine and extracellular proteases. Interestingly, also in 
this case, most of the tested phenotypic traits differs in the GUN mutant relative 
to PAO1 regardless of the presence of glucose, suggesting that Glt, GntP and/or 
KguT may contribute to an accessory function not related to glucose transport. 
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It is tempting to speculate that one or more of the deleted transporters may be 
involved in the regulation of cell metabolism, possibly by modulating the activity 
of histidine kinases (HK) of two-component systems. It has been shown, for 
example, that the E. coli dicarboxylic acid (C4-diC) transporter DauA activates 
the expression of DctA, the main C4-diC transporter at neutral pH, by regulating 
the activity of the HK DcuS (Karinou et al. 2017). This has been proposed as a 
strategy adopted by E. coli to maximize C4-diC utilization. KguT may be eligible 
for such an additional function. Indeed, this transporter plays a prominent role in 
in vitro virulence-related phenotypes and is relevant for the in vivo virulence of 
P. aeruginosa in C. elegans and G. mellonella, with all mutants lacking KguT 
attenuated in G. mellonella, whereas the single ΔkguT and the double ΔgntP 
ΔkguT mutants were slightly more virulent than PAO1 in C. elegans. 
To investigate the putative accessory function of Glt, GntP and/or KguT, we plan 
to implement two-hybrid systems and co-purification assays using the 
transporters (with proper tags) as baits. This will allow to identify their interactors 
and will shed light on their putative additional role. 
We also plan to carry out the analysis of the transcription profile of PAO1 and 
the GUN mutant at the early time upon glucose addition, with the relevant aspects 
that will be validated by RT-qPCR. In particular, the transient over-expression of 
genes implicated in oxidative phosphorylation in the GUN mutant deserves 
consideration. The expression of these genes will be assessed in PAO1 and in the 
single and multiple mutants to assess whether the lack of a specific glucose 
transporter and/or the presence of glucose (or its gluconate and 2-KG derivatives) 
in the periplasm may specifically affect the expression of genes encoding 
functions of the electron transport chain. 
Different virulence degree of our mutants in C. elegans and G. mellonella 
suggests that the ability to import glucose and/or the accessory function of 
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glucose transporters may differently impact P. aeruginosa adaptation to the 
nutritional context posed by the infection in either animal. In order to understand 
whether one or more proteins involved in glucose uptake may be a good target to 
develop novel drugs to tackle P. aeruginosa infections, it will be interesting to 
evaluate the pathogenic potential of our mutants in both acute and chronic murine 
models of infections and in hyperglycaemic mice. 
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MATERIALS AND METHODS 
Bacterial strains, plasmids and oligonucleotides used in this this study are listed 
in Raneri et al., Supplementary Table S1. The experimental procedures are 
described in Raneri et al., Methods and Supplementary Methods. The 
procedures of the experiments not included in the attached article are reported in 
this section. 
Swimming and twitching motilities 
Stationary bacterial cultures were washed in 1x PBS and inoculated as 2 µl spots 
onto swimming and twitching plates. Swimming plates were prepared with M9 
minimal medium supplemented with 5% (v/v) LD in the presence of 0.4% (w/v) 
glucose, 0.4% (w/v) gluconate or 1% (w/v) succinate and 0.3% (w/v) BactoAgar 
(Difco). Bacterial cultures were inoculated at the centre of the plates, which were 
incubated at 37 °C for 24 h. The size of the swimming halo, originating from 
bacterial diffusion inside the semi-solid plates, was then evaluated. Twitching 
plates were made with M9 minimal medium supplemented with 5% (v/v) LD in 
the presence of 0.4% (w/v) glucose, 0.4% (w/v) gluconate or 0.5% (w/v) 
succinate and 1% (w/v) BactoAgar (Difco). 3 mm-thick plates were used for the 
twitching assay. Bacterial cultures were inoculated to the bottom of the Petri dish 
and the plates were incubated at 37 °C for 20 h. The diameter of the twitching 
zone (i.e. the halo resulting from bacterial movement at the agar/Petri dish 
interface) was then measured. 
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Pseudomonas aeruginosa mutants 
defective in glucose uptake have 
pleiotropic phenotype and altered 
virulence in non-mammal infection 
models
Matteo Raneri1, Eva Pinatel2, Clelia Peano2,5, Giordano Rampioni3, Livia Leoni3, 
Irene Bianconi4, Olivier Jousson  4, Chiara Dalmasio1, Palma Ferrante1 & Federica Briani1
Pseudomonas spp. are endowed with a complex pathway for glucose uptake that relies on multiple 
transporters. In this work we report the construction and characterization of Pseudomonas aeruginosa 
single and multiple mutants with unmarked deletions of genes encoding outer membrane (OM) and 
inner membrane (IM) proteins involved in glucose uptake. We found that a triple ΔgltKGF ΔgntP 
ΔkguT mutant lacking all known IM transporters (named GUN for Glucose Uptake Null) is unable to 
grow on glucose as unique carbon source. More than 500 genes controlling both metabolic functions 
and virulence traits show differential expression in GUN relative to the parental strain. Consistent 
with transcriptomic data, the GUN mutant displays a pleiotropic phenotype. Notably, the genome-
wide transcriptional profile and most phenotypic traits differ between the GUN mutant and the wild 
type strain irrespective of the presence of glucose, suggesting that the investigated genes may have 
additional roles besides glucose transport. Finally, mutants carrying single or multiple deletions in the 
glucose uptake genes showed attenuated virulence relative to the wild type strain in Galleria mellonella, 
but not in Caenorhabditis elegans infection model, supporting the notion that metabolic functions may 
deeply impact P. aeruginosa adaptation to specific environments found inside the host.
Pseudomonas aeruginosa is a Gram-negative ubiquitous bacterium with high metabolic versatility, able to thrive 
in disparate environments and to infect hosts as different as plants, insects and mammals. However, the number 
of sugars that P. aeruginosa (and other species belonging to the Pseudomonas genus) can exploit as carbon and 
energy sources is relatively low and substantially limited to glucose, glucuronic acid and fructose1.
Pseudomonas glucose uptake pathway was first clarified in P. putida2,3. Homologues of P. putida transporters 
were identified in P. aeruginosa and in some cases, shown to be bona fide orthologues (i.e. endowed with the same 
function) of P. putida proteins. Once crossed the outer membrane through the OprB porin, glucose can either 
cross the inner membrane thanks to the ABC transporter Glt or enter a periplasmic oxidative pathway producing 
gluconate and 2-ketogluconate (2-KG)4,5. Gluconate and 2-KG are internalized into the cytoplasm by the specific 
transporters GntP and KguT, respectively (Fig. 1a). In the cytoplasm, the two import pathways converge on the 
synthesis of 6-phosphogluconate, which enters the Entner-Doudoroff pathway3. The two alternate pathways (i.e. 
the Glt- dependent phosphorylative pathway and the GntP and KguT-dependent oxidative one) are regulated by 
glucose availability, with the oxidative route being preferentially used under high glucose1,6,7. Different regula-
tors modulate the expression of the operons encoding Glt, GntP and KguT (Fig. 1b). The gntP gene and the kgu 
operon are negatively regulated by the GntR and PtxS repressors, respectively, whereas glt-oprB transcription is 
negatively modulated by the GltR response regulator, whose activity is controlled by the histidine kinase GtrS8. In 
the presence of glucose, repression by all these regulators is relieved (Fig. 1b)1,5,8–11. Interestingly, GtrS and PtxS 
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regulate also transcription of toxA, the gene encoding the key virulence factor exotoxin A, thus establishing a link 
between glucose metabolism and virulence8–10,12.
Metabolic genes have been repeatedly identified in in vivo screenings for P. aeruginosa functions contrib-
uting to virulence13,14, suggesting that the inhibition of metabolic pathways may represent a sound strategy for 
the development of antibacterial therapies. In this respect, factors involved in glucose transport and utilization 
deserve consideration. In fact, pathologies leading to increased glucose concentration in the host fluids, from 
blood to liquid covering the respiratory mucosae, determine an augmented risk of developing serious bacterial 
infections not only for the immunity dysfunction due to hyperglycemia, but also because of glucose-dependent 
stimulation of bacterial growth15–18. Interfering with the ability of pathogenic bacteria to import or use glucose 
could thus represent a promising antibacterial strategy19.
In this work, we report the generation of a collection of P. aeruginosa mutants with unmarked deletions in 
genes encoding the outer membrane (OM) OprB and PA2291 porins or the inner membrane (IM) Glt, GntP and 
KguT transporters. Deletions of the genes for porins and for the IM oxidative route transporters were combined 
in the double ΔoprB ΔPA2291 and ΔgntP ΔkguT mutants, respectively. A triple Δglt ΔgntP ΔkguT mutant 
lacking all IM transporters was also generated and characterized. The mutants were assayed for phenotypes linked 
to P. aeruginosa virulence20. Interestingly, mutants lacking the oxidative route of glucose import showed altered 
virulence in the Caenorhabditis elegans and Galleria mellonella infection models.
Results
Generation of P. aeruginosa mutants defective in glucose uptake. We constructed single mutants 
of P. aeruginosa PAO1 lacking the genes for the OM porin OprB, its paralogue PA2291 (encoding OprB2, a 
porin 95% identical to OprB)21, the IM putative gluconate permease GntP or the 2-KG transporter KguT. Single 
mutations were combined in order to generate strains defective for both oprB and PA2291, or both gntP and kguT 
genes of the oxidative route of glucose transport. We also inserted a ΔgltKGF mutation, eliminating gltG, gltF and 
part of gltK, both in PAO1 and in the double mutant ΔgntP ΔkguT, obtaining P. aeruginosa strains devoid of Glt 
only or lacking all the Glt, GntP and KguT IM transporters (Fig. 1b; Supplementary Table S1).
The growth curves and optical density reached by the mutants after 24 hours of incubation in minimal 
medium supplemented with glucose or gluconate were analysed. As a control, growth in succinate was moni-
tored, since succinate uptake depends on other transporters22. Both single and double mutants lacking the OM 
OprB and/or OprB2 did not show any growth difference with respect to PAO1 (Supplementary Fig. S1) and in 
the optical density reached after 24 h of growth (Fig. 2a) in the tested media. These results indicate that the OprB 
and OprB2 porins are dispensable for glucose utilization, and that glucose can likely pass the OM through other 
porins. Therefore, we did not further characterize the mutants lacking OprB or/and OprB2, and we focused our 
analyses on mutants lacking IM transporters.
Figure 1. Glucose uptake pathways and organization of glucose uptake genes on P. aeruginosa genome. (a) 
Different porins allow glucose (empty square) entry into the periplasm. Once in the periplasm, glucose can 
be transported into the cytoplasm by Glt or oxidized to gluconate (grey square) and 2-KG (black square). 
Gluconate and 2-KG enter the cytoplasm thanks to GntP and KguT. Cylinders, outer membrane (OM) porins 
implicated in glucose uptake; ovals, inner membrane (IM) transporters. (b) Organization and regulation of 
glucose uptake genes in P. aeruginosa PAO1. 10 kbp long genomic regions encompassing the deleted loci 
encoding IM and OM proteins (represented as empty and dark boxes, respectively) are schematized. Boxes, 
ORFs; lines, intergenic regions; arrows on top of boxes indicate the transcription direction. Dashed lines 
connect genes encoding negative regulators with their target promoter(s).
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Single IM mutants and PAO1 reached comparable optical density after 24 h incubation in the tested media 
(Fig. 2b). However, the ΔgntP mutant had a longer lag phase in glucose and gluconate and lower growth rate in 
the latter medium (Table 1; Supplementary Fig. S1). To discriminate the roles of GntP and KguT in the transport 
of gluconate and 2-KG, the growth of the ΔgntP and ΔkguT mutants in minimal medium supplemented with 
2-KG was analysed. The ΔgntP mutant was able to grow on 2-KG as sole carbon source, whereas ΔkguT was not 
(Fig. 2c), thus confirming that 2-KG enters the cytoplasm only through the KguT transporter5.
As expected, the multiple mutants exhibited stronger growth defect in glucose/gluconate media. In fact, the 
ΔgntP ΔkguT double mutant showed reduced growth in glucose and did not grow in gluconate. Finally, the Δglt 
ΔgntP ΔkguT strain was unable to grow in either glucose or gluconate, showing that no transporters other than 
Glt, GntP and KguT operate glucose uptake in P. aeruginosa (Table 1; Fig. 2b). Because of its inability to grow 
with glucose as sole carbon source, the Δglt ΔgntP ΔkguT mutant was named GUN (i.e. Glucose Uptake Null).
Lack of glucose uptake systems deeply affects P. aeruginosa transcription profile. To assess 
how the lack of glucose uptake systems may impact P. aeruginosa physiology, we analysed the global transcription 
profile of the GUN mutant by RNASeq in comparison with that of PAO1. RNA was extracted from GUN and 
PAO1 cultures grown in minimal medium with casamino acids as carbon source (a medium in which glucose is 
virtually absent, see Supplementary Fig. S2) up to mid log phase, and then incubated 60 min with 0.4% glucose. 
In these conditions, genes responding to the presence of glucose and its metabolism and possibly other genes not 
related to glucose metabolism, but responding to the lack of Glt, GntP and KguT, could be differentially expressed 
in GUN relative to PAO1. To discriminate between these two categories and identify glucose responsive genes in 
P. aeruginosa, RNASeq was performed also on RNA extracted from a culture of PAO1 grown in the same condi-
tions as above, but without glucose addition, and the transcriptomes of PAO1 grown in the presence or absence 
Figure 2. Growth of glucose uptake mutants with different carbon sources. PAO1 and mutant strains were 
inoculated at the same OD600 in M9-Triton X-100 supplemented with either 0.4% glucose, 0.4% gluconate, 0.1% 
2-ketogluconate or 0.5% succinate, as indicated below the bars. Bacterial cell density (OD600) was measured 
after aerate incubation for 24 h at 37 °C. The bars represent average (n = 3) with standard deviation (SD). (a) 
OM mutants. ΔΔOM, ΔoprB ΔPA2291 mutant. (b). IM mutants. ΔΔIM, ΔgntP ΔkguT mutant. (c). Growth 
in 0.1% 2-ketogluconate of the indicated mutants. (a,b) Significance was evaluated with One-way Anova 
and Tukey post-hoc test. (a) According to one-way Anova analysis, growth differences were not statistically 
significant at 0.05 level. (b,c). *P < 0.5; ****P < 0.0001. All comparisons for which P is not shown were not 
significant at 0.05 level.
Strainb
Generation time (min)a
Glucosec Gluconatec Succinate
PAO1 36.7 ± 2.8(a) 34.1 ± 3.6(a) 36.4 ± 3.9(ab)
Δglt 39.5 ± 1.6(a) 36.1 ± 2.2(a) 39.9 ± 1.9(ab)
ΔgntP 40.5 ± 1.1(a) 53.4 ± 7.2(b) 32.6 ± 2.4(b)
ΔkguT 38.6 ± 5.7(a) 39.3 ± 3.1(a) 43.5 ± 3.7(ab)
ΔgntP ΔkguT 64.2 ± 11.6(b) na 48.3 ± 4.6(a)
GUN na na 48.8 ± 8.6(a)
Table 1. Generation time of glucose uptake mutants. aMean values (n = 3) with SD of generation time in 
exponential growth phase. Cultures were grown as described in Supplementary Fig. S1 legend. The differences 
between means reported in the same column and sharing at least one letter (in brackets) were not statistically 
significant according to One-way ANOVA and Tukey post-hoc test. bPAO1 single and double mutants are 
indicated by their cognate mutation(s). cna, not applicable. No OD600 increase detectable in the timespan of the 
experiments (7 h).
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of glucose were compared. Moreover, we compared the transcriptome of the GUN mutant grown in the presence 
of glucose with that of PAO1 grown either in the presence or in the absence of glucose. Notably, for the timespan 
of the experiment, PAO1 generation time did not significantly change upon glucose addition with respect to 
the culture without glucose (Supplementary Fig. S3), indicating that glucose is not required to sustain growth. 
Only 24 and 4 genes were up- and down-regulated (e.g. with a log2FC ≥ 1 or ≤ −1 and Padj < 0.05), respectively, 
upon glucose addition to PAO1 cultures (Fig. 3a). Down-regulated genes encoded components of amino acid 
or dipeptide ABC transporters, whereas the 24 up-regulated genes encoded functions mostly related to glucose 
catabolism (Fig. 3a and Supplementary Tables S2 and S3). Only 5 up-regulated genes were not directly related to 
glucose metabolism, namely fruIKA, encoding the phosphotransferase system for fructose transport, gdhA and 
phuR, coding for the glutamate dehydrogenase and the OM receptor of heme uptake, respectively. The gntR and 
gltR genes, encoding the GntR and GltR repressors of gntP and glt-oprB operons, respectively, were identified 
among the genes induced by glucose in PAO1. Conversely, the ptxS gene, which was previously demonstrated to 
be induced by glucose5, was not enclosed among differentially expressed genes because of its adjusted P value, 
which was slightly higher than the selected threshold (i. e. log2FC = 1.55; Padj = 0.08). However, RT-qPCR anal-
ysis of ptxS mRNA demonstrated that ptxS is actually up-regulated by glucose (Fig. 3b). On the whole, glucose 
effect on PAO1 transcriptome is similar to that observed in P. putida2, as in both cases, glucose addition results in 
the up-regulation of genes mainly implicated in glucose uptake and utilization and down-regulation of few genes 
controlling the transport and utilization of alternative carbon sources.
Although in our experimental settings glucose limitedly affected gene expression of PAO1 parental strain, the 
lack of glucose transporters in the GUN mutant had a striking impact on the transcriptome of the mutant relative 
to that of the wild type. 514 genes were differentially regulated at least two-fold in the GUN mutant with respect 
to PAO1 when both strains were grown in the presence of glucose. In detail, 258 and 256 genes were down- or 
up-regulated in the GUN mutant, respectively.
Genes coding for ribosomal proteins, for enzymes required for purine biosynthesis, for the RNA polymerase 
subunits (rpoA, rpoB and rpoC), and genes involved in energy metabolism like the NAD biosynthetic genes 
nadD and nadE, the nuo operon for NADH dehydrogenase and genes encoding cbb3−1 (cco-1), cbb3−2 (cco2) 
and cyo (cyoAB) terminal oxidases of the electron transport were enriched among genes down-regulated in the 
GUN mutant (Table 2; Supplementary Table S2). Conversely, genes for the subunits of aa3 terminal oxidase (i.e. 
coxAB and coIII), whose expression is induced upon nutrient starvation23, were up-regulated in the GUN mutant. 
Likewise, a subset of quorum sensing-dependent genes, including those involved in pyocyanin biosynthesis and 
efflux (namely phz and mexGHI genes24), lectins (lecA and lecB) and extracellular proteases (lasA and lasB), were 
more expressed in the GUN mutant relative to PAO1. Genes encoding chemotactic functions, pyoverdine bio-
synthetic genes and those encoding factors of the Apr and Xcp secretion systems were also up-regulated in the 
GUN mutant. Finally, some genes coding for global regulators (i.e. dnr, argR, rhlR, hfq, gbdR) were differentially 
expressed. In particular, rpoD and rpoS, encoding sigma factors σD and σS, were down- and up-regulated in GUN, 
respectively (Table 3; Supplementary Tables S2 and S4). Interestingly, most of the above mentioned genes showed 
differential expression in the GUN mutant grown with glucose compared with PAO1 grown both with or without 
glucose (Table 3 and Supplementary Table S2).
The RNASeq data for a subset of differentially expressed genes (Table 3) were validated by RT-qPCR and/or 
phenotypic assays. As for the RT-qPCR analyses, the RNA was extracted from PAO1 and GUN cultures grown in 
the same conditions as the cultures for RNASeq. The RNA of the GUN mutant grown in the absence of glucose 
was also enclosed in the analysis. We tested genes with different expression patterns, namely PA2264, which 
was found by RNASeq to be up-regulated in PAO1 upon glucose addition, PA5348, lasB, coxB and napA, all 
up-regulated in GUN with respect to PAO1, and the two genes aruC and hutU, which are down-regulated in the 
GUN mutant. Since lasB gene is positively regulated by LasR25, we also analysed the transcription of lasR, which 
was not included among differentially expressed genes because its log2FC was slightly below the selected thresh-
old (log2FC = 0.9).
Overall, the RT-qPCR results (Fig. 3b) were consistent with those of the RNASeq experiment (Table 3). For 
most genes, the transcription profile of the GUN mutant was not affected by glucose. The only exceptions were 
coxB and napA (coding for subunits of the aa3 terminal oxidase and of the periplasmic nitrate reductase, respec-
tively), whose expression, although remaining much higher than in PAO1, was reduced in the GUN mutant 
upon glucose addition. The RT-qPCR results confirmed the strong repression of hutU and aruC genes of the 
assimilative pathways of histidine and arginine in the GUN mutant in comparison to PAO1 without glucose. This 
observation was unexpected because both PAO1 and the GUN mutant can rely only on casamino acids as carbon 
source in the absence of glucose. Thus, in principle, they should have a similar expression profile of genes involved 
in amino acids transport and metabolism. Indeed, both genes were expressed in all tested strains/conditions in 
cultures at an early time point (10 min after the addition of glucose; Fig. 3b).
Finally, since nadD and nadE were down-regulated in the GUN mutant with respect to PAO1 (Table 3), we 
measured total NAD(H) in PAO1 and GUN. In agreement with transcriptomic data, we found that in the GUN 
mutant growing with or without glucose, NAD(H) cellular content was significantly reduced in comparison to 
PAO1 growing in the absence of glucose (Fig. 3c), whereas the difference was not significant with respect to PAO1 
growing with glucose.
Overall, these results show that the inactivation of glucose uptake systems largely affects P. aeruginosa gene 
expression regardless of the presence of glucose.
Quorum sensing signal molecules and biofilm formation are altered in the GUN mutant. 
Transcriptomic analysis and/or RT-qPCR showed a significant up-regulation of QS-dependent genes in the GUN 
mutant. Accordingly, the QS receptor genes lasR and rhlR, responding to N−3-oxododecanoyl-homoserine 
lactone (3OC12-HSL) and N-butanoyl-homoserine lactone (C4-HSL) signal molecules, respectively, were also 
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Figure 3. Transcriptome analysis results and differential gene expression validation. (a) Venn-diagrams of 
differentially expressed genes (DEGs). Venn diagrams representing the number of under- (left panel) and 
over-(right panel) expressed genes between GUN + and PAO1 + , GUN + and PAO1 and PAO1 and PAO1 + , 
as indicated. + , RNA extracted from cultures supplemented with glucose. (b,d). RT-qPCR mRNA analyses of 
differentially expressed genes. RNA was extracted from cultures of PAO1 or GUN mutant grown in M9-CAA up 
to OD600 = 0.4 and further incubated 60 min with ( + GLU) or without (- GLU) 0.4% (w/v) glucose and analysed 
by RT-qPCR with proper oligonucleotides. For aruC and hutU gene expression, RNA extracted 10 min after the 
addition of glucose was also analysed as indicated below the histograms. The bars represent relative expression 
with respect to the reference condition (i.e. PAO1 incubated 60 min without glucose; the replicate with lower 
expression was used for normalization). The lowest values obtained in two independent experiments, each 
performed on two technical replicates, are reported. The error bars represent the replicate range. (c). NAD(H) 
relative amount (R.A.). NAD(H) was extracted from cultures grown as described above and quantified as 
detailed in Supplementary Methods. Values were normalized for the lowest value obtained for PAO1 grown 
without glucose. Bars represent average (n = 4) with SD. Significance was evaluated with one-way Anova and 
Tukey post hoc test. *P < 0.05; **P < 0.01. Differences between means that share a letter (on top of the columns) 
are not statistically significant at 0.05 level.
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up-regulated in the GUN mutant (Table 3). To test whether the las and rhl QS circuits were actually altered in the 
GUN mutant, the levels of 3OC12-HSL and C4-HSL signals were measured in PAO1 and GUN cultures grown 
in minimal medium supplemented with casamino acids, with or without glucose. As shown in Fig. 4a, maximal 
3OC12-HSL production was significantly increased in the GUN mutant relative to PAO1. This effect did not 
depend on the differential ability of the two strains to import glucose, since it occurred also in the absence of 
glucose. Conversely, C4-HSL levels were not significantly affected in all the tested conditions.
Biofilm formation in P. aeruginosa is a pleiotropic phenotype depending also upon QS and involving lec-
tins and rhamnolipids, which expression was up-regulated in the GUN mutant (i.e. lecA, lecB and rhlAB genes; 
Table 3). Hence the biofilm forming ability of the GUN mutant was investigated by means of both standard crystal 
violet assay in polystyrene 96-well microtiter and laser scanning confocal microscopy (LSCM) on glass slides 
(Fig. 4b,c). These experiments revealed that biofilm formation was reduced in the GUN mutant relative to PAO1 
irrespective of glucose presence in the medium.
Virulence-related traits of P. aeruginosa mutants defective in glucose uptake. The glucose 
uptake defective mutants were assayed for selected virulence traits, according to the results of GUN transcrip-
tomic analysis and/or to literature data linking glucose and P. aeruginosa pathogenic potential20,26–28. In particu-
lar, we investigated the production of: extracellular proteases; pyocyanin, a blue redox-active molecule inducing 
oxidative stress in host cells; pyoverdine, a siderophore allowing iron acquisition and bacterial growth within the 
host; rhamnolipids, biosurfactants playing a role in biofilm formation and chronic infection; growth in microaer-
ophilic and in anaerobic environments. We found that all strains carrying the kguT deletion produced more 
pyocyanin, pyoverdine and rhamnolipids than PAO1, whereas the glt deletion had no effect on their production. 
Single gntP deletion slightly increased and reduced rhamnolipids and pyoverdine production, respectively, and 
had no effect on pyocyanin (Fig. 5 and Supplementary Fig. S4). It should be noted that, albeit statistically signifi-
cant, the differences between the mutants and PAO1 in the production of both pyoverdine and rhamnolipids were 
small and thus their biological meaning uncertain. As for extracellular proteases, they were comparably produced 
by all strains in the absence of glucose. Glucose supplementation repressed protease production by PAO1 and by 
the single mutants, whereas it did not affect production by the ΔgntP ΔkguT and GUN mutants. Finally, none 
of the tested mutations affected the growth in microaerophilic or anaerobic conditions (Supplementary Fig. S4).
Interfering with oxidative route of glucose import has different outcomes on the virulence in 
Caenorhabditis elegans and Galleria mellonella infection models. The virulence of the glucose uptake 
defective mutants was assayed in two P. aeruginosa infection models, i.e. the nematode Caenorhabditis elegans and 
the Galleria mellonella insect larvae. It should be noted that the paths of P. aeruginosa invasion, and presumably the 
physiology of bacterial cells in the two systems, are largely different. In particular, while in G. mellonella infections 
bacteria are injected in the insect hemolymph, thus causing an acute infection that kills the larvae within 18–40 h 
at 37 °C, in C. elegans slow-killing assay worms are fed on P. aeruginosa cells, which colonize the intestine while 
staying embedded in an extracellular matrix and kill the worms over the course of several days at 20 °C29–32.
In C. elegans slow-killing assay (Supplementary Fig. S5), lethality was visible 7–8 days post-infection with 
PAO1. The ΔkguT and the ΔgntP ΔkguT mutants were slightly but significantly more virulent than PAO1, 
whereas ΔgntP, Δglt and GUN mutants did not show significant differences in virulence relative to the wild type.
Preliminarily to G. mellonella infection with P. aeruginosa, we measured the concentration of glucose in the 
larvae hemolymph. We observed that glucose was relatively scarce (mean value 11.2 μM, corresponding to 2.0 μg/
ml; Supplementary Fig. S2) with respect to a previous estimation33, probably because the larvae were starved for 
24h-48h before starting the experiment. In the larva infection model, the ΔkguT mutant was less virulent than 
GUN + vs. PAO1+ GUN + vs. PAO1
Down-regulated DEGsa
Ribosome (45) Ribosome (39)
Purine metabolism (19) Oxidative phosphorylation (20)
Carbon metabolism (24) Purine metabolism (18)
RNA degradation (7) Metabolic pathways (90)
Denitrification (7) Arginine and proline metabolism (13)
Penthose phosphate cycle (8) RNA degradation (6)
Up-regulated DEGsa
Quorum sensing (21) Quorum sensing (16)
Phenazine biosynthesis (7) Pyoverdine synthesis (6)
Xcp type II secretion system (5) Apr type I secretion system (4)
Apr type I secretion system (5) Phenazine biosynthesis (6)
Pyoverdine synthesis (6) Xcp type II secretion system (5)
Bacterial chemotaxis (10) Nitrogen metabolism (9)
AMBb biosynthesis (3) Bacterial chemotaxis (8)
Table 2. Enriched functional categories among DEGs. aCategories are ordered according to increased adjusted 
probability values. The number of DEGs belonging to each category is indicated in brackets. bAMB, L-2-amino-
4-methoxy-trans-3-butenoic acid.
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PAO1, and significant attenuation was shown by the ΔgntT ΔkguT and GUN multiple mutants. Indeed, 24 h 
post-infection (h.p.i.) the mortality of larvae injected with either ΔgntT ΔkguT or GUN was lower than 40%, 
while the mortality rate of larvae challenged with wild type PAO1 exceeded 75% (Fig. 6a). To test whether atten-
uation of strains lacking the kguT gene was due to slower growth of the mutants in vivo, the hemolymph of larvae 
infected with a comparable number (between 20 and 30) of PAO1, ΔkguT, ΔgntT ΔkguT or GUN cells was recov-
ered 16 h.p.i. and bacteria were titrated. As shown in Fig. 6b, the in larva bacterial load was significantly lower for 
all tested mutants compared to PAO1, whereas no significant difference was detectable among the mutants.
We also evaluated the stimulation of the larvae immune system by measuring the activation of prophenolox-
idase cascade in the hemolymph34 after larvae infection with a lethal dose of PAO1 or of single and multiple 
mutants lacking kguT (Fig. 6c). As expected, we observed an increase in the phenoloxidase production in larvae 
infected with either PAO1 or any of the mutants with respect to larvae injected with sterile physiological solution. 
Phenoloxidase was significantly less abundant in larvae infected with the ΔgntT ΔkguT or GUN mutants with 
respect to those infected with PAO1 or the ΔkguT single mutant.
Discussion
In this work we describe the generation and characterization of a collection of single and multiple mutants of P. 
aeruginosa PAO1 with unmarked, non-polar deletions (see Supplementary results and Supplementary Fig. S6 
for the analysis of mutation polarity) of genes encoding IM proteins involved in glucose transport. The inability 
of the GUN mutant to grow on glucose as unique carbon source confirms that P. aeruginosa does not have any 
Locusa Name
Fold Change
Description
PAO1 + vs. 
PAO1−
GUN + vs. 
PAO1+
GUN + vs. 
PAO1−
Genes up-regulated in GUN mutantb
PA0105 coxB 0.8 8.2 6.5 cytochrome C oxidase subunit
PA1174 napA 0.8 4.8 3.6 nitrate reductase subunit
PA1430 lasR 1.0 1.7 1.8 transcriptional regulator LasR
PA2426 pvdS 2.5 1.9 4.8 sigma factor PvdS
PA2570 lecA 0.7 4.7 3.1 LecA lectin
PA3361 lecB 0.6 5.2 2.9 fucose-binding lectin PA-IIL
PA3477 rhlR 0.8 2.4 1.9 transcriptional regulator RhlR
PA3478 rhlB 0.8 3.0 2.3 rhamnosyltransferase subunit B
PA3479 rhlA 0.7 3.3 2.5 rhamnosyltransferase subunit A
PA3622 rpoS 0.9 2.6 2.4 sigma factor σS
PA3724 lasB 0.5 7.8 3.5 elastase LasB
PA4210 phzA1 0.4 6.2 2.7 phenazine biosynthesis protein
PA4211 phzB1 0.5 7.2 3.2 phenazine biosynthesis protein
PA5348 PA5348 0.8 3.0 2.4 probable DNA-binding protein
Genes down-regulated in the GUN mutantb
PA0576 rpoD 1.1 0.4 0.5 sigma factor σD
PA0893 argR 0.6 0.6 0.4 transcriptional regulator ArgR
PA0895 aruC 0.5 0.3 0.2 acetylornithine aminotransferase
PA2259 ptxS 2.9 0.5 1.4 transcriptional regulator PtxS
PA2264 PA2264 3.4 0.5 1.5 conserved hypothetical proteinc
PA2320 gntR 3.7 0.3 1.1 GntR transcriptional regulator
PA4006 nadD 0.9 0.5 0.5 NAM adenylyltransferase
PA4920 nadE 1.5 0.5 0.8 NAD synthetase
PA5100 hutU 0.8 0.0 0.0 urocanate hydratase
PA5105 hutC 0.8 0.2 0.1 Transcriptional regulator HutC
Genes for glucose IM transporters deleted in this work
PA2262 kguT 1.3 0.3 0.4 2-ketogluconate transporter
PA2322 gntP 35.5 0.0 0.6 gluconate permease
PA3187 gltK 52.0 0.1 6.7 ABC transporter ATP-binding protein
PA3188 gltG 31.6 0.0 0.4 sugar ABC transporter permease
PA3189 gltF 3.5 0.3 0.9 probable permease of ABC sugar transporter
Table 3. Differential expression of selected P. aeruginosa genes. aBoldface characters, genes analysed by RT-
qPCR. bGenes up- and down-regulated in GUN mutant with respect to PAO1 (with and/or without glucose). 
cThe protein contains a domain belonging to the Gluconate 2-dehydrogenase subunit 3 family (InterPro 
IPR027056).
www.nature.com/scientificreports/
8SCIeNTIFIC REPORTS |         (2018) 8:16912  | DOI:10.1038/s41598-018-35087-y
other IM transporter for this sugar besides Glt, GntP and KguT. Similarly, the failure of the double mutant ΔgntP 
ΔkguT and of the single mutant ΔkguT to grow on gluconate and on 2-KG, respectively, confirms that GntP and 
KguT are the only transporters involved in the uptake of intermediates of the oxidative branch of glucose utili-
zation, with the latter being specifically required for 2-KG uptake. Conversely, the lack of any apparent growth 
defect on minimal medium supplemented with glucose (or gluconate) of strains defective for the glucose-specific 
OprB porin and for its paralogue OprB2, whose expression is also regulated by glucose, shows that glucose and 
gluconate can cross the OM through other porins. Indeed, the amino acid- and imipenem- specific OprD porin 
has been shown to facilitate gluconate entry in P. aeruginosa35. Gill et al.36 observed slower growth in minimal 
medium supplemented with glucose by a PAO1 ΔoprB mutant. This discrepancy with respect to our results could 
be explained by the known heterogeneity of PAO1 sublines37 used in different laboratories, and may be due to 
differential expression of genes encoding facilitators of glucose entry in the various PAO1 sublines.
The transcription profile of genes involved in glucose, gluconate and 2-KG transport was coherent with their 
expected regulation by GltR, GntR and PtxS, respectively1. Repression by GntR and PtxS is relieved only if their 
cognate effectors (i.e. gluconate/6-phosphogluconate for GntR and 2-KG for PtxS) are present within the cell 
cytoplasm. Conversely, phosphorylation of the response regulator GltR, which determines its detachment from 
DNA, is triggered by 2-KG interaction with the histidine kinase GtrS in the periplasm1. Consistently, in the 
presence of glucose, the GltR-regulated glt-oprB operon was highly and comparably expressed in PAO1 and in 
the GUN mutant, whereas the expression of the gntP and kgu operons was lower in the mutant and similar to 
that observed in PAO1 grown in the absence of glucose. The same expression pattern was shown by other genes 
connected with glucose catabolism and regulated by HexR, whose effector is synthesized only upon glucose entry 
into the cell1.
Figure 4. Autoinducers production and adhesion assays. (a) Histograms reporting the maximal production 
of QS signal molecules 3OC12-HSL and C4-HSL normalized to the cell density of the culture in the indicated 
strains grown in M9-CAA in the absence (−) or in the presence (+) of 0.4% (w/v) glucose; diamonds indicate 
the corresponding cell density (OD600). Median values of three independent experiments are reported with SD 
(*P < 0.05; **P < 0.01; ns, not statistically significant). (b) Adhesion units determined as A595 of the crystal 
violet stained solubilized biofilms formed by the indicated strains in M9-CAA in the absence (−) or in the 
presence (+) of 0.4% (w/v) glucose, normalized to the cell density (OD600) of the corresponding planktonic 
cultures. Median values of three independent experiments, each performed on 6 technical replicates, are 
reported with SD (***P < 0.001). (c) Representative LSCM images of biofilms formed by the indicated strains 
constitutively expressing GFP grown in M9-CAA in the absence (−) or in the presence (+) of 0.4% (w/v) 
glucose.
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We observed enhanced transcription of both the gntR, gltR and ptxS repressor genes and their gntP, glt-oprB 
and kgu target operons upon glucose addition to PAO1 cultures. This result can be explained considering that 
i) transcription of gntR, gltR and ptxS genes is subject to negative auto-regulation and, limitedly to gltR, also 
to repression by HexR; and ii) increased intracellular concentration of GntR, GltR and PtxS should not result 
in repression of their target operons as long as glucose is present because of the allosteric induction of GntR 
and PtxS and the GltS-dependent phosphorylation of GltR triggered by glucose derivatives1. We speculate that 
increasing the GntR, GltR and PtxS amount as part of the response to glucose may contribute to quickly switch off 
the transcription of the operons regulated by such repressors upon glucose exhaustion.
The effect of glucose addition on PAO1 transcriptome was limited to the induction of 24 genes, mostly 
involved in glucose transport and catabolism, and to the down-regulation of few genes mainly belonging to ArgR 
regulon connected with the transport and utilization of arginine38, which is likely used by PAO1 as carbon source 
when growing in minimal medium with casamino acids. Glucose-dependent induction of fruIKA in PAO1 and 
in the GUN mutant (Supplementary Table S2 and Fig. 3d) was likely due to contaminating fructose originated by 
spontaneous glucose isomerization to fructose39.
The lack of glucose transporters deeply impacts P. aeruginosa transcriptome, with a large numbers of genes 
belonging to various pathways differentially regulated in the GUN mutant with respect to PAO1. The results of 
RT-qPCR and phenotypic assays were consistent with those of the RNASeq analysis and showed that the GUN 
mutant is endowed with a complex phenotype having decreased NAD(H) content, dysregulated quorum sensing, 
reduced biofilm formation and virulence attenuation in G. mellonella in spite of enhanced production of virulence 
factors like pyocyanin, pyoverdine and extracellular proteases. The panorama of genes differentially expressed in 
GUN provides some hints on the physiology of this mutant strain. Downregulation of genes typically expressed 
in the exponential phase and connected with growth, like those encoding ribosomal proteins or the RNA poly-
merase subunits, together with the up-regulation of rpoS, encoding the alternative sigma factor σS, testifies the 
stress condition of the GUN strain. Moreover, aru and hut genes for arginine and histidine utilization are equally 
expressed in PAO1 and GUN mutant in cultures in mid exponential phase (i.e. 10 min after glucose addition to 
cultures at OD600 = 0.4), whereas they are down-regulated in the GUN mutant relative to PAO1 at a later time 
point, suggesting that PAO1 and the GUN mutant could use the amino acids in the medium in a different order 
and/or at a different rate. aru and hut operons are regulated by ArgR and HutC, whose genes are down-regulated 
in the GUN mutant (Table 3), and by the CbrA/CbrB response regulator, which activates transcription of the 
arginine and histidine utilization operons in response to an unknown signal40.
The iron starvation sigma factor pvdS, a major global regulator of iron uptake systems and virulence41, is 
up-regulated in the GUN mutant. The consequent up-regulation of PvdS target genes (e.g. pvd pyoverdine bio-
synthetic genes) and the enhanced pyoverdine production may be linked to a dysregulated iron metabolism. 
Indeed, transcriptomic data suggest that in the GUN mutant a complex reorganization of the electron transport 
chain may take place, and this would require the synthesis of heme- (and thus iron-) containing proteins, possi-
bly enhancing the iron demand of the mutant. However, a regulatory link coordinating iron supply and carbon 
Figure 5. Pyocyanin and pyoverdine production by glucose uptake mutants. Cultures of the strains listed 
above the panels were grown 24 h at 37 °C in LD. ΔΔ indicates PAO1 ΔgntP ΔkguT strain. Pyocyanin (a) and 
pyoverdine (b) were measured as described in Supplementary Experimental procedures. The median (line) 
is reported inside the boxes (n ≥ 5). The whiskers represent the minimum and maximum values observed. 
Significance was estimated with one-way Anova and Tukey post-hoc analysis (ns, not significant; *P < 0.05; 
**P < 0.01; ***P < 0.001), only the results relative to PAO1 are reported.
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Figure 6. G. mellonella infection assay. (a) Survival curves of G. mellonella larvae infected with glucose uptake 
mutants. Kaplan-Meyer curves represent results deriving from three independent experiments in which groups 
of 15 larvae were injected with the indicated strains. The average number of P. aeruginosa cells injected was 
26 ± 5 (PAO1), 31 ± 6 (Δglt), 30 ± 5 (ΔgntP), 28 ± 8 (ΔkguT), 27 ± 6 (ΔgntP ΔkguT), 34 ± 6 (GUN). h, hours 
post-infection. NI (not infected), larvae injected with sterile physiological solution. Significance was estimated 
with log-rank test; only the results relative to PAO1 are reported (*P < 0.05; ****P < 0.0001; ns, not significant). 
(b) The dots represent bacterial titre 16 h post-infection in the hemolymph of larvae (n = 24 ± 4) infected 
with 10 µl of physiological solution containing the following number of bacterial cells: 33 ± 8 (PAO1), 37 ± 5 
(ΔkguT), 34 ± 8 (ΔΔ, ΔgntP ΔkguT), 34 ± 9 (GUN). The results were plotted with OriginPro (OriginLab). 
The line represents the mean value. Significance was estimated with one-way Anova and Tukey post-hoc 
analysis (***P < 0.001). Differences among the ΔkguT, ΔgntP ΔkguT and GUN mutants were not significant 
at 0.05 level. (c) Phenoloxidase activity assay. Hemolymph was collected 4 h post-infection with 20000 cfu of 
the bacterial strains listed in the panel. The hemolymph samples deriving from groups of ten larvae infected 
with the same strain were pooled and phenoloxidase activity at 30 min was estimated as described in Methods. 
The results of four experiments done in different days (n = 12) are shown. Bars represent average with SD. 
Significance was estimated with one-way Anova and Tukey post-hoc analysis (****P < 0.0001; **P < 0.01; 
P*P < 0.05). Differences between means that share a letter (on the columns) are not statistically significant at 
0.05 level.
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metabolism has been recently established in pseudomonads42,43, opening the possibility that pvdS up-regulation 
may be actually part of a stress response elicited by carbon metabolism defects of the GUN mutant.
It is likely that the altered QS cascade and biofilm formation observed in in the GUN mutant may also be 
related to its complex metabolic dysregulation. We observed increased production of the 3OC12-HSL signal mole-
cule in the GUN mutant relative to PAO1, in line with increased RNA level of the lasR gene and with the enhanced 
production of LasR-controlled virulence factors, like pyocyanin and proteases. The las QS system usually exerts a 
positive regulatory role on the C4- HSL-dependent rhl QS circuit. Indeed, the rhlR gene and the RhlR-dependent 
rhlAB genes for rhamnolipids production were up-regulated, but unexpectedly production of the C4-HSL signal 
molecule was unaffected. QS circuits in P. aeruginosa not only respond to cell density, since their activation is 
finely modulated by a plethora of environmental and metabolic stimuli44,45. Moreover, hierarchical organization 
of the QS cascade in P. aeruginosa, with the las system being required for full activation of the rhl QS circuit, has 
been mainly described in rich media, while this connection is possibly missing or altered in other growth condi-
tions46,47. Altered QS cascade may in turn interfere with biofilm formation, as it is known that a large number of 
factors controlled by QS may impact biofilm formation48. However, biofilm formation is a pleiotropic phenotype 
affected by multiple environmental and metabolic stimuli whose signalling pathways are altered in the GUN 
mutant, including QS, iron uptake systems, and arginine metabolism49,50. Hence, while altered biofilm formation 
in the GUN mutant relative to PAO1 is not surprising, defining the specific impact of GUN-controlled pheno-
types on biofilm formation is a puzzling issue that will deserve further investigation.
Interestingly, the global transcription profile and most of the assayed phenotypic traits differ between the 
GUN mutant and PAO1 irrespective of the presence of glucose. In particular, the GUN mutant seems to per-
ceive nutrient starvation in conditions in which PAO1 does not. As an example, in the GUN mutant, a strong 
up-regulation of cox genes encoding the aa3 terminal oxidase, which is expressed in nutrient starvation condi-
tions23, is observed (Table 3 and Fig. 3b). This suggests that the investigated glucose uptake systems may have 
other functions independent of glucose transport. It is tempting to speculate that one or more of the proteins 
missing in the GUN mutant may participate in the regulation of cell metabolism, for instance by modulating the 
activity of sensor histidine kinases (HK) of two-component systems as it has been found for the E. coli dicarbox-
ylic acid transporters DauA, which regulates the HK DcuS51. KguT could be a good candidate for such an acces-
sory function as it plays a major role in determining relevant phenotypes in vitro and in vivo. Indeed, we observed 
enhanced in vitro secretion of the virulence factors pyocyanin and pyoverdine by all mutants lacking the KguT 
transporter. On the other hand, such mutants showed attenuated virulence in G. mellonella, suggesting that pyo-
cyanin and pyoverdine increased production, if occurring also in vivo, is either scarcely relevant or counteracted 
by other mutants’ features detrimental to the in larva growth.
Larvae infected with the GUN mutant showed lower phenoloxidase production than those infected with 
PAO1 or the ΔkguT single mutant. Pro-phenoloxidase cascade is triggered not only by the lipopolysaccharide 
of the bacterial OM, but also by specific bacterial proteins like thermolysin52. Further analyses will be required 
to assess whether factors stimulating pro-phenoloxidase cascade are differentially produced by the GUN mutant 
with respect to PAO1 and the ΔkguT strain.
The single ΔkguT and the double ΔgntP ΔkguT mutants were slightly more virulent than PAO1 in C. elegans. 
Thus, the bacterial ability to import (and use) glucose, as well as the accessory function of the glucose uptake 
transporters in the regulation of cell metabolism highlighted in this study, may have a different relevance in differ-
ent infection models. In agreement with this observation, PAO1 mutants defective in glucose metabolism genes 
(i.e. ΔoprB, ΔgltK, ΔgtrS and Δglk mutants) were shown to cause a reduced bacterial load with respect to wild 
type PAO1 in the airways of hyperglycaemic mice, but not in those of normal ones36. This suggests that targeting 
glucose metabolism with specific drugs may differentially impact the outcome of chronic and acute human infec-
tions caused by P. aeruginosa, depending on the particular nutritional milieu at the site of infection and on the 
specific strategy adopted by P. aeruginosa to thrive within the host in each case. A deeper knowledge of bacterial 
physiological state in the different human infections together with the availability of proper preclinical infection 
models recapitulating them are needed to develop effective therapeutic strategies based on the inhibition of bac-
terial metabolic functions.
Methods
Bacteria, plasmids and oligonucleotides. Bacterial strains, plasmids and oligonucleotides used in this 
study are listed in Supplementary Table S1. P. aeruginosa genome coordinates throughout this work refer to PAO1 
strain, Genbank Accession Number NC_002516.2. Construction of PAO1 deletion mutants in glucose uptake 
genes by gene replacement53 and kguT cloning in pGM2071 plasmid are detailed in Supplementary Methods. 
Bacterial cultures were grown in LD broth or M8 and M9 minimal media54,55. M9-CAA is M9 supplemented with 
0.2% (w/v) casamino acids (i.e. Casein Hydrolysate, Sigma-Aldrich). When needed, media were supplemented 
as follows: 100 µg/ml ampicillin, 150–300 µg/ml carbenicillin, 10 µg/ml nalidixic acid, 0.4% (w/v) glucose, 0.4% 
(w/v) gluconate, 0.1% (w/v) 2-ketogluconate, 0.5–1% (w/v) succinate, 0.02% (w/v) arabinose, 10% (w/v) sucrose 
and 0.05% (v/v) Triton X-100. To prevent calcium precipitation, a calcium free solution of 2-ketogluconate was 
prepared as previously indicated5.
RNA extraction for RNA-Seq. Total RNA was extracted as previously described56 from P. aeruginosa cul-
tures grown in M9-CAA at 37 °C up to OD600 = 0.4 and further incubated 60 min with or without 0.4% (w/v) 
glucose; biological duplicates of the experiments were performed. Ribosomal RNA was depleted from 1 µg of 
total RNA with the RiboZero Gram positive kit (Illumina) according to the manufacturer’s instructions. Strand 
specific RNA-Seq libraries were prepared with the ScriptSeqTM v2 RNAseq library preparation kit (Illumina) 
from 50 ng of rRNA-depleted RNA. The libraries were sequenced on a MiSeq Illumina sequencer; 75 bp Single 
End reads were produced.
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RNA-Seq data analysis and PAO1 genome annotation. The strategy that we followed to obtain a 
comprehensive annotation of PAO1 genome is detailed in Supplementary Methods. Bowtie 2 (v2.2.6)57 was used 
to align raw reads to P. aeruginosa PAO1 genome (GCF_000006765.1) and only high quality reads (MAPQ > 30) 
were considered for the subsequent step of the analysis. The R58 package DESeq. 2 (v1.14.1)59 was used to nor-
malize the counts and to produce the differentially expressed gene lists, setting independent filtering to FALSE. 
The enrichment of functional categories was calculated using Fisher test and Benjamini Hochberg correction for 
multiple testing. The categories with an adjusted P value (Padj) ≤ 0.05 were considered significantly enriched.
RT-qPCR mRNA analysis. RT-qPCR (Reverse Transcription-quantitative PCR) was performed on 1 µg of 
RNA extracted from two independent cultures for each strain grown as for the RNASeq. Technical details and the 
list of primers specific for each analysed gene is provided in Supplementary Methods and Table S1. Two technical 
duplicates were performed for each biological replicate. 16 S rRNA was used as reference gene.
In vitro phenotypic assays. Anaerobic and microaerophilic growth condition and a detailed description 
of the in vitro phenotypic assays applied in this work are provided in Supplementary Methods. In brief, NAD(H) 
content in samples of PAO1 and GUN cultures grown as for the RNASeq was quantified by a cyclic assay60. 
Pyocyanin, pyoverdine and rhamnolipids production was estimated as described54,61,62 on stationary cultures 
grown in LD at 37 °C. Extracellular proteases were tested by spotting supernatants of cultures grown 17 h at 
37 °C in M9-CAA with or without 0.4% glucose onto casein-agar plates. Levels of QS signal molecules in P. 
aeruginosa PAO1 wild type and GUN mutant culture supernatants were determined at different times during 
bacterial growth in M9-CAA with or without 0.4% (w/v) glucose as described63. Maximal QS signal molecule 
concentration determined during bacterial growth is reported in Fig. 4a. Biofilm formation by PAO1 wild type 
GUN mutant grown in M9-CAA with or without 0.4% (w/v) glucose for overnight (i.e. 16 h) was assessed using 
the microtiter plate biofilm assay64. For microscopic visualization of biofilm, P. aeruginosa PAO1 wild type and 
GUN mutant constitutively expressing GFP via the pMRP9–1 plasmid65 were grown in an 8-well chamber slide, 
as previously described66, in M9-CAA in the absence or in the presence of 0.4% (w/v) glucose. Biofilms formation 
was examined after 3 days incubation by using the Leica TCS SP5 confocal microscope. For QS signal molecules 
and CV biofilm quantification statistical analyses were performed by using the GraphPad Prism software (San 
Diego, CA, USA), with a Tuckey test of the One-way ANOVA tool.
C. elegans slow killing assay. 50 worms synchronised at the L4 stage67,68 (see Supplementary Methods) 
were individually transferred from a Nematode Growth Medium (NGM) plate (US Biological) onto an NGM 
plate supplemented with 5-Fluoro-2′-deoxyuridine thymidylate synthase inhibitor (FUDR, Sigma-Aldrich), an 
inhibitor of DNA synthesis preventing C. elegans reproduction, without interfering with nematodes development 
and ageing69. Each plate was seeded with one bacterial strain using a sterilized platinum wire with the aid of a 
stereomicroscope. As negative control, 50 synchronized worms were transferred to an NGM plus FUDR plate 
seeded with E. coli OP50. Plates were incubated at 20 °C and the number of live nematodes was counted every day 
over a period of 21 days. A worm was considered dead when it no longer responded to touch. The experiment was 
repeated at least three times for each strains. The software GraphPad Prism (GraphPad Software, San Diego, CA, 
USA) was used to plot charts and perform statistical analyses.
G. mellonella infection experiments. P. aeruginosa cultures for G. mellonella infections were grown to 
mid-log phase in LD medium, washed, re-suspended to OD600 = 1 and diluted in physiological solution (0.9% 
(w/v) NaCl) accordingly to the required inoculum size. G. mellonella caterpillars in the final instar larval stage 
were purchased from the Allevamento Cirà, Como, Italy, and starved 24–48 h before starting the experiments. 
The larvae were infected by injection in the last proleg of bacterial cells resuspended in 10 µl of physiological 
solution. Infected and mock-infected (i.e. with sterile physiological solution) larvae were incubated at 37 °C in 
Petri dishes and survival monitored for 42 h. Larvae were considered dead when they did not respond to gen-
tle prodding. Statistical analyses were carried out using GraphPad Prism (GraphPad Software, San Diego, CA, 
USA). Survival curves were plotted using the Kaplan-Meier method, and differences in survival were calculated 
using the log-rank test for multiple comparisons. For measuring the bacterial titre in the hemolymph, larvae 
infected as described above, were sacrificed after 16 h incubation at 37 °C. The hemolymph was collected by punc-
turing with a needle cold-anesthetized larvae, diluted in physiological solution and plated on LD-ampicillin. 
Prophenoloxidase cascade activation in the hemolymph was measured as described70 on samples collected 
as described above from larvae infected with 10 µl of physiological solution containing about 2 × 104 CFU or 
mock-infected. The larvae were sacrificed after 4 h incubation at 37 °C. Hemolymph samples obtained from 5 
individuals per condition (15 µl/larva) were mixed and centrifuged at 1500 g for 10 min at 4 °C for removing 
hemocytes. Immediately after centrifugation, samples were diluted tenfold in TBS (50 mM Tris–HCl pH 6.8, 
1 mM NaCl). 2 µl were added to 18 µl of TBS additionated with 5 mM CaCl2 in polystyrene 96-well microplates 
and incubated 20 min at room temperature. 180 µl of 2 mM dopamine in 50 mM sodium phosphate (pH 6.5) were 
added. Melanin formation was estimated by measuring absorbance at 490 nm over 45 min at 15-min intervals 
using an Ensight (PerkinElmer) microplate reader.
Glucose quantification in growth media and G. mellonella hemolymph. Glucose concentration in 
growth media (LD and 2% casamino acids stock solution) and Galleria mellonella hemolymph was measured with 
the Glucose (HK) Assay Kit (Sigma-Aldrich) as detailed in Supplementary Methods.
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Data Availability
Raw sequencing data are publicly available at Sequence Reads Archive under accession number PRJNA479815. 
Bacterial strains and other datasets presented in this study are available from the corresponding author.
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 SUPPLEMENTARY RESULTS 
 
glt, gntP and kguT deletions have not polar effect on the transcription of downstream genes 
We analysed the transcription profile in the GUN mutant of oprB, gapN and kguD genes, which are 
located downstream of gltK, gntP and kguT, respectively, to verify whether the Δglt, ΔgntP and 
ΔkguT deletions may have polar effect. We observed that the transcription pattern of gapN and 
oprB was very similar in the GUN mutant and in the wild type PAO1 (regardless of the presence of 
glucose; Supplementary Fig. S6). However, the analysis of transcription profile did not allow to 
draw any conclusion about the expression of kguD, the gene downstream of kguT, because the kgu 
operon was poorly transcribed in the tested strains. We thus expressed in trans the kguT gene in the 
ΔkguT mutant via an arabinose-inducible expression vector, and tested the ability of this strain to 
growth on 2-KG as sole carbon source. As shown in Supplementary Figure S6, plasmid-driven 
expression of kguT restored growth to wild type levels in the ΔkguT mutant in this medium. Since 
the kguT downstream gene kguD should be required for P. aeruginosa growth on 2-KG1, this result 
suggests that the ΔkguT mutation has no polar effect on the expression of kguD. 
 
SUPPLEMENTARY METHODS 
Bacterial strains and plasmid construction 
PAO1 deletion mutants of glucose uptake genes were constructed by gene replacement2. 500 bp 
long amplicons corresponding to the regions flanking the section to be deleted were obtained by 
PCR with proper oligonucleotides (i.e. oprB, 3287-3288 and 3289-3290; PA2291, 3291-3292 and 
3304-3294; kguT, 3338-3339 and 3340-3341; gntP, 3343-3344 and 3345-3346; gltKGF, 3287-3367 
and 3368-3369; Supplementary Table S1) and fused by overlapping PCR into a unique 1kb-long 
fragment, which was cloned into the BamHI-SpeI restriction sites of the suicide vector pKNG101. 
The recombinant plasmids (Supplementary Table S1) were constructed in E. coli CC118λpir and 
mobilized into P. aeruginosa by triparental conjugation3. Clones bearing the plasmids integrated 
into the chromosome were selected on streptomycin plates. The deletion mutants were selected on 
LD plates containing 10% sucrose as previously described2. Gene deletion was confirmed by PCR 
with proper oligonucleotides. 
pGM2071 plasmid was constructed as follows. A PCR product covering the 2490689-2492060 
region (i.e. the kguT open reading frame with the 50 bp upstream) was amplified using 
oligonucleotides 3401 and 3402. The product was digested with KpnI and ligated into pGM931 
downstream of the araBp promoter, obtaining pGM2071. The plasmid was constructed in E. coli 
DH10B and transferred into PAMO108 (namely PAO1 ΔkguT) by transformation. 
 
PAO1 genome annotation and RNA-Seq data analysis  
To obtain a comprehensive annotation of PAO1 genome, we merged the annotations provided by 
the Pseudomonas Genome Database www.Pseudomonas.com4 and RefSeq in the versions available 
on Dec 2017. The Pseudomonas Genome Database was selected as main reference and records 
present only in RefSeq annotation were manually integrated. Few genes showed the same 
Locus_Tag but different start and/or end among the two annotations; in such case, we choose to 
consider the largest gene unless if it included other annotated features. To functionally annotate the 
genome, we integrated KEGG and pseudoCAP information in the version provided by the 
Pseudomonas Genome Database and we merged the corresponding functional categories showing 
slightly different names among the two (see Supplementary Table S2).  
BEDTools (v2.24.0)5 and SAMtools (v0.1.19)6 were adopted to verify library preparation and 
sequencing performances (see sequencing statistics sheet in Supplementary Table S2). A minimum 
of 2.8 M of reads was produced for each sample and biological replica and, on average, more than 
90% of the reads resulted of high quality. Less than 1% of the mapped reads mapped on ribosomal 
RNAs; reads strand specificity, calculated on annotated CDS, was higher than 90% in every sample 
and the CDS coverage was enough for the gene expression analysis (i.e. 90% of the genes were 
covered by a minimum of 4 strand specific reads). To avoid double counting of reads mapping 
across two genes, only strand specific reads covering a CDS for at least 50% of their length were 
considered for gene read counts. 
 
RT-qPCR mRNA analysis 
The RNA was reverse-transcribed with the Takara PrimeScriptTM RT kit (Perfect Real Time) and 
cDNA was used for Real-Time PCR with SYBR® Premix Ex TaqTM (Takara) and primers specific 
for each gene (3478-3479, lasR; 3480-3481, ptxS; 3482-3483, PA2264; 3492-3493, fruI; 3494-
3495, lasB; 3511-3512, coxB; 3513-3514, napA; 3522-3523, aruC; 3524-3525, hutU; 3526-3527, 
PA5348; see Supplementary Table S1). 16S rRNA was used as reference gene (primers 3398-3399) 
to normalize Real Time PCR results and to calculate the relative fold change in gene expression 
with the 2-ΔΔCt method7. 
 
 
 
NAD(H) quantification 
Cells were harvested by centrifugation from 40 ml cultures of PAO1 and GUN strains grown as for 
the RNASeq. Cells were resuspended in 1 ml of cold physiological solution, split in two 1.5 ml 
tubes and immediately centrifuged at 16000xg for 1 min. 100 μl of either 0.2 M NAOH (for NAD+ 
extraction) or 0.2 M HCl (for NADH extraction) were added to the cell pellets. Samples were 
incubated 10 min at 50 °C and then on ice for 10 min. 100 μl of either 0.1 M HCl (for NAD+ 
extraction) or 0.1 M NaOH (for NADH extraction) were added dropwise while agitating the 
samples, which were then centrifuged 10 min at 16000xg. The supernatants containing NAD 
dinucleotide were transferred to fresh tubes. NADH and NAD+ were immediately quantified by a 
cyclic assay as previously described8. 90-μl aliquots of a mix prepared with 1 vol of Bicine buffer 
(2.0 M, pH 8.0), 8 vol water, 1 vol 80 mM EDTA, 2 vol 100% ethanol, 2 vol 4.2 mM thiazolyl blue 
and 4 vol 16.6 mM phenazine ethosulfate were dispensed into the wells of a 96-well microtiter 
plate. Five microliters of either NAD+ (Sigma) and NADH (Sigma) standard solutions or sample 
were added to each well and the reaction was started by the addition of 5 μl of alcohol 
dehydrogenase (Sigma) at 347 units/ml in 0.1 M Bicine (pH 8.0). Absorbance at 570 nm was read 
every 60 seconds by means an Ensight (PerkinElmer) microplate reader. Slopes of the absorbance 
curves over time of NADH and NAD+ solutions were used to generate standard curves, which were 
used to calculate NAD concentrations (in μM) in the samples. Values were normalized for the 
optical density of the original cell culture sample and for NAD concentration in reference condition 
(i.e. PAO1 without glucose). 
 
Secretion of pyocyanin, pyoverdine, proteases and rhamnolipids 
Bacterial cultures for pyocyanin and pyoverdine extraction were grown at 37°C for 24 h in LD. 
Pyocyanin was extracted from the supernatant with chloroform and HCl as described9. The relative 
concentration of pyocyanin was determined as the ratio between the A520 of the resulting solution 
and the OD600 of the culture. Relative pyoverdine concentration10 was determined as the ratio 
between the A405 of the culture supernatant mixed with an equal volume of 200 mM Tris-HCl (pH 
8) and the OD600 of the culture. Extracellular proteases were tested by spotting onto casein-agar 
plates (1% agar supplemented with 1% casein and 150 µg/ml carbenicillin, to prevent cell growth) 2 
µl of supernatants of cultures grown as described in Supplementary Fig. S4 legend and properly 
diluted to the same OD600 before cells removal by centrifugation and plating. For detection of 
rhamnolipids11, overnight cultures in LD were washed in 1x PBS and resuspended in the same 
solution at OD600= 4. 5 µl were spotted onto 1.6% M8-BactoAgar (Difco) medium supplemented 
with 2 mM MgSO4, 0.05% (w/v) glutamic acid, 2% (v/v) glycerol, 0.5% (w/v) succinate, 0.02% 
(w/v) cetyltrimethylammonium bromide (CTAB), and 0.0005% (w/v) methylene blue. Plates were 
incubated at 37°C for 24 h, then at room temperature for 4 days, and finally at 4°C for 24 h. The 
dark blue halo surrounding the cell spot due to the precipitation of CTAB and methylene blue was 
measured as an indication of rhamnolipid secretion.  
 
Growth in anaerobiosis and microaerophilic conditions 
A single colony was resuspended in 100 μl of 1x PBS in 96-well polystyrene microplates. Serial 
ten-fold dilutions were replicated on plates of LD/Agar supplemented with 100 mM KNO3. The 
plates were incubated at 37°C for 16 h in aerobic conditions or for 48 h inside an anaerobic jar 
AnaeroJar (Oxoid) containing an AnaeroGen sachet (Oxoid). For microaerophilic growth, bacterial 
cultures were inoculated at OD600= 0.1 in 100 μl of LD or M9-CAA in 96-well polystyrene 
microplates and overlaid with 50 μl of paraffin oil to prevent evaporation. The microplates were 
incubated static for 16 h at 37°C and the OD600 was measured by means of an Ensight 
(PerkinElmer) microplate reader.  
 
Quantification of QS signal molecules 
Levels of QS signal molecules in P. aeruginosa PAO1 wild type and GUN mutant culture 
supernatants were determined at different times during bacterial growth as previously described12. 
Briefly, the strains were grown at 37°C in shaking (200 rpm) in M9-CAA in the absence or in the 
presence of 0.4 % (w/v) glucose. Ten-µl of culture supernatants (or appropriate dilutions) were 
added to 190 µl of LB inoculated with reporter strains specific for 3OC12-HSL13, or C4-HSL14 to a 
final OD600 of 0.045 in black clear-bottom 96-well microtiter plates. Microtiter plates were 
incubated at 37°C with gentle shaking, and the OD600 and relative light units (RLU) were measured 
after 4 h of growth for the 3OC12-HSL biosensor or 7 h of growth for the C4-HSL biosensor. 
Dedicated calibration curves were generated by growing each reporter strain in the presence of 
increasing concentrations of the corresponding synthetic signal molecule, and these curves were 
used to calculate the concentration of the different QS signal molecules in each culture supernatant. 
Maximal QS signal molecule concentration determined during bacterial growth is reported in Fig. 
4a.  
 
Biofilm formation  
Biofilm formation was assessed using the microtiter plate biofilm assay15. Briefly, P. aeruginosa 
PAO1 wild type an GUN mutant were grown in M9-CAA at 37°C in shaking (200 rpm) in M9-
CAA in the absence or in the presence of 0.4 % (w/v) glucose for overnight (i.e. 16 h). Overnight 
cultures were diluted to an OD600 of 0.05 in the corresponding medium, and 100 µl aliquots were 
transferred to a sterile 96-well polystyrene microtiter plate (6 wells per sample) and incubated at 
30°C for 8 h. Planktonic cells were transferred to a sterile microtiter plate for OD600 measurements 
in a TECAN Spark 10M multilabel plate reader, while the attached cells were stained with 1% 
(w/v) crystal violet. After washing the wells five times with distilled water, the surface-associated 
dye was solubilized with 200 µl of ethanol. The A595 of the dye solution was measured in a TECAN 
Spark 10M multilabel plate reader. Adhesion units were determined as A595 normalized to OD600. 
For microscopic visualization of biofilm, P. aeruginosa PAO1 wild type and GUN mutant 
constitutively expressing GFP via the pMRP9-1 plasmid16 were grown in an 8-well chamber slide, 
as previously described17, with minor modifications. Briefly, bacterial cells were inoculated at an 
OD600 of 0.02 in 700 µL of M9-CAA in the absence or in the presence of 0.4 % (w/v) glucose. 
Cultures were incubated at 30°C for 24 h to allow the adhesion of the bacterial cells on the glass 
surface. To maintain bacterial viability, the medium was changed every 24 h. Biofilms formation 
was examined after 3 days incubation by using the Leica TCS SP5 confocal microscope. Ten 
random fields were examined for each sample, and representative images are reported in Fig. 4c. 
 
Synchronization of C. elegans  
The bleaching technique was used to synchronise C. elegans at the first larval stage (L1)18, with 
minor modifications. Adult worms are sensitive to bleach (5% solution of sodium hypochlorite, 
NaClO) and die quickly, while the embryos are protected by the eggshell. C. elegans NGM plates 
were washed twice with 7 ml of M9 medium (Sigma-Aldrich). The supernatant containing the 
worms was transfer in a centrifuge tube and the worms pelleted for 1 min centrifugation at 1500xg. 
Worms’ pellet was washed with until the liquid was clear. 3.5 ml of M9, 500 µl of 5 M NaOH and 1 
ml of bleach were then added to the pellet. To not damage embryos, bleach-induced death was 
observed by using a stereomicroscope to verify the dissolution of adult worms that typically occurs 
within 4 minutes. Bleach was inactivated by adding M9 to a final volume of 15 ml, and the tubes 
centrifuged 2 minutes at 1500xg. Eggs’ pellet was then washed five times with 15 ml of M9. 6 ml 
of M9 were then added and the tubes were placed in a dark environment at room temperature and 
slow agitation for two days. Synchronized worms were then gently transferred to NGM plates 
seeded with E. coli OP50 and maintained at 20° C for two days. 
 
Glucose quantification in growth media and G. mellonella hemolymph 
Glucose concentration in growth media (LD and 2% casamino acids stock solution) and Galleria 
mellonella hemolymph was measured with the Glucose (HK) Assay Kit (Sigma-Aldrich) following 
the recommendations of the provider. Hemolymph samples obtained from 5 larvae (30 µl/larva) 
were mixed and centrifuged at 1500xg for 10 min at 4°C for hemocytes removal. 40 µl samples 
were combined with 200 µl of either Glucose Assay Reagent or 50mM Tris-HCl pH 7.5 (blank 
samples) and incubated 15 min at room temperature before reading the absorbance at 340 nm by 
means of an Ensight (PerkinElmer) microplate reader. Glucose concentration was determined by 
comparison with a glucose standard curve obtained by testing known dilutions of Glucose Standard 
Solution (Sigma-Aldrich). 
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 Supplementary Table S1. Bacterial strains, oligonucleotides and plasmids 
Bacteria 
Strain  Mutation  Deletiona  Reference 
P. aeruginosa 
PAO1  na  none  19 
PAMO104  ΔoprB  Δ1 (3575912-3577276)  this work  
PAMO105  ΔPA2291  Δ2 (2521224-2522643)   this work  
PAMO106  ΔoprB ΔPA2291  Δ1 and Δ2  this work  
PAMO107  ΔgntP  Δ3 (2560762-2562114)  this work  
PAMO108  ΔkguT  Δ4 (2490738-2492045)  this work  
PAMO109  ΔgntP ΔkguT  Δ3 and Δ4  this work  
PAMO110  ΔgltKGF ΔgntP ΔkguT  Δ3, Δ4 and Δ5  this work 
PAMO111  ΔgltKGF  Δ5 (3577778-3580283)  this work  
E. coli 
CC118λpir      20 
DH10B      21 
HB101      22 
Oligonucleotides 
Name 5’→3’ Sequenceb Coordinatesa 
3287 GGGGGATCCTCATCGGTTCGCCGCCGA 3577777 - 3577760 
3288 TTCCAGCGTCCTCGTGGTTG 3577277 - 3577296 
3289 CACGAGGACGCTGGAATCGTCGCGTTGCCTGCTC 3577292 - 3577277 
3575911 - 3575894 
3290 GGGACTAGTGCGGCCATTCGCTGCCG 3575412 - 3575428 
3291 GGGGGATCCGCAATGCCGGGCGCAGC 2523117 - 2523101 
3292 GCGAACGCTTCCTCGTTGC 2522617 - 2522635 
3294 GGGACTAGTGTCGGCCAGCAGCGGGC 2520757 - 2520773 
3304 GATCCAGACGGTGTTCTAGGC 2521276 - 2521256 
3316 CGGGGTCGACGAGGTCGACAACGCG 2521318 - 2521294 
3317 CTGGTGGCGGGGATCAAGATCCAGACGGTG 2521293 - 2521264 
3338 GGGGGATCCCATGATCGCCGAGATCAACGC 2490261 - 2490281 
3339 GGTCGGGTATCTCCTGAGC 2490737 - 2490719 
3340 GCTCAGGAGATACCCGACCCCGACTCCGGAGCATCCG 2490719 - 2490737 
2492046 - 2492063 
3341 GGGACTAGTCCCATGCCGACGATACCGAG 2492521 -2492502 
3342 CAACCCGCACGCCGACAAGCGCG 2491967 - 2491989 
3343 GGGGGATCCACATCCGCAAGATGAGCGCC 2560274 - 2560293 
3344 GGAGGGCTCTCCTTTTGTCG 2560761 - 2560742 
3345 CGACAAAAGGAGAGCCCTCCGCACCAGCCCGACCGGA 2560742 - 2560761 
2562115 - 2562131 
3346 GGGACTAGTCGAGGAATACCGGGCTGCGT 2562609 - 2562590 
3347 GACCGCGATGGAGACCATCCTCTCCG 2562045 - 2562070 
3354 TCGCTGTGGCCCAGCGAGCGCCG 2490238 - 2490260 
3355 CGGGCCAGGGCCTCGCCGATGC 2492524 - 2492545 
3367 GGGACTAGTTGGTCTAGGCAGTACGAAAGGAT 3577297 - 3577319 
3368 TCGGCGGCGAACCGATGAGCGTTTTCTCGCGTGCGAAG 3577760 - 3577777 
3580284 - 3580303 
3369 GGGGTCGACAGCAACGCGGAGAACCGCAA 3580722 - 3580703 
3370 ACTCGCTGGTGATGTTCAAGCT 3580745 - 3580724 
3371 TATTCCGAACTGCGAGGCAAGC 3579383 - 3579362 
3372 TTGTGCAGGTTGCGCAGTTCG 3578449 - 3578469 
3401 GGGGGTACCATGCTCCGGAGTCGGTCAG 2492060 - 2492042 
3402 GGGGGTACCGCGGCACCTGTTGCGACAA 2490689 - 2490707 
3478 AGCACGAGTTCTTCGAGGAAG 1558463 - 1558483 
3479 GTTTTCCGCTTCCACGCTGA 1558578 - 1558559 
3480 AACACGGCTACAGCCTGGTG 2488148 - 2488167 
3481 ACGATCAGTCCTTCGACGTTGTA 2488250 - 2488228 
3482 CATCGACCGACAGATGGAAAC 2493478 - 2493498 
3483 GTGGCACCAGCTTCAACTGAT 2493590 - 2493570 
3492 ACCGAACAGTTGCAGCAGGC 3992539 - 3992520 
3493 AGGTTGGCGCAGACTTCCAC 3992412 - 3992431 
3494 AAGACCGGCGAAGTGCTCGA 4169934 - 4169915 
3495 TAGTCGCTACCGTAGGTGTACTT 4169831 - 4169853 
3511 GAGAGCACCACGGTGGAAAT 127618 - 127637 
3512 GGAAGTGTCGTAGATGTGGATC 127722 - 127701 
3513 ACATCAAGGCCGAGGTCAAC 1275599 - 1275580 
3514 AACTTGCCGTCCTTCATGCG 1275482 - 1275501 
3522 AACTGATCGATTTCGCCGGC 978037 - 978056 
3523 GACGTTGGAAACGTGCCAGAT 978149 - 978129 
3524 GCATGCTGATGAACAACCTCG 5744659 - 5744639 
3525 TGTCGTAGCACTCCCAGTTG 5744555 - 5744574 
3526 AAGGCCGATCTCACCAAGGAA 6017386 - 6017366 
3527 GTTGCAGGAAGGTGCCGAAA 6017266 - 6017285 
Plasmids 
 
Name Relevant characteristicsc Reference 
pRK2013 ColE1 ori tra+ mob+ Kmr 23 
pKNG101 Suicide vector in P. aeruginosa sacB Smr 2 
pGM931 pHERD20T derivative carrying araBp-tΩ region 24 
pGM2050 pKNG101 derivative, carries oprB US (3577277-       
3577777) and DS (3575412-3575911) fragments 
this work 
pGM2051 pKNG101 derivative, carries PA2291 US (2522617-      -
2523117) and DS (2520757-2521257) fragments 
this work 
pGM2059 pKNG101 derivative, carries gntP US (2560274-2560761) 
and DS (2562115-2562609) fragments 
this work 
pGM2060 pKNG101 derivative, carries kguT US (2490261-2490737) 
and DS (2492046-2492545) fragments 
this work 
pGM2066 pKNG101 derivative, carries gltF US (3580284-3580722) 
and gltK (3577297-3577777) fragments 
this work 
pGM2071 pGM931 derivative, carries kguT (2490689-2492060) 
under araBp control 
this work 
pMRP9-1  16 
aCoordinates refer to P. aeruginosa PAO1 NCBI Reference Sequence: NC_002516.2.  
bUnderlined characters, restriction sites. 
cUS, upstream; DS, downstream 
Supplementary Table S2. List of differentially expressed genes and general statistics 
Locus2 
Log2 Fold Change1 
Name Description 
GUN+ vs. 
PAO1+ 
GUN+ vs. 
PAO1 
PAO1+ 
vs. PAO1 
PA0009 -0,94 -1,05 -0,11 glyQ glycyl-tRNA synthetase alpha chain 
PA0039 1,17 1,39 0,22 NA hypothetical protein 
PA0045 -1,62 -1,93 -0,31 NA hypothetical protein 
PA0046 -1,97 -2,00 -0,04 NA hypothetical protein 
PA0047 -1,20 -1,29 -0,09 NA hypothetical protein 
PA0049 -3,54 -4,25 -0,71 NA hypothetical protein 
PA0052 1,67 0,95 -0,72 NA hypothetical protein 
PA0059 1,37 1,93 0,56 osmC osmotically inducible protein OsmC 
PA0082 -0,73 -1,38 -0,65 tssA1 TssA1 
PA0083 -0,75 -1,28 -0,53 tssB1 TssB1 
PA0084 -0,79 -1,22 -0,42 tssC1 TssC1 
PA0090 -0,76 -1,19 -0,43 clpV1 ClpV1 
PA0105 3,03 2,69 -0,33 coxB cytochrome c oxidase, subunit II 
PA0106 3,06 2,94 -0,12 coxA cytochrome c oxidase, subunit I 
PA0107 2,40 2,60 0,19 NA conserved hypothetical protein 
PA0108 2,38 2,19 -0,19 coIII cytochrome c oxidase, subunit III 
PA0110 2,85 2,11 -0,75 NA hypothetical protein 
PA0111 2,44 1,97 -0,47 NA hypothetical protein 
PA0112 1,91 1,48 -0,43 NA hypothetical protein 
PA0113 2,14 1,36 -0,78 NA probable cytochrome c oxidase 
assembly factor 
PA0122 2,61 1,91 -0,70 rahU rahU 
PA0128 -1,21 -1,27 -0,06 phnA conserved hypothetical protein 
PA0141 -2,05 -1,50 0,55 NA conserved hypothetical protein 
PA0176 1,64 1,55 -0,09 aer2 aerotaxis transducer Aer2 
PA0177 1,57 1,50 -0,07 NA probable purine-binding chemotaxis 
protein 
PA0178 1,81 1,26 -0,55 NA probable two-component sensor 
PA0179 1,44 1,10 -0,34 NA probable two-component response 
regulator 
PA0180 1,30 1,02 -0,27 cttP chemotactic transducer for 
trichloroethylene [positive chemotaxis], 
CttP 
PA0208 3,19 2,22 -0,97 mdcA malonate decarboxylase alpha subunit 
PA0209 2,63 2,39 -0,24 mdcB conserved hypothetical protein 
PA0210 1,67 1,63 -0,04 mdcC malonate decarboxylase delta subunit 
PA0211 1,99 1,88 -0,11 mdcD malonate decarboxylase beta subunit 
PA0212 2,05 1,74 -0,31 mdcE malonate decarboxylase gamma subunit 
PA0213 1,95 1,50 -0,44 mdcG hypothetical protein 
PA0214 2,55 2,03 -0,52 mdcH probable acyl transferase 
PA0215 1,60 1,59 0,00 madL malonate transporter MadL 
PA0216 1,58 1,07 -0,51 madM malonate transporter MadM 
PA0256 1,03 0,80 -0,23 NA hypothetical protein 
PA0277 -1,37 -1,52 -0,15 NA conserved hypothetical protein 
PA0285 -0,76 -1,07 -0,31 NA conserved hypothetical protein 
PA0316 -1,08 -0,84 0,24 serA D-3-phosphoglycerate dehydrogenase 
PA0329 1,17 1,67 0,50 NA conserved hypothetical protein 
PA0355 2,02 2,43 0,41 pfpI protease PfpI 
PA0365 1,17 0,64 -0,53 NA hypothetical protein 
PA0394 -0,83 -1,19 -0,37 yggS conserved hypothetical protein 
PA0447 -1,21 -0,73 0,48 gcdH glutaryl-CoA dehydrogenase 
PA0459 0,93 1,16 0,22 clpC probable ClpA/B protease ATP binding 
subunit 
PA0484 1,62 1,26 -0,36 NA conserved hypothetical protein 
PA0510 -2,01 -1,75 0,25 nirE NirE 
PA0511 -2,14 -1,77 0,37 nirJ heme d1 biosynthesis protein NirJ 
PA0512 -1,80 -1,58 0,22 nirH NirH 
PA0513 -1,33 -1,39 -0,06 nirG NirG 
PA0517 -1,35 -0,91 0,44 nirC probable c-type cytochrome precursor 
PA0519 -1,58 -1,18 0,40 nirS nitrite reductase precursor 
PA0527 -1,46 -0,64 0,82 dnr transcriptional regulator Dnr 
PA0546 1,09 1,16 0,08 metK methionine adenosyltransferase 
PA0547 1,23 1,04 -0,19 NA probable transcriptional regulator 
PA0551 -0,52 -1,19 -0,66 epd D-erythrose 4-phosphate 
dehydrogenase 
PA0563 -0,68 -1,05 -0,37 NA conserved hypothetical protein 
PA0575 1,34 1,10 -0,24 NA conserved hypothetical protein 
PA0576 -1,21 -1,12 0,09 rpoD sigma factor RpoD 
PA0577 -1,09 -1,23 -0,13 dnaG DNA primase 
PA0579 -1,04 -1,15 -0,11 rpsU 30S ribosomal protein S21 
PA0586 2,09 1,87 -0,22 ycgB conserved hypothetical protein 
PA0587 2,29 1,90 -0,39 yeaH conserved hypothetical protein 
PA0588 2,27 2,02 -0,26 yeaG conserved hypothetical protein 
PA0654 -2,26 -2,24 0,02 speD S-adenosylmethionine decarboxylase 
proenzyme 
PA0663 -0,72 -1,05 -0,33 NA hypothetical protein 
PA0708 1,90 1,65 -0,25 NA probable transcriptional regulator 
PA0709 -1,07 -1,11 -0,04 NA hypothetical protein 
PA0710 -1,75 -1,94 -0,19 gloA2 lactoylglutathione lyase 
PA0713 -1,93 -1,97 -0,04 NA hypothetical protein 
PA0714 -1,70 -1,36 0,34 NA hypothetical protein 
PA0730 -0,87 -1,05 -0,17 NA probable transferase 
PA0745 1,02 0,80 -0,22 NA probable enoyl-CoA 
hydratase/isomerase 
PA0779 -1,50 -1,45 0,05 asrA AsrA 
PA0783 -1,08 -0,85 0,24 putP sodium/proline symporter PutP 
PA0789 -1,59 -2,08 -0,48 NA probable amino acid permease 
PA0792 1,40 1,55 0,16 prpD propionate catabolic protein PrpD 
PA0798 1,82 1,22 -0,61 pmtA phospholipid methyltransferase 
PA0852 1,42 1,02 -0,39 cbpD chitin-binding protein CbpD precursor 
PA0852.1 1,37 1,00 -0,37 NA Uncharacterized protein 
PA0866 1,85 1,16 -0,69 aroP2 aromatic amino acid transport protein 
AroP2 
PA0888 -1,49 -2,80 -1,31 aotJ arginine/ornithine binding protein AotJ 
PA0889 -1,09 -2,04 -0,94 aotQ arginine/ornithine transport protein 
AotQ 
PA0890 -1,25 -1,80 -0,55 aotM arginine/ornithine transport protein 
AotM 
PA0891 -1,54 -2,61 -1,06 aotO hypothetical protein 
PA0892 -1,31 -1,68 -0,37 aotP arginine/ornithine transport protein 
AotP 
PA0893 -0,69 -1,39 -0,69 argR transcriptional regulator ArgR 
PA0895 -1,56 -2,63 -1,06 aruC N2-Succinylornithine 5-
aminotransferase (SOAT) = N2-
acetylornithine 5-aminotransferase 
(ACOAT) 
PA0896 -1,04 -2,23 -1,19 aruF subunit I of arginine N2-
succinyltransferase = ornithine N2-
succinyltransferase 
PA0897 -1,69 -2,91 -1,22 aruG subunit II of arginine N2-
succinyltransferase = ornithine N2-
succinyltransferase 
PA0898 -1,45 -2,34 -0,89 aruD N-Succinylglutamate 5-semialdehyde 
dehydrogenase 
PA0899 -1,13 -1,82 -0,69 aruB N2-Succinylarginine dihydrolase 
PA0901 -0,89 -1,15 -0,26 aruE N-Succinylglutamate desuccinylase 
PA0916 -0,93 -1,50 -0,56 yliG conserved hypothetical protein 
PA0945 -1,08 -1,09 -0,01 purM phosphoribosylaminoimidazole 
synthetase 
PA0956 -0,89 -1,11 -0,22 proS prolyl-tRNA synthetase 
PA0969 -1,13 -0,80 0,33 tolQ TolQ protein 
PA1011 -0,91 -1,12 -0,21 NA hypothetical protein 
PA1041 2,94 2,39 -0,55 NA probable outer membrane protein 
precursor 
PA1070 -0,58 -1,15 -0,57 braG branched-chain amino acid transport 
protein BraG 
PA1071 -0,56 -1,24 -0,68 braF branched-chain amino acid transport 
protein BraF 
PA1123 -1,22 -1,33 -0,11 NA hypothetical protein 
PA1130 2,15 1,40 -0,75 rhlC rhamnosyltransferase 2 
PA1135 1,02 1,29 0,27 yedU conserved hypothetical protein 
PA1155 -1,13 -0,88 0,24 nrdB NrdB, tyrosyl radical-harboring 
component of class Ia ribonucleotide 
reductase 
PA1156 -1,05 -0,99 0,06 nrdA NrdA, catalytic component of class Ia 
ribonucleotide reductase 
PA1166 1,58 1,59 0,02 NA hypothetical protein 
PA1168 1,97 1,88 -0,10 NA hypothetical protein 
PA1169 1,73 1,51 -0,22 NA probable lipoxygenase 
PA1172 1,79 2,06 0,27 napC cytochrome c-type protein NapC 
PA1173 1,59 1,63 0,04 napB cytochrome c-type protein NapB 
precursor 
PA1174 2,26 1,86 -0,40 napA periplasmic nitrate reductase protein 
NapA 
PA1175 2,12 1,74 -0,39 napD NapD protein of periplasmic nitrate 
reductase 
PA1176 2,31 1,89 -0,43 napF ferredoxin protein NapF 
PA1177 1,50 1,70 0,20 napE periplasmic nitrate reductase protein 
NapE 
PA1190 2,08 2,11 0,02 yohC conserved hypothetical protein 
PA1196 -1,46 -0,61 0,86 ddaR transcriptional regulator DdaR 
PA1211 1,63 1,82 0,19 NA hypothetical protein 
PA1212 2,29 2,50 0,20 NA probable major facilitator superfamily 
(MFS) transporter 
PA1213 3,77 2,90 -0,87 NA hypothetical protein 
PA1214 3,31 2,88 -0,42 NA hypothetical protein 
PA1215 3,15 1,94 -1,20 NA hypothetical protein 
PA1216 3,56 2,91 -0,66 NA hypothetical protein 
PA1217 3,21 2,62 -0,58 NA probable 2-isopropylmalate synthase 
PA1218 3,13 2,36 -0,78 NA hypothetical protein 
PA1219 1,96 1,75 -0,20 NA hypothetical protein 
PA1220 3,09 2,68 -0,41 NA hypothetical protein 
PA1221 2,98 2,46 -0,52 NA hypothetical protein 
PA1228 -1,81 -1,59 0,22 NA hypothetical protein 
PA1245 1,25 1,28 0,04 aprX AprX 
PA1246 1,69 1,51 -0,17 aprD alkaline protease secretion protein 
AprD 
PA1247 1,35 1,16 -0,19 aprE alkaline protease secretion protein AprE 
PA1248 1,22 0,82 -0,41 aprF Alkaline protease secretion outer 
membrane protein AprF precursor 
PA1249 2,41 1,80 -0,61 aprA alkaline metalloproteinase precursor 
PA1250 1,23 1,11 -0,12 aprI alkaline proteinase inhibitor AprI 
PA1256 1,62 0,97 -0,65 lhpO ABC transporter ATP-binding protein, 
LhpO 
PA1317 -1,00 -1,19 -0,19 cyoA cytochrome o ubiquinol oxidase subunit 
II 
PA1318 -1,01 -1,12 -0,11 cyoB cytochrome o ubiquinol oxidase subunit 
I 
PA1323 2,13 2,63 0,50 NA hypothetical protein 
PA1324 2,22 2,55 0,33 NA hypothetical protein 
PA1353 2,07 2,31 0,24 NA hypothetical protein 
PA1361 -0,73 -1,26 -0,54 norM NorM 
PA1404 2,00 1,80 -0,19 NA hypothetical protein 
PA1471 0,95 1,33 0,38 NA hypothetical protein 
PA1546 -1,16 -0,33 0,82 hemN oxygen-independent 
coproporphyrinogen III oxidase 
PA1549 -0,81 -1,21 -0,40 fixI probable cation-transporting P-type 
ATPase 
PA1551 -0,93 -1,23 -0,30 fixG probable ferredoxin 
PA1552 -0,82 -1,04 -0,22 ccoP1 Cytochrome c oxidase, cbb3-type, CcoP 
subunit 
PA1554 -0,86 -1,19 -0,33 ccoN1 Cytochrome c oxidase, cbb3-type, 
CcoN subunit 
PA1555 -2,37 -1,93 0,43 ccoP2 Cytochrome c oxidase, cbb3-type, CcoP 
subunit 
PA1555.1 -2,24 -2,21 0,03 ccoQ2 Cytochrome c oxidase, cbb3-type, 
CcoQ subunit 
PA1556 -2,10 -1,44 0,66 ccoO2 Cytochrome c oxidase, cbb3-type, 
CcoO subunit 
PA1557 -2,03 -1,35 0,68 ccoN2 Cytochrome c oxidase, cbb3-type, 
CcoN subunit 
PA1562 0,98 1,02 0,04 acnA aconitate hydratase 1 
PA1582 -0,65 -1,07 -0,43 sdhD succinate dehydrogenase (D subunit) 
PA1583 -0,86 -1,27 -0,41 sdhA succinate dehydrogenase (A subunit) 
PA1584 -0,81 -1,20 -0,38 sdhB succinate dehydrogenase (B subunit) 
PA1592 1,12 1,71 0,59 NA hypothetical protein 
PA1596 -1,80 -1,62 0,18 htpG heat shock protein HtpG 
PA1617 1,13 1,10 -0,03 NA probable AMP-binding enzyme 
PA1643a 1,50 1,15 -0,35 NA NA 
PA1673 -1,73 -1,29 0,43 NA hypothetical protein 
PA1687 -1,13 -0,80 0,33 speE spermidine synthase 
PA1732 1,40 0,82 -0,58 NA conserved hypothetical protein 
PA1745 1,70 1,27 -0,44 NA hypothetical protein 
PA1750 -0,96 -1,14 -0,17 NA phospho-2-dehydro-3-deoxyheptonate 
aldolase 
PA1761 1,62 1,21 -0,40 NA hypothetical protein 
PA1784 2,16 1,61 -0,55 NA hypothetical protein 
PA1791 -1,22 -1,49 -0,27 NA hypothetical protein 
PA1805 -0,96 -1,11 -0,15 ppiD peptidyl-prolyl cis-trans isomerase D 
PA1818 -0,66 -1,86 -1,20 ldcA,cadA lysine decarboxylase 
PA1830 0,59 1,20 0,61 NA hypothetical protein 
PA1837a 1,58 1,06 -0,51 NA NA 
PA1838 -1,07 -0,42 0,64 cysI sulfite reductase 
PA1839 -0,88 -1,34 -0,46 NA hypothetical protein 
PA1869 1,46 0,77 -0,69 NA probable acyl carrier protein 
PA1871 2,45 1,75 -0,70 lasA LasA protease precursor 
PA1874 1,46 1,03 -0,43 NA hypothetical protein 
PA1880 1,56 1,21 -0,35 NA probable oxidoreductase 
PA1881 1,30 1,07 -0,23 NA probable oxidoreductase 
PA1887 1,79 2,26 0,47 NA hypothetical protein 
PA1888 2,46 2,62 0,16 NA hypothetical protein 
PA1894 1,15 0,71 -0,44 NA hypothetical protein 
PA1895 1,12 0,55 -0,57 NA hypothetical protein 
PA1897 1,42 0,93 -0,49 NA hypothetical protein 
PA1899 4,48 3,32 -1,16 phzA2 probable phenazine biosynthesis protein 
PA1900 4,30 3,01 -1,28 phzB2 probable phenazine biosynthesis protein 
PA1927 1,80 1,38 -0,42 metE 5-methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase 
PA1930 1,82 2,10 0,28 NA probable chemotaxis transducer 
PA1946 1,17 1,08 -0,09 rbsB binding protein component precursor of 
ABC ribose transporter 
PA1951 2,00 1,56 -0,44 fapF FapF 
PA1964 -1,20 -1,06 0,14 ybiT probable ATP-binding component of 
ABC transporter 
PA2018 1,50 1,41 -0,08 mexY Resistance-Nodulation-Cell Division 
(RND) multidrug efflux transporter 
MexY 
PA2042 -0,78 -1,71 -0,93 ygjU probable transporter (membrane 
subunit) 
PA2066 2,32 1,99 -0,33 NA hypothetical protein 
PA2068 2,61 2,33 -0,28 NA probable major facilitator superfamily 
(MFS) transporter 
PA2069 3,92 2,50 -1,42 NA probable carbamoyl transferase 
PA2071 1,29 1,22 -0,07 fusA2 elongation factor G 
PA2072 2,00 1,72 -0,27 NA conserved hypothetical protein 
PA2109 -2,42 -2,46 -0,04 NA hypothetical protein 
PA2111 -3,35 -3,42 -0,08 NA hypothetical protein 
PA2112 -1,93 -2,07 -0,14 NA conserved hypothetical protein 
PA2113 -1,57 -2,23 -0,66 opdO pyroglutamate porin OpdO 
PA2142a 1,62 2,05 0,43 NA NA 
PA2164 1,58 1,29 -0,29 NA probable glycosyl hydrolase 
PA2167 1,47 1,51 0,04 NA hypothetical protein 
PA2171 1,52 2,18 0,66 NA hypothetical protein 
PA2177 1,07 1,42 0,35 NA probable sensor/response regulator 
hybrid 
PA2262 -1,86 -1,42 0,43 kguT probable 2-ketogluconate transporter 
PA2264 -1,13 0,62 1,75 NA conserved hypothetical protein 
PA2265 -0,84 0,93 1,77 gad gluconate dehydrogenase 
PA2290 -0,48 1,20 1,68 gcd glucose dehydrogenase 
PA2291 -0,09 1,79 1,88 oprB2; opbA probable glucose-sensitive porin 
PA2300 1,96 1,28 -0,68 chiC chitinase 
PA2302 1,41 1,28 -0,13 ambE AmbE 
PA2303 1,17 0,96 -0,20 ambD AmbD 
PA2304 1,18 1,22 0,04 ambC AmbC 
PA2320 -1,67 0,20 1,88 gntR transcriptional regulator GntR 
PA2321 -5,62 -0,34 5,28 gntV; gntK; 
gnuK 
gluconokinase 
PA2322 -5,87 -0,72 5,15 gntP gluconate permease 
PA2323 -1,62 3,09 4,71 gapN; gapB probable glyceraldehyde-3-phosphate 
dehydrogenase 
PA2329 1,13 1,29 0,15 NA probable ATP-binding component of 
ABC transporter 
PA2331 1,67 1,47 -0,20 NA hypothetical protein 
PA2363 1,44 1,14 -0,30 hsiJ3 HsiJ3 
PA2365 2,55 2,00 -0,55 hsiB3 HsiB3 
PA2366 2,79 2,10 -0,69 hsiC3 HsiC3 
PA2367 2,66 2,11 -0,55 hcp3 Hcp3 
PA2369 2,48 2,03 -0,45 hsiG3 HsiG3 
PA2371 2,04 1,32 -0,73 clpV3 ClpV3 
PA2372 2,25 1,74 -0,52 NA hypothetical protein 
PA2373 1,58 1,10 -0,48 vgrG3 VgrG3 
PA2375 1,29 1,62 0,33 NA hypothetical protein 
PA2385 1,33 1,83 0,50 pvdQ 3-oxo-C12-homoserine lactone acylase 
PvdQ 
PA2386 1,49 2,40 0,91 pvdA L-ornithine N5-oxygenase 
PA2392 1,19 1,57 0,38 pvdP PvdP 
PA2393 1,50 2,10 0,59 NA putative dipeptidase 
PA2394 1,22 2,00 0,78 pvdN PvdN 
PA2396 1,37 2,09 0,72 pvdF pyoverdine synthetase F 
PA2397 1,21 1,43 0,22 pvdE pyoverdine biosynthesis protein PvdE 
PA2399 0,87 1,31 0,44 pvdD pyoverdine synthetase D 
PA2400 0,60 1,02 0,42 pvdJ PvdJ 
PA2402 1,02 1,50 0,48 NA probable non-ribosomal peptide 
synthetase 
PA2412 1,42 2,21 0,79 NA conserved hypothetical protein 
PA2413 1,42 2,09 0,68 pvdH L-2,4-diaminobutyrate:2-ketoglutarate 
4-aminotransferase, PvdH 
PA2414 1,25 1,53 0,28 NA L-sorbosone dehydrogenase 
PA2424 1,15 1,86 0,71 pvdL PvdL 
PA2426 0,96 2,27 1,31 pvdS sigma factor PvdS 
PA2433 2,07 2,59 0,52 NA hypothetical protein 
PA2441 1,03 1,66 0,63 NA hypothetical protein 
PA2486 1,00 1,23 0,23 NA hypothetical protein 
PA2504 1,49 1,83 0,35 NA hypothetical protein 
PA2512 -0,75 -1,46 -0,71 antA anthranilate dioxygenase large subunit 
PA2513 -0,77 -1,41 -0,64 antB anthranilate dioxygenase small subunit 
PA2514 -1,05 -1,73 -0,67 antC anthranilate dioxygenase reductase 
PA2544 1,19 1,39 0,20 NA hypothetical protein 
PA2562 1,27 1,49 0,21 NA hypothetical protein 
PA2564 1,60 1,09 -0,50 tam hypothetical protein 
PA2566 2,26 1,39 -0,87 NA conserved hypothetical protein 
PA2570 2,23 1,61 -0,61 lecA LecA 
PA2571 1,24 1,00 -0,23 NA probable two-component sensor 
PA2572 1,51 1,46 -0,05 NA probable two-component response 
regulator 
PA2573 2,36 1,87 -0,49 NA probable chemotaxis transducer 
PA2579 -0,55 -1,06 -0,52 kynA L-Tryptophan:oxygen 2,3-
oxidoreductase (decyclizing) KynA 
PA2584 -0,59 -1,12 -0,53 pgsA CDP-diacylglycerol--glycerol-3-
phosphate 3-phosphatidyltransferase 
PA2622 1,55 1,64 0,09 cspD cold-shock protein CspD 
PA2624 -1,49 -1,21 0,29 idh isocitrate dehydrogenase 
PA2629 -1,25 -1,35 -0,10 purB adenylosuccinate lyase 
PA2630 -1,49 -1,03 0,46 ycfD conserved hypothetical protein 
PA2634 1,01 0,58 -0,43 aceA isocitrate lyase AceA 
PA2639 -1,02 -1,04 -0,01 nuoD NADH dehydrogenase I chain C,D 
PA2641 -1,17 -1,26 -0,09 nuoF NADH dehydrogenase I chain F 
PA2647 -1,02 -0,99 0,03 nuoL NADH dehydrogenase I chain L 
PA2722 1,36 1,22 -0,14 NA hypothetical protein 
PA2740 -1,12 -0,90 0,22 pheS phenylalanyl-tRNA synthetase, alpha-
subunit 
PA2743 -0,87 -1,19 -0,32 infC translation initiation factor IF-3 
PA2747 1,99 1,88 -0,11 NA hypothetical protein 
PA2754 0,54 1,70 1,17 NA conserved hypothetical protein 
PA2760 -0,72 -1,08 -0,35 oprQ OprQ 
PA2765 -0,72 -1,01 -0,29 NA hypothetical protein 
PA2771 1,97 1,62 -0,35 NA diguanylate cyclase with a self-blocked 
I-site, Dcsbis 
PA2787 1,11 1,73 0,61 cpg2 carboxypeptidase G2 precursor 
PA2815 1,44 1,34 -0,10 yafH probable acyl-CoA dehydrogenase 
PA2851 -1,28 -1,20 0,07 efp translation elongation factor P 
PA2853 0,45 1,19 0,74 oprI Outer membrane lipoprotein OprI 
precursor 
PA2862 1,86 1,85 -0,02 lipA lactonizing lipase precursor 
PA2863 1,48 1,36 -0,12 lipH lipase modulator protein 
PA2864 1,53 1,48 -0,05 NA conserved hypothetical protein 
PA2911 -1,03 -1,02 0,00 NA probable TonB-dependent receptor 
PA2937 2,48 2,03 -0,45 NA hypothetical protein 
PA2939 3,88 3,23 -0,66 pepB probable aminopeptidase 
PA2950 -1,00 -1,03 -0,03 pfm¦ proton motive force protein, PMF 
PA2967 -1,11 -1,33 -0,22 fabG 3-oxoacyl-[acyl-carrier-protein] 
reductase 
PA2968 -1,01 -0,97 0,04 fabD malonyl-CoA-[acyl-carrier-protein] 
transacylase 
PA2969 -1,52 -1,68 -0,16 plsX fatty acid biosynthesis protein PlsX 
PA2971 -0,82 -1,30 -0,48 yceD conserved hypothetical protein 
PA2976 -1,05 -1,09 -0,04 rne ribonuclease E 
PA2995 -0,80 -1,09 -0,30 nqrE Na+-translocating NADH:quinone 
oxidoreductase subunit Nqr5 
PA2997 -1,04 -1,14 -0,10 nqrC Na+-translocating NADH:ubiquinone 
oxidoreductase subunit Nrq3 
PA3019 -0,82 -1,03 -0,21 uup probable ATP-binding component of 
ABC transporter 
PA3023 1,27 1,42 0,15 yegS conserved hypothetical protein 
PA3032 2,01 1,90 -0,11 snr1 cytochrome c Snr1 
PA3040 1,50 1,62 0,12 yqjD conserved hypothetical protein 
PA3042 0,99 1,51 0,52 NA hypothetical protein 
PA3049 2,47 2,09 -0,38 rmf ribosome modulation factor 
PA3089 1,00 1,96 0,96 NA hypothetical protein 
PA3162 -1,56 -1,57 -0,01 rpsA 30S ribosomal protein S1 
PA3179 -0,72 -1,14 -0,42 yciL conserved hypothetical protein 
PA3181 -3,77 -0,99 2,78 edaA 2-keto-3-deoxy-6-phosphogluconate 
aldolase 
PA3182 -3,77 -1,03 2,74 pgl 6-phosphogluconolactonase 
PA3183 -4,01 -1,09 2,92 zwf glucose-6-phosphate 1-dehydrogenase 
PA3186 -0,15 5,55 5,69 oprB Glucose/carbohydrate outer membrane 
porin OprB precursor 
PA3187 -2,96 2,74 5,70 gltK probable ATP-binding component of 
ABC transporter 
PA3188 -6,24 -1,26 4,98 gltG probable permease of ABC sugar 
transporter 
PA3189 -1,92 -0,10 1,82 gltF probable permease of ABC sugar 
transporter 
PA3190 0,23 5,83 5,60 gltB probable binding protein component of 
ABC sugar transporter 
PA3191 -1,32 0,04 1,36 gtrS glucose transport sensor, GtrS 
PA3192 -1,90 -0,12 1,78 gltR two-component response regulator GltR 
PA3193 -1,91 -0,12 1,79 glk glucokinase 
PA3194 -3,07 -0,72 2,35 edd phosphogluconate dehydratase 
PA3195 -3,04 -0,58 2,46 gapA glyceraldehyde 3-phosphate 
dehydrogenase 
PA3229 1,04 1,48 0,45 NA hypothetical protein 
PA3236 1,43 1,11 -0,31 betX BetX 
PA3246 -1,30 -1,27 0,03 rluA pseudouridine synthase RluA 
PA3250 1,78 1,47 -0,31 NA hypothetical protein 
PA3251 0,92 1,63 0,71 NA hypothetical protein 
PA3263 -1,14 -0,78 0,37 yaiD conserved hypothetical protein 
PA3268 -1,58 -0,98 0,60 NA probable TonB-dependent receptor 
PA3274 1,63 1,72 0,08 NA hypothetical protein 
PA3308 -0,99 -1,00 -0,01 hepA RNA helicase HepA 
PA3309 -1,20 -0,41 0,79 uspK conserved hypothetical protein 
PA3311 1,50 1,57 0,07 nbdA NbdA 
PA3327 1,34 0,62 -0,72 NA probable non-ribosomal peptide 
synthetase 
PA3328 1,61 1,13 -0,47 NA probable FAD-dependent 
monooxygenase 
PA3329 1,73 1,14 -0,58 NA hypothetical protein 
PA3330 1,67 0,98 -0,70 NA probable short chain dehydrogenase 
PA3331 1,80 1,20 -0,60 NA cytochrome P450 
PA3332 1,75 1,27 -0,49 NA conserved hypothetical protein 
PA3333 1,83 1,03 -0,80 fabH2 3-oxoacyl-[acyl-carrier-protein] 
synthase III 
PA3334 2,19 1,32 -0,87 NA probable acyl carrier protein 
PA3335 1,70 1,13 -0,57 NA hypothetical protein 
PA3336 1,83 1,04 -0,78 NA probable major facilitator superfamily 
(MFS) transporter 
PA3347 1,15 1,17 0,02 hsbA HptB-dependent secretion and biofilm 
anti anti-sigma factor HsbA 
PA3361 2,37 1,56 -0,81 lecB fucose-binding lectin PA-IIL 
PA3369 1,57 1,49 -0,08 NA hypothetical protein 
PA3415 1,93 1,53 -0,40 NA probable dihydrolipoamide 
acetyltransferase 
PA3416 2,34 2,36 0,02 NA probable pyruvate dehydrogenase E1 
component, beta chain 
PA3417 1,71 2,05 0,33 NA probable pyruvate dehydrogenase E1 
component, alpha subunit 
PA3418 1,65 2,17 0,52 ldh leucine dehydrogenase 
PA3432 -1,67 -0,73 0,94 NA hypothetical protein 
PA3451 2,46 1,90 -0,56 NA hypothetical protein 
PA3459 0,89 1,23 0,34 asnB probable glutamine amidotransferase 
PA3465 0,57 1,35 0,78 yfiS conserved hypothetical protein 
PA3477 1,25 0,89 -0,37 rhlR transcriptional regulator RhlR 
PA3478 1,60 1,19 -0,40 rhlB rhamnosyltransferase chain B 
PA3479 1,74 1,31 -0,43 rhlA rhamnosyltransferase chain A 
PA3484 -0,83 -1,09 -0,26 tse3 Tse3 
PA3516 1,21 0,94 -0,27 NA probable lyase 
PA3519 1,90 1,28 -0,63 NA hypothetical protein 
PA3531 -1,40 -1,36 0,05 bfrB bacterioferritin 
PA3560 -0,39 2,01 2,40 fruA phosphotransferase system transporter 
fructose-specific IIBC component, 
FruA 
PA3561 0,16 2,55 2,38 fruK 1-phosphofructokinase 
PA3562 -0,25 2,53 2,78 fruI phosphotransferase system transporter 
enzyme I, FruI 
PA3568 1,93 0,82 -1,11 ymmS probable acetyl-coa synthetase 
PA3569 1,33 0,42 -0,90 mmsB 3-hydroxyisobutyrate dehydrogenase 
PA3570 1,56 0,87 -0,69 mmsA methylmalonate-semialdehyde 
dehydrogenase 
PA3621 -1,27 -1,27 0,00 fdxA ferredoxin I 
PA3622 1,36 1,26 -0,10 rpoS sigma factor RpoS 
PA3635 -1,11 -1,13 -0,02 eno enolase 
PA3640 -0,82 -1,00 -0,18 dnaE DNA polymerase III, alpha chain 
PA3641 -1,78 -1,92 -0,14 NA probable amino acid permease 
PA3645 -0,77 -1,09 -0,31 fabZ (3R)-hydroxymyristoyl-[acyl carrier 
protein] dehydratase 
PA3652 -1,17 -1,23 -0,06 uppS undecaprenyl pyrophosphate synthetase 
PA3653 -1,05 -1,23 -0,18 frr ribosome recycling factor 
PA3655 -1,50 -1,41 0,09 tsf elongation factor Ts 
PA3656 -1,46 -1,52 -0,06 rpsB 30S ribosomal protein S2 
PA3675 -1,09 -1,01 0,08 NA hypothetical protein 
PA3688 1,06 1,70 0,63 NA hypothetical protein 
PA3691 1,61 2,11 0,50 NA hypothetical protein 
PA3692 1,54 2,05 0,50 lptF Lipotoxon F, LptF 
PA3700 -1,40 -1,27 0,13 lysS lysyl-tRNA synthetase 
PA3709 1,46 1,51 0,05 NA probable major facilitator superfamily 
(MFS) transporter 
PA3710 1,36 0,75 -0,62 NA probable GMC-type oxidoreductase 
PA3716 -1,03 -1,04 -0,01 NA hypothetical protein 
PA3723 2,20 1,42 -0,79 yqjM probable FMN oxidoreductase 
PA3724 2,96 1,82 -1,14 lasB elastase LasB 
PA3729 -0,99 -1,21 -0,22 NA conserved hypothetical protein 
PA3734 1,65 1,64 -0,01 NA hypothetical protein 
PA3742 -1,53 -1,05 0,48 rplS 50S ribosomal protein L19 
PA3743 -1,15 -1,35 -0,20 trmD tRNA (guanine-N1)-methyltransferase 
PA3744 -1,11 -1,32 -0,22 rimM 16S rRNA processing protein 
PA3745 -1,35 -1,73 -0,38 rpsP 30S ribosomal protein S16 
PA3763 -0,99 -1,04 -0,05 purL phosphoribosylformylglycinamidine 
synthase 
PA3769 -1,41 -1,27 0,14 guaA GMP synthase 
PA3770 -1,09 -1,17 -0,08 guaB inosine-5'-monophosphate 
dehydrogenase 
PA3790 -1,52 -1,68 -0,16 oprC Putative copper transport outer 
membrane porin OprC precursor 
PA3795 0,93 1,02 0,08 NA probable oxidoreductase 
PA3807 -1,02 -0,76 0,26 ndk nucleoside diphosphate kinase 
PA3812 -0,78 -1,17 -0,39 iscA probable iron-binding protein IscA 
PA3818 -1,06 -0,89 0,17 suhB extragenic suppressor protein SuhB 
PA3821 -1,58 -1,62 -0,04 secD secretion protein SecD 
PA3822 -0,79 -1,07 -0,27 yajC conserved hypothetical protein 
PA3834 -1,09 -0,90 0,19 valS valyl-tRNA synthetase 
PA3858 1,16 0,86 -0,30 aapJ probable amino acid-binding protein 
PA3863 -1,51 -0,84 0,67 dauA FAD-dependent catabolic D-arginine 
dehydrogenase, DauA 
PA3890 0,95 1,28 0,33 opuCB OpuC ABC transporter, permease 
protein, OpuCB 
PA3891 0,91 1,33 0,42 opuCA OpuC ABC transporter, ATP-binding 
protein, OpuCA 
PA3892 -0,99 -1,37 -0,38 NA conserved hypothetical protein 
PA3919 1,02 1,26 0,23 ylaK conserved hypothetical protein 
PA3922 2,37 1,95 -0,42 NA conserved hypothetical protein 
PA3923 2,11 1,53 -0,58 NA hypothetical protein 
PA3924 1,08 0,90 -0,18 NA probable medium-chain acyl-CoA 
ligase 
PA3934 -0,55 -1,51 -0,96 NA conserved hypothetical protein 
PA3969a -0,74 -1,34 -0,59 NA NA 
PA3980 -0,98 -1,20 -0,22 miaB; yleA conserved hypothetical protein 
PA3986 1,50 1,58 0,08 NA hypothetical protein 
PA4000 -0,63 -1,07 -0,44 rlpA RlpA 
PA4006 -0,87 -1,07 -0,20 nadD1,nadD nicotinate mononucleotide 
adenylyltransferase NadD1 
PA4015 1,29 1,33 0,04 NA conserved hypothetical protein 
PA4031 -1,20 -1,16 0,04 ppa inorganic pyrophosphatase 
PA4053 -1,09 -1,34 -0,25 ribE 6,7-dimethyl-8-ribityllumazine synthase 
PA4061 -1,03 -1,08 -0,06 ybbN probable thioredoxin 
PA4067 -1,43 -0,75 0,69 oprG Outer membrane protein OprG 
precursor 
PA4078 1,94 1,66 -0,29 NA probable nonribosomal peptide 
synthetase 
PA4112 1,56 1,37 -0,19 NA probable sensor/response regulator 
hybrid 
PA4139 2,23 1,83 -0,40 NA hypothetical protein 
PA4140 2,02 1,53 -0,49 NA hypothetical protein 
PA4141 2,00 1,69 -0,31 NA hypothetical protein 
PA4142 1,54 1,17 -0,37 NA probable secretion protein 
PA4205 1,69 1,90 0,21 mexG hypothetical protein 
PA4206 1,90 1,45 -0,45 mexH probable Resistance-Nodulation-Cell 
Division (RND) efflux membrane 
fusion protein precursor 
PA4207 1,59 1,24 -0,34 mexI probable Resistance-Nodulation-Cell 
Division (RND) efflux transporter 
PA4209 2,72 1,80 -0,91 phzM probable phenazine-specific 
methyltransferase 
PA4210 2,63 1,42 -1,21 phzA1 probable phenazine biosynthesis protein 
PA4211 2,84 1,70 -1,14 phzB1 probable phenazine biosynthesis protein 
PA4212 1,92 0,96 -0,95 phzC1 phenazine biosynthesis protein PhzC 
PA4217 3,01 1,82 -1,19 phzS flavin-containing monooxygenase 
PA4234 -1,13 -0,90 0,23 uvrA excinuclease ABC subunit A 
PA4237 -1,08 -0,57 0,51 rplQ 50S ribosomal protein L17 
PA4238 -1,43 -1,40 0,03 rpoA DNA-directed RNA polymerase alpha 
chain 
PA4239 -1,51 -1,62 -0,11 rpsD 30S ribosomal protein S4 
PA4240 -1,20 -0,92 0,28 rpsK 30S ribosomal protein S11 
PA4241 -1,40 -1,05 0,36 rpsM 30S ribosomal protein S13 
PA4242 -1,32 -1,68 -0,36 rpmJ 50S ribosomal protein L36 
PA4243 -1,62 -1,63 0,00 secY secretion protein SecY 
PA4244 -1,86 -1,96 -0,10 rplO 50S ribosomal protein L15 
PA4245 -1,52 -1,59 -0,08 rpmD 50S ribosomal protein L30 
PA4246 -1,68 -1,79 -0,11 rpsE 30S ribosomal protein S5 
PA4247 -1,78 -1,68 0,10 rplR 50S ribosomal protein L18 
PA4248 -1,84 -1,69 0,16 rplF 50S ribosomal protein L6 
PA4249 -1,47 -1,36 0,12 rpsH 30S ribosomal protein S8 
PA4250 -1,03 -0,56 0,46 rpsN 30S ribosomal protein S14 
PA4251 -1,24 -1,09 0,15 rplE 50S ribosomal protein L5 
PA4252 -1,46 -1,56 -0,10 rplX 50S ribosomal protein L24 
PA4253 -1,12 -1,05 0,07 rplN 50S ribosomal protein L14 
PA4254 -1,27 -1,10 0,17 rpsQ 30S ribosomal protein S17 
PA4255 -1,47 -1,40 0,07 rpmC 50S ribosomal protein L29 
PA4256 -1,36 -1,42 -0,06 rplP 50S ribosomal protein L16 
PA4257 -1,49 -1,27 0,22 rpsC 30S ribosomal protein S3 
PA4258 -1,65 -1,54 0,11 rplV 50S ribosomal protein L22 
PA4259 -1,60 -1,75 -0,14 rpsS 30S ribosomal protein S19 
PA4260 -1,78 -2,22 -0,44 rplB 50S ribosomal protein L2 
PA4261 -2,01 -1,91 0,10 rplW 50S ribosomal protein L23 
PA4262 -2,08 -2,16 -0,08 rplD 50S ribosomal protein L4 
PA4263 -1,69 -1,55 0,14 rplC 50S ribosomal protein L3 
PA4264 -1,77 -1,90 -0,13 rpsJ 30S ribosomal protein S10 
PA4265 -1,45 -1,40 0,04 tufA elongation factor Tu 
PA4266 -1,47 -1,49 -0,02 fusA1 elongation factor G 
PA4267 -1,35 -1,30 0,06 rpsG 30S ribosomal protein S7 
PA4268 -1,56 -1,56 0,00 rpsL 30S ribosomal protein S12 
PA4269 -1,27 -1,39 -0,12 rpoC DNA-directed RNA polymerase beta* 
chain 
PA4270 -1,12 -1,05 0,07 rpoB DNA-directed RNA polymerase beta 
chain 
PA4271 -1,64 -1,35 0,30 rplL 50S ribosomal protein L7 / L12 
PA4272 -1,94 -2,03 -0,09 rplJ 50S ribosomal protein L10 
PA4273 -1,72 -1,88 -0,17 rplA 50S ribosomal protein L1 
PA4274 -1,62 -1,49 0,13 rplK 50S ribosomal protein L11 
PA4276 -1,07 -1,36 -0,29 secE secretion protein SecE 
PA4277 -1,34 -1,35 0,00 tufB elongation factor Tu 
PA4279 -0,96 -1,09 -0,13 NA hypothetical protein 
PA4280 -0,92 -1,28 -0,36 birA BirA bifunctional protein 
PA4292 -1,25 -1,43 -0,18 NA probable phosphate transporter 
PA4296 1,88 1,31 -0,57 pprB two-component response regulator, 
PprB 
PA4305 1,25 1,56 0,31 rcpC RcpC 
PA4311 1,47 1,27 -0,19 NA conserved hypothetical protein 
PA4333 -1,12 -1,12 0,00 fumA probable fumarase 
PA4362 1,98 1,89 -0,09 NA hypothetical protein 
PA4377 1,32 1,56 0,24 NA hypothetical protein 
PA4385 -1,49 -1,39 0,10 groEL GroEL protein 
PA4386 -1,55 -1,51 0,04 groES GroES protein 
PA4387 -1,78 -2,11 -0,33 fxsA conserved hypothetical protein 
PA4402 -0,98 -1,36 -0,39 argJ glutamate N-acetyltransferase 
PA4428 -1,13 -1,19 -0,06 sspA stringent starvation protein A 
PA4429 -1,05 -1,02 0,03 NA probable cytochrome c1 precursor 
PA4430 -1,14 -1,15 -0,01 NA probable cytochrome b 
PA4431 -1,06 -1,01 0,04 NA probable iron-sulfur protein 
PA4433 -1,53 -1,53 0,00 rplM 50S ribosomal protein L13 
PA4438 -1,03 -1,23 -0,19 yhcM conserved hypothetical protein 
PA4443 -1,15 -0,67 0,48 cysD ATP sulfurylase small subunit 
PA4457 -0,73 -1,04 -0,31 kpsF; yrbH; 
kdsD 
arabinose-5-phosphate isomerase KdsD 
PA4458 -0,85 -1,12 -0,27 yrbI conserved hypothetical protein 
PA4463 0,69 1,12 0,43 yhbH conserved hypothetical protein 
PA4468 1,03 1,76 0,73 sodM superoxide dismutase 
PA4469 0,73 1,53 0,79 NA hypothetical protein 
PA4470 0,48 1,61 1,14 fumC1 fumarate hydratase 
PA4471 1,16 1,90 0,73 fagA hypothetical protein 
PA4480 -1,06 -1,13 -0,06 mreC rod shape-determining protein MreC 
PA4481 -0,99 -1,10 -0,11 mreB rod shape-determining protein MreB 
PA4483 -1,12 -1,14 -0,01 gatA Glu-tRNA(Gln) amidotransferase 
subunit A 
PA4484 -1,20 -1,20 0,01 gatB Glu-tRNA(Gln) amidotransferase 
subunit B 
PA4496 1,23 -0,05 -1,28 dppA1 probable binding protein component of 
ABC transporter 
PA4497 1,43 0,58 -0,84 dppA2 probable binding protein component of 
ABC transporter 
PA4501 1,48 0,86 -0,62 opdD,opdP Glycine-glutamate dipeptide porin 
OpdP 
PA4542 -1,68 -1,48 0,20 clpB ClpB protein 
PA4566 -1,02 -1,00 0,03 obg GTP-binding protein Obg 
PA4568 -1,53 -1,79 -0,26 rplU 50S ribosomal protein L21 
PA4572 -1,20 -1,24 -0,04 fklB peptidyl-prolyl cis-trans isomerase 
FklB 
PA4587 -1,74 -1,59 0,15 ccpR cytochrome c551 peroxidase precursor 
PA4588 0,36 2,09 1,74 gdhA glutamate dehydrogenase 
PA4590 2,01 1,72 -0,29 pra protein activator 
PA4602 -1,10 -1,10 0,00 glyA3 serine hydroxymethyltransferase 
PA4607 2,49 2,46 -0,03 NA hypothetical protein 
PA4614 1,23 1,85 0,62 mscL conductance mechanosensitive channel 
PA4623 1,20 1,28 0,08 NA hypothetical protein 
PA4624 1,04 0,66 -0,37 cdrB cyclic diguanylate-regulated TPS 
partner B, CdrB 
PA4640 -1,06 -1,28 -0,22 mqoB malate:quinone oxidoreductase 
PA4645 -0,89 -1,06 -0,17 hpt; hprT probable purine/pyrimidine 
phosphoribosyl transferase 
PA4646 -1,06 -1,21 -0,15 upp uracil phosphoribosyltransferase 
PA4647 -0,81 -1,06 -0,25 uraA uracil permease 
PA4665 -1,01 -1,03 -0,02 prfA peptide chain release factor 1 
PA4670 -1,13 -1,47 -0,35 prs ribose-phosphate pyrophosphokinase 
PA4671 -1,63 -1,60 0,03 rplY probable ribosomal protein L25 
PA4672 -0,87 -1,14 -0,27 pth peptidyl-tRNA hydrolase 
PA4673 -1,55 -1,21 0,34 ychF conserved hypothetical protein 
PA4675 -1,36 -0,88 0,48 chtA ChtA 
PA4680 1,69 1,78 0,09 NA hypothetical protein 
PA4681 1,41 1,52 0,11 NA hypothetical protein 
PA4682 1,39 1,23 -0,16 NA hypothetical protein 
PA4684 -0,98 -1,05 -0,07 NA hypothetical protein 
PA4686 -1,19 -0,96 0,22 NA hypothetical protein 
PA4695 -0,85 -1,03 -0,18 ilvH acetolactate synthase isozyme III small 
subunit 
PA4709 0,06 1,24 1,18 phuS PhuS 
PA4710 -0,05 1,26 1,31 phuR Heme/Hemoglobin uptake outer 
membrane receptor PhuR precursor 
PA4720 -1,56 -1,36 0,20 trmA tRNA (uracil-5-)-methyltransferase 
PA4730 -1,20 -1,09 0,10 panC pantoate--beta-alanine ligase 
PA4738 3,20 3,44 0,24 yjbJ conserved hypothetical protein 
PA4739 2,64 2,73 0,09 NA conserved hypothetical protein 
PA4740 -1,07 -1,02 0,05 pnp polyribonucleotide 
nucleotidyltransferase 
PA4741 -1,19 -0,81 0,38 rpsO 30S ribosomal protein S15 
PA4743 -1,19 -1,03 0,16 rbfA ribosome-binding factor A 
PA4744 -1,51 -1,52 -0,01 infB translation initiation factor IF-2 
PA4745 -1,25 -1,33 -0,08 nusA N utilization substance protein A 
PA4746 -0,69 -1,21 -0,52 yhbC conserved hypothetical protein 
PA4748 -0,54 -1,00 -0,47 tpiA triosephosphate isomerase 
PA4749 -1,24 -1,24 0,01 glmM phosphoglucosamine mutase 
PA4750 -1,01 -1,23 -0,21 folP dihydropteroate synthase 
PA4757 -0,87 -1,00 -0,13 yeaS conserved hypothetical protein 
PA4759 -1,26 -1,21 0,05 dapB dihydrodipicolinate reductase 
PA4760 -1,57 -1,59 -0,02 dnaJ DnaJ protein 
PA4761 -2,02 -1,88 0,14 dnaK DnaK protein 
PA4762 -1,93 -1,86 0,07 grpE heat shock protein GrpE 
PA4765 -0,91 -1,20 -0,29 omlA Outer membrane lipoprotein OmlA 
precursor 
PA4774 -0,94 -1,08 -0,13 NA hypothetical protein 
PA4781 1,23 1,03 -0,20 NA cyclic di-GMP phosphodiesterase 
PA4848 -1,11 -0,92 0,19 accC biotin carboxylase 
PA4852 -1,13 -1,37 -0,25 yhdG conserved hypothetical protein 
PA4854 -1,39 -1,21 0,18 purH phosphoribosylaminoimidazolecarboxa
mide formyltransferase 
PA4855 -1,63 -1,23 0,40 purD phosphoribosylamine--glycine ligase 
PA4876 1,87 2,86 0,99 osmE osmotically inducible lipoprotein OsmE 
PA4877 1,25 1,71 0,45 NA hypothetical protein 
PA4880 1,20 1,23 0,03 NA probable bacterioferritin 
PA4910 1,52 1,54 0,02 NA branched chain amino acid ABC 
transporter ATP binding protein 
PA4911 1,61 1,07 -0,54 NA probable permease of ABC branched-
chain amino acid transporter 
PA4913 1,96 1,40 -0,56 NA probable binding protein component of 
ABC transporter 
PA4915 1,56 1,17 -0,40 NA probable chemotaxis transducer 
PA4918 -1,92 -1,44 0,48 pcnA nicotinamidase, PcnA 
PA4920 -1,00 -0,39 0,62 nadE NH3-dependent NAD synthetase 
PA4928 -0,79 -1,04 -0,25 ygiR; ygiQ conserved hypothetical protein 
PA4929 1,56 1,31 -0,25 NA hypothetical protein 
PA4932 -1,34 -0,92 0,42 rplI 50S ribosomal protein L9 
PA4933 -1,56 -1,44 0,12 NA hypothetical protein 
PA4934 -1,46 -1,07 0,39 rpsR 30S ribosomal protein S18 
PA4935 -1,65 -1,77 -0,12 rpsF 30S ribosomal protein S6 
PA4943 -1,08 -1,09 -0,01 hflX probable GTP-binding protein 
PA4944 -1,02 -0,90 0,12 hfq Hfq 
PA5001 -0,98 -1,02 -0,04 ssg cell surface-sugar biosynthetic 
glycosyltransferase, Ssg 
PA5002 -0,77 -1,06 -0,29 dnpA de-N-acetylase involved in persistence, 
DnpA 
PA5009 -0,85 -1,01 -0,16 waaP lipopolysaccharide kinase WaaP 
PA5010 -1,11 -1,19 -0,08 waaG UDP-glucose:(heptosyl) LPS alpha 1,3-
glucosyltransferase WaaG 
PA5015 -1,46 -0,98 0,47 aceE pyruvate dehydrogenase 
PA5016 -1,55 -0,99 0,56 aceF dihydrolipoamide acetyltransferase 
PA5036 0,11 1,23 1,12 gltB glutamate synthase large chain 
precursor 
PA5046 -1,19 -1,19 -0,01 NA malic enzyme 
PA5047 -0,89 -1,03 -0,15 NA hypothetical protein 
PA5049 -1,44 -0,86 0,58 rpmE 50S ribosomal protein L31 
PA5052 -1,41 -1,53 -0,12 NA hypothetical protein 
PA5053 -1,54 -1,64 -0,10 hslV heat shock protein HslV 
PA5054 -1,80 -1,54 0,25 hslU heat shock protein HslU 
PA5058 1,41 1,03 -0,38 phaC2 poly(3-hydroxyalkanoic acid) synthase 
2 
PA5087 -1,06 -1,44 -0,38 NA hypothetical protein 
PA5088 -1,57 -1,83 -0,25 NA hypothetical protein 
PA5089 -1,64 -2,11 -0,47 pldB PldB 
PA5090 -1,46 -1,92 -0,46 vgrG5 VgrG5 
PA5091 -2,40 -2,65 -0,25 hutG N-formylglutamate amidohydrolase 
PA5092 -2,92 -3,18 -0,27 hutI imidazolone-5-propionate hydrolase 
HutI 
PA5093 -2,73 -3,06 -0,33 NA probable histidine/phenylalanine 
ammonia-lyase 
PA5094 -2,31 -2,60 -0,29 NA probable ATP-binding component of 
ABC transporter 
PA5095 -2,06 -2,44 -0,38 NA probable permease of ABC transporter 
PA5096 -1,81 -2,52 -0,71 NA probable binding protein component of 
ABC transporter 
PA5097 -2,06 -2,58 -0,52 hutT probable amino acid permease 
PA5098 -4,21 -4,74 -0,54 hutH histidine ammonia-lyase 
PA5099 -4,05 -4,73 -0,68 NA probable transporter 
PA5100 -5,11 -5,50 -0,38 hutU urocanase 
PA5105 -2,55 -2,79 -0,24 hutC histidine utilization repressor HutC 
PA5106 -3,54 -3,86 -0,32 NA conserved hypothetical protein 
PA5117 -1,34 -1,11 0,23 typA regulatory protein TypA 
PA5118 -1,31 -1,49 -0,19 thiI thiazole biosynthesis protein ThiI 
PA5136 -0,88 -1,34 -0,45 NA hypothetical protein 
PA5139 -1,38 -1,12 0,26 NA hypothetical protein 
PA5152 -0,27 -1,77 -1,50 NA probable ATP-binding component of 
ABC transporter 
PA5153 0,26 -0,93 -1,18 NA amino acid 
(lysine/arginine/ornithine/histidine/octo
pine) ABC transporter periplasmic 
binding protein 
PA5154 -0,07 -1,29 -1,22 NA probable permease of ABC transporter 
PA5171 -2,42 -2,38 0,03 arcA arginine deiminase 
PA5172 -2,59 -2,36 0,23 arcB ornithine carbamoyltransferase, 
catabolic 
PA5173 -2,74 -2,57 0,18 arcC carbamate kinase 
PA5178 1,23 1,51 0,27 NA conserved hypothetical protein 
PA5180 -1,66 -2,31 -0,65 fdhD conserved hypothetical protein 
PA5181 -1,63 -2,15 -0,52 NA probable oxidoreductase 
PA5201 -1,33 -1,36 -0,02 yhgF; tex conserved hypothetical protein 
PA5203 -1,02 -1,02 0,00 gshA glutamate--cysteine ligase 
PA5212 1,05 1,38 0,33 NA hypothetical protein 
PA5219 1,61 0,89 -0,72 NA hypothetical protein 
PA5220 1,96 1,27 -0,69 NA hypothetical protein 
PA5239 -1,01 -1,09 -0,08 rho transcription termination factor Rho 
PA5261 0,84 1,14 0,30 algR alginate biosynthesis regulatory protein 
AlgR 
PA5298 -1,17 -1,31 -0,14 xpt xanthine phosphoribosyltransferase 
PA5303 1,44 1,17 -0,28 NA conserved hypothetical protein 
PA5304 0,81 1,15 0,34 dadA D-amino acid dehydrogenase, small 
subunit 
PA5316 -1,38 -1,25 0,14 rpmB 50S ribosomal protein L28 
PA5340 -1,10 -0,91 0,19 NA hypothetical protein 
PA5348 1,59 1,27 -0,32 NA probable DNA-binding protein 
PA5359 1,74 1,71 -0,03 NA hypothetical protein 
PA5366 -0,65 -1,19 -0,54 pstB ATP-binding component of ABC 
phosphate transporter 
PA5380 1,08 0,62 -0,46 gbdR GbdR 
PA5396 1,52 0,88 -0,64 NA hypothetical protein 
 PA5410 1,23 0,79 -0,44 gbcA GbcA 
PA5418 1,15 1,08 -0,07 soxA sarcosine oxidase alpha subunit 
PA5421 1,98 1,74 -0,24 fdhA glutathione-independent formaldehyde 
dehydrogenase 
PA5424 1,21 1,94 0,74 yeaQ conserved hypothetical protein 
PA5425 -1,20 -1,28 -0,08 purK phosphoribosylaminoimidazole 
carboxylase 
PA5426 -1,29 -1,48 -0,19 purE phosphoribosylaminoimidazole 
carboxylase, catalytic subunit 
PA5427 -1,36 -0,79 0,57 adhA alcohol dehydrogenase 
PA5435 -1,58 -0,81 0,77 oadA probable transcarboxylase subunit 
PA5436 -1,53 -0,56 0,97 NA probable biotin carboxylase subunit of a 
transcarboxylase 
PA5445 -1,40 -1,30 0,10 psecoA probable coenzyme A transferase 
PA5479 -1,48 -1,76 -0,28 gltP proton-glutamate symporter 
PA5481 2,43 2,40 -0,03 NA hypothetical protein 
PA5482 2,20 1,78 -0,42 NA hypothetical protein 
PA5490 -1,09 -1,31 -0,22 cc4 cytochrome c4 precursor 
PA5502 -0,53 -1,26 -0,73 NA hypothetical protein 
PA5504 -1,04 -1,05 -0,01 NA D-methionine ABC transporter 
membrane protein 
PA5544 1,26 0,93 -0,33 NA conserved hypothetical protein 
PA5545 1,39 1,11 -0,28 NA conserved hypothetical protein 
PA5546 1,24 0,96 -0,29 NA conserved hypothetical protein 
PA5556 -1,01 -1,08 -0,07 atpA ATP synthase alpha chain 
PA5557 -1,00 -1,22 -0,23 atpH ATP synthase delta chain 
PA5559 -0,93 -1,07 -0,13 atpE atp synthase C chain 
PA5560 -0,81 -1,05 -0,24 atpB ATP synthase A chain 
PA5562 -0,98 -1,15 -0,16 spoOJ chromosome partitioning protein Spo0J 
PA5564 -1,36 -1,30 0,06 gidB glucose inhibited division protein B 
PA5568 -1,74 -1,77 -0,03 yidC conserved hypothetical protein 
1Red figures, significant difference (Padj<0.05) 
2Boldface characters, deleted genes  
 
 
 
 General sequencing statistics 
 Raw reads Mapped reads  HQ reads HQ% 
Strand 
Specific reads 
on  known 
transcripts SS% 
PAO1+GLU A 2858342 2774119 2665486 93,25% 2405388 84,15% 
PAO1+GLU B 3612457 3499804 3263219 90,33% 2957221 81,86% 
PAO1 A 3849630 3751918 3585149 93,13% 3167795 82,29% 
PAO1 B 2965373 2917262 2793833 94,22% 2530642 85,34% 
GUN+GLU A 3244245 3141297 2920182 90,01% 2528829 77,95% 
GUN+GLU B 3116320 2976641 2795184 89,70% 2469372 79,24% 
       
 rRNA removal evaluation Strand specificity evaluation 
 mRNA% rRNA% tRNA % 
mRNA 
SS% rRNA SS% tRNA SS% 
PAO1+GLU A 68,26 0,23 0,54 94,94 83,77 98,47 
PAO1+GLU B 72,16 0,56 0,77 93,94 78,33 98,47 
PAO1 A 68,50 0,74 0,83 93,38 89,61 98,26 
PAO1 B 75,71 0,24 0,44 95,12 88,25 98,18 
GUN+GLU A 70,90 0,26 0,74 90,01 69,99 96,85 
GUN+GLU B 58,64 2,30 0,68 91,04 97,13 96,30 
*evaluation performed on mapped reads     
       
 CDS strand specific coverage statitsics    
 Not expressed % 
Reads covering 
90% of the 
transcripts  
Transcripts 
covered for half 
of their length 
(%)    
PAO1+GLU A 2,6 4 76,2    
PAO1+GLU B 1,3 8 86,0    
PAO1 A 1,5 7 84,1    
PAO1 B 2,1 4 77,3    
GUN+GLU A 1,1 13 91,9    
GUN+GLU B 1,4 8 84,1    
       
 
 
 
 
 
 
 
  
aRed figures indicate statistically significant difference (Padj<0.05) 
bSuperscripts refer to bibliographic references. nd, not determined 
Supplementary Table S3. Glucose responsive genes in PAO1 
Locus Log2 FCa Name Description Regulatorb 
 PAO1+ 
vs. PAO1 
GUN+ vs. 
PAO1+ 
GUN+ vs. 
PAO1 
   
PA0888 -1.31 -1.49 -2.80 aotJ arginine/ornithine ABC 
transporter  
ArgR25 
PA2264 1.75 -1.13 0.62  hypothetical protein PtxS26 
PA2265 1.77 -0.84 0.93 gad gluconate dehydrogenase PtxS26 
PA2290 1.68 -0.48 1.20 gcd glucose dehydrogenase nd 
PA2291 1.88 -0.09 1.79  glucose-sensitive porin nd 
PA2320 1.88 -1.67 0.20 gntR GntR transcriptional regulator GntR26 
PA2321 5.28 -5.62 -0.34 gntK gluconokinase nd  
PA2322 5.15 -5.87 -0.72 gntP gluconate permease GntR26 
PA2323 4.71 -1.62 3.09 gapN glyceraldehyde-3-phosphate 
dehydrogenase 
nd 
PA3181 2.78 -3.77 -0.99 edaA 2-dehydro-3-deoxy-
phosphogluconate aldolase 
HexR26 
PA3182 2.74 -3.77 -1.03 pgl 6-phosphogluconolactonase HexR26 
PA3183 2.92 -4.01 -1.09 zwf glucose-6-phosphate 1-
dehydrogenase 
HexR26 
PA3186 5.69 -0.15 5.55 oprB porin B GltR26 
PA3187 5.70 -2.96 2.74 gltK ABC transporter ATP-binding 
protein 
GltR26 
PA3188 4.98 -6.24 -1.26 gltG sugar ABC transporter permease GltR26 
PA3190 5.60 0.23 5.83 gltB sugar ABC transporter substrate-
binding protein 
GltR26 
PA3192 1.78 -1.90 -0.12 gltR response regulator GltR nd 
PA3193 1.79 -1.91 -0.12 glk glucokinase nd 
PA3194 2.35 -3.07 -0.72 edd phosphogluconate dehydratase nd 
PA3195 2.46 -3.04 -0.58 gapA glyceraldehyde 3-phosphate 
dehydrogenase 
nd 
PA3560 2.40 -0.39 2.01 fruA PTS system fructose-specific 
transporter subunit IIBC 
FruR27 
PA3561 2.38 0.16 2.55 fruK 1-phosphofructokinase FruR27 
PA3562 2.78 -0.25 2.53 fruI PTS system fructose-specific 
transporter subunit FruI 
FruR27 
PA4496 -1.28 1.23 -0.05 dppA1 ABC transporter nd 
PA4588 1.74 0.36 2.09 gdhA glutamate dehydrogenase ArgR25 
PA4710 1.31 -0.05 1.26 phuR heme/hemoglobin uptake outer 
membrane receptor PhuR 
Fur28 
PA5152 -1.50 -0.27 -1.77  ABC transporter ATP-binding 
protein 
ArgR25 
PA5153 -1.18 0.26 -0.93  amino acid ABC transporter  ArgR25 
Supplementary Table S4. DEGs encoding putative/known transcription regulators 
Locus Log2 FC1 Name Description2 
 PAO1+ 
vs. PAO1 
GUN+ vs. 
PAO1+ 
GUN+ 
vs. PAO1 
  
PA0179 -0.34 1.44 1.10  TC response regulator 
PA0527 0.82 -1.46 -0.64 dnr transcriptional regulator Dnr 
PA0547 -0.19 1.23 1.04  transcriptional regulator 
PA0576 0.09 -1.21 -1.12 rpoD sigma factor RpoD 
PA0708 -0.25 1.90 1.65  transcriptional regulator 
PA0893 -0.69 -0.69 -1.39 argR transcriptional regulator ArgR 
PA1196 0.86 -1.46 -0.61 ddaR transcriptional regulator DdaR 
PA2177 0.35 1.07 1.42  sensor/response regulator hybrid protein 
PA22593 1.55 -1.07 0.48 ptxS PtxS transcriptional regulator 
PA2320 1.88 -1.67 0.20 gntR GntR transcriptional regulator 
PA2572 -0.05 1.51 1.46  TC response regulator 
PA3192 1.78 -1.90 -0.12 gltR TC response regulator GltR 
PA3308 -0.01 -0.99 -1.00 hepA RNA polymerase-associated protein RapA 
PA3477 -0.37 1.25 0.89 rhlR transcriptional regulator RhlR 
PA3622 -0.10 1.36 1.26 rpoS sigma factor RpoS 
PA4112 -0.19 1.56 1.37  sensor/response regulator hybrid protein 
PA4296 -0.57 1.88 1.31 pprB TC response regulator PprB 
PA5105 -0.24 -2.55 -2.79 hutC histidine utilization repressor HutC 
PA5261 0.30 0.84 1.14 algR TC response regulator AlgR 
PA5380 -0.46 1.08 0.62 gbdR protein GbdR 
1Red figures indicate statistically significant difference (Padj<0.05) 
2TC, Two-Component 
3differential expression validated by qPCR 
 
 
 
 Fig. S1. Growth curves of glucose uptake mutants with different carbon source. Cultures of 
PAO1 and the indicated mutant strains were inoculated at the same OD600 in M9-Triton X-100 
supplemented with 0.4% glucose, 0.4% gluconate or 0.5% succinate. The growth at 37°C was 
monitored every 40 min for 7 h. Symbols represent average (n=2) with SD of bacterial cell density 
(OD600) at different time points. Generation time of PAO1 and IM mutants growing in the above 
media is reported in Table 1. 
 Fig. S2. Glucose concentration in bacterial media and G. mellonella hemolymph. Glucose 
concentration was estimated on 2% casamino acid stock solution (CAA; n=3); LD broth (LD; n=7) 
and G. mellonella hemolymph (HEM; n=10, each sample being a mix composed by 30 μl aliquots of 
hemolymph of 5 larvae). Diamonds indicate glucose concentration in individual samples.  
 
 Fig. S3. Growth of cultures for RNA-Seq analysis. Independent cultures of PAO1 and GUN were 
grown in M9-CAA up to OD600= 0.4. Glucose (0.4% (w/v) final concentration) was added and 
incubation at 37°C was protracted for 60 min before sampling the cultures for RNA extraction (red 
arrow). Triangle, PAO1; circle, GUN mutant. Empty symbols, no glucose added; black symbols, 
cultures supplemented with glucose.  
 
 Fig. S4. In vitro phenotypic assays on glucose uptake mutants. In all panels, ΔΔ indicates PAO1 
ΔgntP ΔkguT strain. Rhamnolipids (a) were measured as described in Supplementary Experimental 
procedures. Bars represent average (n=3) with SD. Significance was estimated with one-way Anova 
and Tukey post-hoc analysis, only the results of comparisons with PAO1 are reported (*, P<0.05; **, 
P<0.01; ns, not significant). Differences among ΔkguT, ΔΔ and GUN strains were not significant. b. 
Extracellular proteases from supernatants of cultures grown 17 h at 37°C in M9-CAA not 
supplemented (-) or supplemented with 0.4% glucose were detected by casein diffusion plate assay. 
The secretion of proteases is indicated by the formation of a white precipitate resulting from the 
hydrolysis of soluble casein to the insoluble para-casein derivative. The cultures were diluted to the 
same OD600 before the test. Three replicates gave comparable results. c. Growth in microaerophilic 
conditions. Light grey bars, cultures grown in M9-CAA; dark grey bars, cultures grown in LD. Bars 
represent average (n=3) with standard deviation. According to one-way Anova analysis, growth 
differences were not statistically significant at 0.05 level. d. Growth in anaerobiosis. Cultures were 
plated on LD-agar plates supplemented with 100 mM KNO3 and incubated at 37 °C in aerobiosis 
(AE) for 16h or in anaerobiosis (AN) for 48h.  
 
 Fig. S5. C. elegans infection assay. Survival curves of C. elegans infected with glucose uptake mutants. 
Kaplan-Meyer curves represent results deriving from 3 independent experiments in which groups of 
50 worms were fed on the indicated strains. OP50, E. coli strain. d, days post-infection. Significance 
was estimated with log-rank test; only the results relative to PAO1 are reported (*, P< 0.05; ns, not 
significant).  
 
 
Fig. S6. Polarity analysis of glucose uptake genes deletions. a. Transcriptional landscape of 
genomic regions encompassing the loci deleted in glucose uptake mutants. Illumina whole 
transcriptome reads per base in different strains/ conditions are reported below the map of the 10 kbp 
long genomic regions corresponding to deleted loci. Boxes, ORFs; lines, intergenic regions; arrows 
on top of boxes indicate the transcription direction. +, cultures supplemented with glucose; A and B, 
replicate samples analysed in the RNA-Seq experiment. b. ΔkguT mutation complementation assay. 
Cultures of PAO1 ΔkguT carrying either pGM931 (vector) or pGM2071 (pkguT) were inoculated in 
M9-Triton X-100-carbenicillin-arabinose supplemented with 0.1% 2-ketogluconate (light grey bars) 
or 0.5% succinate (dark grey bars). The cultures were incubated at 37°C and the OD600 was measured 
after 24 h. The bars represent average (n=3) with SD. Significance was evaluated with one-way 
Anova and Tukey post hoc test. Differences between means that share a letter (on the columns) are 
not statistically significant at 0.05 level. 
DEGs
PA0023 -0,79 -1,28 -0,49 qor oxygen-dependent quinone oxidoreductase
PA0038 -0,76 -1,09 -0,33 NA hypothetical protein
PA0039 0,64 -0,63 -1,27 NA hypothetical protein
PA0045 1,22 1,19 -0,03 NA hypothetical protein
PA0046 1,24 1,06 -0,18 NA hypothetical protein
PA0048 -0,99 -1,20 -0,21 NA transcriptional regulator
PA0050 2,19 1,31 -0,88 NA hypothetical protein
PA0059 -1,69 -1,45 0,24 osmC osmotically inducible protein OsmC
PA0060 -0,53 -1,13 -0,60 NA hypothetical protein
PA0085 0,21 -1,34 -1,55 hcp1 protein secretion apparatus assembly protein
PA0102 1,01 0,85 -0,16 NA carbonic anhydrase
PA0103 1,54 2,19 0,65 NA sulfate transporter
PA0115 -0,70 -1,23 -0,53 elaA hypothetical protein
PA0118 -1,03 -0,86 0,17 NA hypothetical protein
PA0119 -1,07 -1,69 -0,62 NA C4-dicarboxylate transporter DctA
PA0120 -0,80 -1,01 -0,22 NA transcriptional regulator
PA0121 -0,79 -1,36 -0,57 NA hypothetical protein
PA0122 2,12 1,79 -0,33 rahU hypothetical protein
PA0127 -0,97 -1,60 -0,63 NA hypothetical protein
PA0130 -0,77 -1,18 -0,41 bauC 3-oxopropanoate dehydrogenase
PA0131 -0,85 -1,36 -0,51 bauB beta-alanine degradation protein BauB
PA0132 -0,70 -1,42 -0,72 bauA beta alanine--pyruvate transaminase
PA0147 -0,52 -1,02 -0,50 NA oxidoreductase
PA0161 1,22 1,74 0,52 NA NA
PA0162 1,89 2,41 0,52 opdC histidine porin OpdC
PA0165 0,91 1,84 0,93 NA hypothetical protein
PA0168 -0,90 -1,45 -0,55 yigZ hypothetical protein
PA0169 1,09 1,53 0,44 siaD hypothetical protein
PA0170 0,69 1,29 0,61 NA hypothetical protein
PA0171 1,20 2,05 0,85 NA hypothetical protein
PA0172 0,63 1,30 0,67 siaA hypothetical protein
PA0192 0,77 1,69 0,93 NA TonB-dependent receptor
PA0195 2,02 2,65 0,63 pntAA NAD(P) transhydrogenase subunit alpha
PA0196 1,30 1,58 0,27 pntB pyridine nucleotide transhydrogenase subunit beta
PA0200 0,90 1,10 0,20 NA hypothetical protein
PA0208 2,44 2,83 0,39 mdcA malonate decarboxylase subunit alpha
PA0209 1,73 2,14 0,41 mdcB 2-(5''-triphosphoribosyl)-3'-dephosphocoenzyme-A synthase
PA0211 2,11 2,00 -0,11 mdcD malonate decarboxylase subunit beta
PA0213 2,06 1,69 -0,37 mdcG phosphoribosyl-dephospho-CoA transferase
PA0214 2,49 2,06 -0,43 mdcH acyl transferase
PA0226 -1,13 -1,61 -0,48 NA CoA transferase subunit A
PA0227 -1,03 -1,30 -0,27 pcaJ CoA transferase subunit B
PA0228 -0,82 -1,09 -0,27 pcaF beta-ketoadipyl CoA thiolase
PA0229 -1,06 -1,35 -0,30 pcaT dicarboxylic acid transporter PcaT
PA0231 -1,19 -1,47 -0,28 pcaD 3-oxoadipate enol-lactonase
PA0232 -1,10 -1,31 -0,21 pcaC 4-carboxymuconolactone decarboxylase
PA0248 -0,60 -1,56 -0,96 pobR transcriptional regulator
PA0250 -0,60 -1,26 -0,66 NA hypothetical protein
PA0252 0,50 1,64 1,14 NA hypothetical protein
PA0258 -0,69 -1,07 -0,38 NA hypothetical protein
PA0265 -1,81 -2,04 -0,23 davD glutarate-semialdehyde dehydrogenase DavD
PA0266 -1,92 -2,19 -0,26 davT 5-aminovalerate aminotransferase DavT
PA0277 1,51 1,76 0,26 NA hypothetical protein
PA0290 -0,56 -1,01 -0,45 NA hypothetical protein
PA0296 -1,70 -2,07 -0,37 spuI glutamine synthetase
PA0297 -2,34 -2,43 -0,09 spuA glutamine amidotransferase
PA0298 -2,22 -2,60 -0,38 spuB glutamine synthetase
PA0299 -2,11 -2,75 -0,64 spuC aminotransferase
PA0300 -1,46 -1,96 -0,51 spuD putrescine ABC transporter substrate-binding protein SpuD
PA0301 -1,32 -1,55 -0,23 spuE spermidine ABC transporter substrate-binding protein SpuE
PA0302 -1,54 -1,82 -0,28 spuF polyamine transporter PotG
PA0303 -1,77 -2,03 -0,26 spuG polyamine transporter PotH
PA0304 -1,58 -2,05 -0,47 spuH polyamine transporter PotI
PA0312 -0,67 -1,24 -0,57 NA hypothetical protein
PA0321 -0,95 -1,45 -0,50 NA acetylpolyamine aminohydrolase
PA0328 -1,31 -1,98 -0,67 aaaA hypothetical protein
PA0329 -0,51 -1,76 -1,25 NA hypothetical protein
PA0355 -2,29 -2,51 -0,22 pfpI protease PfpI
PA0358 0,42 1,06 0,64 NA hypothetical protein
PA0382 1,07 1,31 0,25 micA tRNA (guanine-N(7)-)-methyltransferase
PA0425 0,62 1,64 1,02 mexA multidrug resistance protein MexA
PA0426 0,72 1,59 0,86 mexB multidrug resistance protein MexB
PA0427 0,92 1,97 1,05 oprM outer membrane protein OprM
PA0430 0,87 1,20 0,34 metF 5,10-methylenetetrahydrofolate reductase
PA0431 1,24 1,63 0,39 NA hypothetical protein
PA0432 0,96 1,21 0,25 sahH adenosylhomocysteinase
PA0434 0,51 1,81 1,31 NA hypothetical protein
PA0437 0,59 1,04 0,44 codA cytosine deaminase
PA0438 0,82 1,36 0,54 codB cytosine permease
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PA0439 0,85 1,77 0,91 dypB dihydropyrimidine dehydrogenase
PA0446 -0,38 0,93 1,31 NA hypothetical protein
PA0447 -0,60 0,53 1,13 gcdH glutaryl-CoA dehydrogenase
PA0456 -0,52 -1,29 -0,77 NA cold-shock protein
PA0460 -0,95 -1,80 -0,85 NA hypothetical protein
PA0461 -0,54 -1,02 -0,48 yihG acyltransferase
PA0462 -0,60 -1,10 -0,50 NA hypothetical protein
PA0465 0,57 1,53 0,97 creD hypothetical protein
PA0466 0,56 1,91 1,35 NA hypothetical protein
PA0470 0,32 1,70 1,39 fiuA ferrichrome receptor FiuA
PA0475 -0,55 -1,50 -0,96 NA transcriptional regulator
PA0484 -0,12 -1,26 -1,13 NA hypothetical protein
PA0490 -0,51 -1,41 -0,90 NA hypothetical protein
PA0505 -0,33 -1,19 -0,86 NA hypothetical protein
PA0513 0,77 1,80 1,03 nirG heme d1 biosynthesis protein NirG
PA0519 0,74 1,34 0,60 nirS nitrite reductase
PA0527 1,04 1,86 0,82 dnr transcriptional regulator Dnr
PA0546 1,54 1,58 0,04 metK S-adenosylmethionine synthetase
PA0547 1,29 1,85 0,56 NA transcriptional regulator
PA0567 -1,11 -1,38 -0,27 yqaE hypothetical protein
PA0574 -1,00 -1,45 -0,46 NA hypothetical protein
PA0578 0,60 1,20 0,60 NA hypothetical protein
PA0579 0,68 1,23 0,55 rpsU 30S ribosomal protein S21
PA0580 0,82 1,55 0,73 gcp tRNA N6-adenosine threonylcarbamoyltransferase
PA0599 -0,77 -1,05 -0,28 NA hypothetical protein
PA0602 -0,86 -1,41 -0,54 NA ABC transporter
PA0603 -2,38 -2,62 -0,24 agtA ABC transporter ATP-binding protein
PA0604 -2,57 -2,69 -0,13 agtB ABC transporter
PA0605 -1,90 -1,57 0,33 agtC ABC transporter permease
PA0606 -1,08 -1,42 -0,34 agtD ABC transporter permease
PA0639 0,68 1,08 0,41 NA hypothetical protein
PA0648 -0,63 -1,15 -0,52 NA hypothetical protein
PA0654 1,13 2,19 1,06 speD S-adenosylmethionine decarboxylase
PA0656 -0,15 -1,20 -1,05 ycfF HIT family protein
PA0708 -1,22 -2,56 -1,34 NA transcriptional regulator
PA0709 1,24 1,65 0,41 NA hypothetical protein
PA0710 1,12 2,02 0,90 gloA2 lactoylglutathione lyase
PA0713 1,02 2,25 1,23 NA hypothetical protein
PA0714 1,51 1,74 0,23 NA hypothetical protein
PA0715 -0,75 -1,03 -0,28 NA hypothetical protein
PA0730 1,37 1,84 0,47 NA (R)-3-hydroxydecanoyl-ACP:CoA transacylase
PA0732 -0,75 -1,45 -0,70 NA hypothetical protein
PA0736 -0,53 -1,13 -0,60 NA hypothetical protein
PA0744 -1,34 -1,47 -0,13 NA enoyl-CoA hydratase
PA0745 -1,20 -1,52 -0,32 NA enoyl-CoA hydratase
PA0746 -1,09 -0,99 0,10 NA acyl-CoA dehydrogenase
PA0747 -1,14 -1,61 -0,46 NA aldehyde dehydrogenase
PA0754 -0,97 -1,23 -0,27 NA hypothetical protein
PA0755 -0,85 -1,16 -0,30 opdH cis-aconitate porin OpdH
PA0765 -0,70 -1,16 -0,46 mucC positive regulator for alginate biosynthesis MucC
PA0767 0,44 1,22 0,78 lepA elongation factor 4
PA0768 0,51 1,08 0,57 lepB signal peptidase I
PA0771 0,63 1,21 0,58 era GTPase Era
PA0775 0,73 1,62 0,89 yecO tRNA (cmo5U34)-methyltransferase
PA0779 -0,87 -2,13 -1,26 asrA ATP-dependent protease
PA0781 0,76 2,41 1,65 NA hypothetical protein
PA0788 0,78 1,34 0,56 NA hypothetical protein
PA0789 -0,51 -1,34 -0,82 NA amino acid permease
PA0792 -1,51 -1,68 -0,17 prpD 2-methylcitrate dehydratase
PA0793 -1,40 -1,86 -0,46 NA hypothetical protein
PA0794 -1,79 -2,05 -0,26 NA aconitate hydratase
PA0795 -1,67 -1,84 -0,16 prpC methylcitrate synthase
PA0796 -1,58 -1,66 -0,08 prpB 2-methylisocitrate lyase
PA0797 -1,95 -1,77 0,18 NA transcriptional regulator
PA0799 0,39 1,12 0,73 NA helicase
PA0805 -0,49 -1,26 -0,76 NA hypothetical protein
PA0815 -0,82 -1,42 -0,61 NA transcriptional regulator
PA0820 -0,60 -1,13 -0,53 NA hypothetical protein
PA0822 -0,73 -1,25 -0,52 NA NA
PA0831 -1,01 -1,34 -0,33 oruR ornithine utilization transcriptional regulator OruR
PA0833 -0,60 -1,18 -0,58 NA hypothetical protein
PA0834 0,30 1,01 0,71 NA acyltransferase
PA0839 -0,88 -1,09 -0,21 NA transcriptional regulator
PA0840 -0,54 -1,20 -0,66 NA oxidoreductase
PA0846 -0,79 -1,07 -0,28 cysZ sulfate transporter CysZ
PA0852 1,59 1,70 0,12 cbpD chitin-binding protein CbpD
PA0852.1 1,59 1,78 0,19 NA NA
PA0857 -0,67 -1,15 -0,49 bolA morphogene protein BolA
PA0862 -0,71 -1,15 -0,43 NA hypothetical protein
PA0866 -1,28 -1,88 -0,60 aroP2 aromatic amino acid transporter AroP
PA0867 -0,73 -1,18 -0,45 mliC lysozyme inhibitor
PA0886 -0,04 1,71 1,75 dctM C4-dicarboxylate transporter
PA0887 -1,62 -4,00 -2,37 acsA acetyl-CoA synthetase
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PA0895 -1,38 -1,69 -0,31 aruC acetylornithine aminotransferase
PA0896 -1,08 -1,27 -0,19 aruF arginine N-succinyltransferase subunit alpha
PA0897 -1,27 -1,22 0,05 aruG arginine N-succinyltransferase subunit beta
PA0898 -1,42 -1,60 -0,18 aruD N-succinylglutamate 5-semialdehyde dehydrogenase
PA0899 -1,35 -1,65 -0,30 aruB N-succinylarginine dihydrolase
PA0900 -0,98 -1,32 -0,33 NA hypothetical protein
PA0901 -0,98 -1,30 -0,32 aruE succinylglutamate desuccinylase
PA0906 -0,83 -1,24 -0,41 alpR transcriptional regulator
PA0915 1,86 2,79 0,93 yehS hypothetical protein
PA0916 1,59 2,55 0,96 yliG ribosomal protein S12 methylthiotransferase RimO
PA0923 0,08 1,18 1,10 dinB DNA polymerase IV
PA0945 0,60 1,04 0,44 purM phosphoribosylformylglycinamidine cyclo-ligase
PA0947 0,17 1,02 0,85 NA DNA replication initiation factor
PA0954 -0,84 -1,12 -0,27 NA acylphosphatase
PA0958 -1,36 -1,85 -0,48 oprD porin D
PA0968 0,63 1,18 0,55 ybgC hypothetical protein
PA0975 1,06 1,52 0,46 NA radical activating enzyme
PA0976 1,10 0,50 -0,61 NA 7-cyano-7-deazaguanine synthase
PA0982 -0,49 -1,10 -0,61 NA hypothetical protein
PA0988 -0,88 -1,43 -0,55 NA hypothetical protein
PA1001 0,94 1,32 0,38 phnA anthranilate synthase component I
PA1002 1,08 0,91 -0,17 phnB anthranilate synthase component II
PA1035 -0,81 -1,28 -0,47 NA hypothetical protein
PA1048 -0,38 -1,04 -0,66 NA hypothetical protein
PA1053 0,51 1,14 0,62 slyB hypothetical protein
PA1070 -1,19 -1,65 -0,46 braG ABC transporter ATP-binding protein
PA1071 -1,04 -1,01 0,04 braF ABC transporter ATP-binding protein
PA1072 -1,14 -1,45 -0,32 braE branched-chain amino acid ABC transporter permease BraE
PA1073 -0,85 -1,66 -0,81 braD branched-chain amino acid ABC transporter permease BraD
PA1074 -1,03 -1,62 -0,60 braC branched-chain amino acid ABC transporter substrate-binding protein BraC
PA1100 -0,59 -1,27 -0,68 fliE flagellar hook-basal body complex protein FliE
PA1116 0,93 1,33 0,40 NA hypothetical protein
PA1124 -0,61 -1,19 -0,58 dgt deoxyguanosinetriphosphate triphosphohydrolase
PA1127 -0,63 -1,08 -0,45 gsp69 oxidoreductase
PA1140 -0,79 -1,21 -0,42 ylbA hypothetical protein
PA1152 0,60 1,10 0,50 NA NA
PA1159 -0,88 -2,16 -1,28 NA cold-shock protein
PA1168 1,92 1,70 -0,22 NA hypothetical protein
PA1169 1,47 1,28 -0,19 NA arachidonate 15-lipoxygenase
PA1181 1,17 1,42 0,25 yegE sensor protein
PA1189 0,70 1,43 0,73 NA Zn-dependent metalloprotease
PA1190 -0,93 -1,39 -0,46 yohC hypothetical protein
PA1203 -1,21 -1,54 -0,32 NA hypothetical protein
PA1204 -0,94 -1,47 -0,52 yieF NAD(P)H-dependent FMN reductase
PA1205 -1,11 -1,66 -0,55 NA quercetin 2,3-dioxygenase
PA1213 1,43 2,12 0,69 NA hypothetical protein
PA1214 1,38 2,00 0,61 NA hypothetical protein
PA1215 1,62 2,38 0,76 NA hypothetical protein
PA1216 2,23 2,54 0,32 NA hypothetical protein
PA1217 2,08 2,44 0,36 NA 2-isopropylmalate synthase
PA1218 1,75 2,02 0,27 NA hypothetical protein
PA1221 1,16 0,82 -0,34 NA hypothetical protein
PA1228 1,17 1,78 0,61 NA hypothetical protein
PA1249 0,64 1,04 0,40 aprA alkaline metalloproteinase
PA1260 -0,87 -1,44 -0,57 lhpP amino acid ABC transporter substrate-binding protein
PA1273 0,50 1,13 0,63 cobB hydrogenobyrinate a,c-diamide synthase
PA1302 0,65 2,16 1,51 hxuC heme utilization protein
PA1317 4,64 6,34 1,70 cyoA cytochrome o ubiquinol oxidase subunit II
PA1318 4,55 5,97 1,42 cyoB cytochrome o ubiquinol oxidase subunit I
PA1319 3,79 5,11 1,32 cyoC cytochrome o ubiquinol oxidase subunit III
PA1320 3,29 4,12 0,83 cyoD cytochrome o ubiquinol oxidase subunit IV
PA1321 3,18 3,74 0,56 cyoE protoheme IX farnesyltransferase
PA1322 0,39 1,30 0,92 pfuA TonB-dependent receptor
PA1323 -1,01 -0,69 0,31 NA hypothetical protein
PA1324 -1,17 -1,07 0,10 NA hypothetical protein
PA1337 -1,19 -2,16 -0,97 ansB glutaminase-asparaginase
PA1338 -0,68 -2,37 -1,69 ggt gamma-glutamyltranspeptidase
PA1339 -0,37 -1,52 -1,14 aatP amino acid ABC transporter ATP binding protein
PA1340 -0,32 -1,57 -1,25 aatM amino acid ABC transporter permease
PA1341 -0,07 -1,53 -1,47 aatQ amino acid ABC transporter permease
PA1342 -0,95 -1,77 -0,82 aatJ ABC transporter
PA1343 0,57 1,37 0,80 NA hypothetical protein
PA1373 0,84 1,37 0,53 fabF2 3-oxoacyl-ACP synthase
PA1376 -0,88 -1,16 -0,27 aceK bifunctional isocitrate dehydrogenase kinase/phosphatase
PA1377 -0,64 -1,28 -0,65 yhhY hypothetical protein
PA1401 -1,03 -1,30 -0,27 NA hypothetical protein
PA1414 1,27 1,50 0,23 NA hypothetical protein
PA1418 -0,94 -1,51 -0,57 NA sodium:solute symport protein
PA1419 -1,84 -2,07 -0,22 NA transporter
PA1420 -1,83 -2,26 -0,43 NA hypothetical protein
PA1421 -2,02 -2,20 -0,18 gbuA guanidinobutyrase
PA1422 1,08 1,60 0,51 gbuR protein GbuR
PA1425 1,86 1,52 -0,33 NA ABC transporter ATP-binding protein
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PA1427 1,00 1,98 0,98 NA NA
PA1471 -0,54 -1,23 -0,69 NA hypothetical protein
PA1476 0,67 1,34 0,67 ccmB heme exporter protein CcmB
PA1478 0,91 1,17 0,27 helD heme exporter protein CcmD
PA1479 0,86 1,30 0,44 ccmE cytochrome c-type biogenesis protein CcmE
PA1481 0,96 1,27 0,31 ccmG cytochrome c-type biogenesis protein CcmG
PA1483 0,98 1,36 0,38 cycH cytochrome c-type biogenesis protein CycH
PA1499 0,52 1,94 1,42 NA hypothetical protein
PA1535 -0,91 -1,69 -0,77 NA acyl-CoA dehydrogenase
PA1546 1,55 2,00 0,44 hemN oxygen-independent coproporphyrinogen-III oxidase
PA1549 1,49 1,24 -0,26 fixI cation-transporting P-type ATPase
PA1550 1,48 1,65 0,17 NA hypothetical protein
PA1551 1,45 2,04 0,59 fixG ferredoxin
PA1552 1,56 2,35 0,79 ccoP1 cytochrome C oxidase cbb3-type subunit CcoP
PA1552.1 1,54 1,81 0,27 ccoQ1 cytochrome C oxidase cbb3-type subunit CcoQ
PA1553 1,52 1,91 0,39 ccoO1 cbb3-type cytochrome C oxidase subunit II
PA1554 1,64 2,34 0,70 ccoN1 cbb3-type cytochrome C oxidase subunit I
PA1555 2,48 1,86 -0,62 ccoP2 cytochrome C oxidase cbb3-type subunit CcoP
PA1555.1 1,77 1,87 0,10 ccoQ2 cytochrome C oxidase cbb3-type subunit CcoQ
PA1556 1,99 2,04 0,06 ccoO2 cbb3-type cytochrome C oxidase subunit II
PA1557 2,09 2,46 0,37 ccoN2 cbb3-type cytochrome C oxidase subunit I
PA1577 1,84 1,06 -0,78 NA hypothetical protein
PA1578 1,29 1,64 0,35 NA hypothetical protein
PA1579 -0,14 -1,02 -0,88 NA hypothetical protein
PA1584 1,05 1,09 0,04 sdhB succinate dehydrogenase iron-sulfur subunit
PA1591 1,36 1,96 0,60 NA hypothetical protein
PA1592 -0,61 -1,31 -0,70 NA hypothetical protein
PA1596 -0,45 -1,61 -1,15 htpG chaperone protein HtpG
PA1597 -1,33 -2,27 -0,94 NA hypothetical protein
PA1608 0,56 1,05 0,50 NA chemotaxis transducer
PA1609 1,31 1,41 0,11 fabB 3-oxoacyl-ACP synthase
PA1610 1,38 1,32 -0,06 fabA 3-hydroxydecanoyl-ACP dehydratase
PA1617 -1,75 -3,31 -1,56 NA AMP-binding protein
PA1618 -0,62 -1,22 -0,60 ybdB esterase
PA1634 1,63 1,58 -0,05 kdpB potassium-transporting ATPase subunit B
PA1641 -0,45 -1,10 -0,66 NA hypothetical protein
PA1655 -0,75 -1,01 -0,26 NA glutathione S-transferase
PA1656 1,01 0,82 -0,18 hsiA2 hypothetical protein
PA1657 1,35 1,28 -0,07 hsiB2 hypothetical protein
PA1658 1,21 1,07 -0,13 hsiC2 hypothetical protein
PA1660 0,88 1,21 0,33 hsiG2 hypothetical protein
PA1661 1,32 1,16 -0,16 hsiH2 hypothetical protein
PA1662 1,23 0,97 -0,26 clpV2 ClpA/B-type protease
PA1663 1,01 1,39 0,38 sfa2 transcriptional regulator
PA1666 1,29 1,10 -0,19 lip2 hypothetical protein
PA1667 1,16 0,85 -0,31 hsiJ2 hypothetical protein
PA1668 1,52 1,16 -0,36 dotU2 hypothetical protein
PA1669 1,18 1,04 -0,14 icmF2 hypothetical protein
PA1673 1,23 1,23 -0,01 NA bacteriohemerythrin
PA1687 1,05 1,64 0,60 speE polyamine aminopropyltransferase
PA1688 0,66 1,22 0,55 NA hypothetical protein
PA1689 0,64 1,22 0,58 NA hypothetical protein
PA1697 1,11 1,86 0,75 pscN type III secretion system ATPase
PA1698 0,70 1,61 0,91 popN type III secretion outer membrane protein PopN
PA1712 1,04 1,08 0,04 exsB exoenzyme S synthesis protein ExsB
PA1717 1,01 1,63 0,63 pscD type III export protein PscD
PA1718 1,01 1,55 0,54 pscE type III export protein PscE
PA1719 0,77 1,02 0,26 pscF type III export protein PscF
PA1721 0,22 1,45 1,23 pscH type III export protein PscH
PA1727 0,62 1,25 0,64 mucR signaling protein
PA1742 -2,07 -2,55 -0,48 pauD2 amidotransferase
PA1746 0,52 1,19 0,67 NA hypothetical protein
PA1749 -0,65 -1,25 -0,60 NA hypothetical protein
PA1751 -0,64 -1,15 -0,51 NA hypothetical protein
PA1757 0,40 1,02 0,63 thrH phosphoserine phosphatase
PA1759 -1,16 -1,91 -0,75 NA transcriptional regulator
PA1760 -1,25 -1,39 -0,14 NA transcriptional regulator
PA1761 -1,09 -1,97 -0,88 NA hypothetical protein
PA1762 -1,15 -1,66 -0,51 NA hypothetical protein
PA1763 -0,70 -1,29 -0,59 NA hypothetical protein
PA1768 0,42 1,21 0,79 NA hypothetical protein
PA1774 2,27 2,14 -0,14 crfX hypothetical protein
PA1775 1,46 1,71 0,25 cmpX hypothetical protein
PA1781 1,05 2,25 1,20 nirB assimilatory nitrite reductase large subunit
PA1791 1,22 1,76 0,53 NA hypothetical protein
PA1796 0,33 1,05 0,71 folD bifunctional 5,10-methylene-tetrahydrofolate dehydrogenase/cyclohydrolase
PA1812 0,62 1,28 0,66 mltD membrane-bound lytic murein transglycosylase D
PA1817 -0,95 -1,18 -0,23 NA hypothetical protein
PA1818 -1,56 -2,00 -0,44 ldcA lysine-specific pyridoxal 5'-phosphate-dependent carboxylase LdcA
PA1819 -1,11 -1,85 -0,74 yjdE amino acid permease
PA1837 0,71 1,11 0,41 NA hypothetical protein
PA1838 0,77 1,15 0,38 cysI sulfite reductase
PA1839 1,08 1,75 0,67 NA RNA methyltransferase
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PA1852 2,84 2,96 0,12 NA hypothetical protein
PA1854 0,24 1,72 1,48 NA hypothetical protein
PA1856 0,78 1,97 1,19 NA cbb3-type cytochrome C oxidase subunit I
PA1866 0,64 1,39 0,75 NA hypothetical protein
PA1868 0,75 1,73 0,98 xqhA secretion protein XqhA
PA1869 2,21 1,89 -0,32 NA acyl carrier protein
PA1871 1,19 1,44 0,24 lasA protease LasA
PA1874 0,93 1,44 0,52 NA hypothetical protein
PA1885 -1,01 -1,47 -0,46 NA hypothetical protein
PA1892 1,68 2,04 0,36 NA hypothetical protein
PA1893 1,83 2,16 0,32 NA hypothetical protein
PA1894 2,23 2,56 0,33 NA hypothetical protein
PA1895 2,20 2,85 0,65 NA hypothetical protein
PA1896 1,95 2,42 0,46 NA hypothetical protein
PA1897 2,00 2,07 0,07 NA hypothetical protein
PA1899 3,38 3,49 0,11 phzA2 phenazine biosynthesis protein PhzA
PA1900 4,22 4,58 0,36 phzB2 phenazine biosynthesis protein PhzB
PA1909 1,14 1,72 0,58 NA hypothetical protein
PA1910 0,88 1,91 1,03 femA ferric-mycobactin receptor FemA
PA1914 1,25 1,53 0,29 hvn hypothetical protein
PA1920 0,90 2,14 1,24 nrdD anaerobic ribonucleoside triphosphate reductase
PA1923 0,81 1,68 0,88 NA cobaltochelatase subunit CobN
PA1926 1,02 1,33 0,31 ycaO hypothetical protein
PA1941 -0,46 -1,02 -0,56 NA hypothetical protein
PA1946 -0,92 -1,77 -0,85 rbsB ribose ABC transporter substrate-binding protein
PA1947 -0,80 -1,37 -0,57 rbsA ribose transporter RbsA
PA1950 -0,68 -1,19 -0,51 rbsK ribokinase
PA1952 0,10 1,71 1,61 fapE hypothetical protein
PA1954 0,78 1,66 0,87 fapC hypothetical protein
PA1959 0,92 1,32 0,40 bacA undecaprenyl-diphosphatase
PA1963 -0,69 -1,47 -0,78 NA hypothetical protein
PA1964 1,04 1,73 0,69 ybiT ABC-F family ATPase
PA1970 0,02 -1,59 -1,61 NA hypothetical protein
PA1972 1,08 2,21 1,13 NA hypothetical protein
PA1974 0,47 2,62 2,15 NA hypothetical protein
PA1982 0,64 1,35 0,71 exaA quinoprotein ethanol dehydrogenase
PA1991 -0,83 -1,58 -0,75 NA iron-containing alcohol dehydrogenase
PA1992 -1,05 -1,55 -0,49 ercS sensor histidine kinase
PA1996 0,49 1,47 0,98 ppiC1 peptidyl-prolyl cis-trans isomerase C1
PA1999 -1,39 -2,00 -0,61 dhcA dehydrocarnitine CoA transferase subunit A
PA2000 -1,38 -1,94 -0,57 dhcB dehydrocarnitine CoA transferase subunit B
PA2001 -1,07 -1,15 -0,08 atoB acetyl-CoA acetyltransferase
PA2002 -1,20 -1,58 -0,37 atoE hypothetical protein
PA2006 -1,00 -1,29 -0,29 NA major facilitator superfamily transporter
PA2011 -1,25 -1,52 -0,27 liuE 3-hydroxy-3-isohexenylglutaryl-CoA/hydroxy-methylglutaryl-CoA lyase
PA2012 -1,55 -1,79 -0,24 liuD methylcrotonyl-CoA carboxylase subunit alpha
PA2013 -1,64 -1,74 -0,10 liuC gamma-carboxygeranoyl-CoA hydratase
PA2014 -1,62 -1,85 -0,23 liuB methylcrotonyl-CoA carboxylase subunit beta
PA2015 -1,56 -1,76 -0,20 liuA isovaleryl-CoA dehydrogenase
PA2016 -1,61 -1,89 -0,28 liuR liu genes regulator
PA2018 2,54 2,34 -0,20 mexY multidrug efflux protein
PA2019 2,47 3,00 0,52 mexX multidrug efflux lipoprotein
PA2031 0,95 1,16 0,21 NA hypothetical protein
PA2040 -2,85 -3,20 -0,35 pauA4 glutamine synthetase
PA2041 -3,12 -3,63 -0,51 NA amino acid permease
PA2057 0,45 1,54 1,09 sppR hypothetical protein
PA2069 2,74 2,58 -0,16 NA carbamoyl transferase
PA2070 0,91 2,12 1,21 NA hypothetical protein
PA2076 0,71 1,36 0,65 NA transcriptional regulator
PA2079 -1,57 -2,03 -0,47 NA amino acid permease
PA2080 -1,17 -1,14 0,03 kynU kynureninase KynU
PA2081 -1,11 -1,13 -0,02 kynB kynurenine formamidase KynB
PA2082 -0,84 -1,38 -0,54 kynR transcriptional regulator
PA2089 0,47 1,82 1,35 NA hypothetical protein
PA2119 1,58 1,70 0,12 adh alcohol dehydrogenase
PA2130 0,37 2,31 1,94 cupA3 usher CupA3
PA2131 1,00 2,24 1,23 cupA4 fimbrial subunit CupA4
PA2152 0,29 1,76 1,47 NA trehalose synthase
PA2160 0,78 1,53 0,75 glgX glycosyl hydrolase
PA2179 0,60 1,75 1,16 NA hypothetical protein
PA2189 0,72 2,63 1,91 NA hypothetical protein
PA2193 3,77 3,96 0,18 hcnA hydrogen cyanide synthase subunit HcnA
PA2194 3,34 3,62 0,28 hcnB hydrogen cyanide synthase subunit HcnB
PA2195 3,36 3,71 0,34 hcnC hydrogen cyanide synthase subunit HcnC
PA2196 1,10 1,39 0,29 NA transcriptional regulator
PA2198 1,09 0,88 -0,21 NA hypothetical protein
PA2231 0,90 1,03 0,13 pslA biofilm formation protein PslA
PA2234 1,22 1,35 0,13 pslD biofilm formation protein PslD
PA2235 1,34 1,34 0,00 pslE biofilm formation protein PslE
PA2236 1,33 1,97 0,64 pslF biofilm formation protein PslF
PA2237 1,30 0,87 -0,44 pslG biofilm formation protein PslG
PA2242 0,85 1,25 0,41 pslL hypothetical protein
PA2246 -1,43 -1,37 0,06 bkdR Bkd operon transcriptional regulator BkdR
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PA2247 -1,02 -1,00 0,02 bkdA1 2-oxoisovalerate dehydrogenase subunit alpha
PA2248 -0,95 -1,24 -0,28 bkdA2 2-oxoisovalerate dehydrogenase subunit beta
PA2250 -0,73 -1,08 -0,35 lpdV branched-chain alpha-keto acid dehydrogenase complex dihydrolipoyl dehydrogenase
PA2252 1,81 2,30 0,49 NA AGCS sodium/alanine/glycine symporter
PA2254 0,90 1,62 0,72 pvcA paerucumarin biosynthesis protein PvcA
PA2259 -2,31 -1,34 0,97 ptxS transcriptional regulator PtxS
PA2261 -2,91 -1,07 1,84 kguK 2-ketogluconate kinase
PA2262 -3,25 -1,27 1,98 kguT 2-ketogluconate transporter
PA2263 -2,24 -0,56 1,68 kguD 2-hydroxyacid dehydrogenase
PA2264 -0,12 1,53 1,65 NA hypothetical protein
PA2265 0,04 1,64 1,60 gad gluconate dehydrogenase
PA2266 -0,20 1,42 1,62 NA cytochrome C
PA2289 1,39 3,80 2,41 NA hypothetical protein
PA2290 1,27 2,80 1,52 gcd glucose dehydrogenase
PA2291 0,98 2,52 1,53 oprB2 glucose-sensitive porin
PA2300 1,44 2,08 0,65 chiC chitinase
PA2307 0,60 1,60 1,00 NA ABC transporter permease
PA2320 -3,17 -0,81 2,35 gntR GntR family transcriptional regulator
PA2321 -8,47 -1,37 7,11 gntK gluconokinase
PA2322 -7,69 -1,73 5,96 gntP gluconate permease
PA2323 -2,94 2,73 5,68 gapN glyceraldehyde-3-phosphate dehydrogenase
PA2335 0,72 1,55 0,84 optO TonB-dependent receptor
PA2349 0,68 1,57 0,89 NA hypothetical protein
PA2352 0,97 1,51 0,54 NA glycerophosphoryl diester phosphodiesterase
PA2366 1,18 1,14 -0,04 hsiC3 uricase
PA2371 1,05 1,08 0,02 clpV3 ClpA/B-type protease
PA2389 1,19 1,49 0,31 pvdR pyoverdine biosynthesis protein PvdR
PA2419 1,01 1,38 0,37 slsA hydrolase
PA2424 0,83 1,28 0,45 pvdL peptide synthase
PA2433 -0,83 -1,00 -0,18 NA hypothetical protein
PA2439 0,51 1,49 0,99 NA hypothetical protein
PA2466 0,82 1,21 0,39 foxA ferrioxamine receptor FoxA
PA2486 -0,55 -1,23 -0,68 NA hypothetical protein
PA2507 -1,82 -1,98 -0,16 catA catechol 1,2-dioxygenase
PA2508 -1,41 -2,04 -0,63 catC muconolactone delta-isomerase
PA2509 -1,51 -1,97 -0,46 catB muconate cycloisomerase I
PA2512 0,89 1,12 0,24 antA anthranilate dioxygenase large subunit
PA2513 1,06 1,65 0,59 antB anthranilate dioxygenase small subunit
PA2520 0,46 1,62 1,16 czcA resistance-nodulation-cell division (RND) divalent metal cation efflux transporter CzcA
PA2533 -0,65 -1,09 -0,44 NA sodium:alanine symporter
PA2550 -0,78 -1,00 -0,22 NA acyl-CoA dehydrogenase
PA2552 -1,64 -1,66 -0,02 acdB acyl-CoA dehydrogenase
PA2553 -1,65 -1,67 -0,02 NA acyl-CoA thiolase
PA2554 -1,73 -1,78 -0,05 NA short-chain dehydrogenase
PA2555 -1,89 -2,27 -0,38 NA AMP-binding protein
PA2556 -1,79 -2,46 -0,67 NA transcriptional regulator
PA2557 -2,29 -2,79 -0,50 NA AMP-binding protein
PA2561 0,95 1,37 0,42 ctpH methyl-accepting chemotaxis protein CtpH
PA2563 1,42 1,90 0,48 NA sulfate transporter
PA2570 1,44 1,59 0,15 lecA PA-I galactophilic lectin
PA2592 1,36 1,41 0,05 potF5 spermidine/putrescine-binding protein
PA2629 1,32 2,49 1,17 purB adenylosuccinate lyase
PA2630 1,05 1,70 0,65 ycfD hypothetical protein
PA2653 1,19 1,78 0,59 yuiF transporter
PA2664 1,17 1,53 0,35 fhp flavohemoprotein
PA2666 0,42 1,15 0,73 ptpS 6-carboxytetrahydropterin synthase QueD
PA2667 -0,87 -1,45 -0,58 mvaU hypothetical protein
PA2686 0,94 1,62 0,69 pfeR two-component response regulator PfeR
PA2688 0,68 1,88 1,20 pfeA ferric enterobactin receptor
PA2747 -0,96 -1,95 -0,99 NA hypothetical protein
PA2754 -1,24 -1,61 -0,37 NA hypothetical protein
PA2756 -0,45 -1,13 -0,69 NA hypothetical protein
PA2759 -1,07 -1,65 -0,58 NA hypothetical protein
PA2761 0,38 1,45 1,07 NA hypothetical protein
PA2769 0,98 1,05 0,07 NA hypothetical protein
PA2770 0,73 1,52 0,79 NA isomerase
PA2774 0,27 -1,00 -1,27 tse4 hypothetical protein
PA2776 -2,31 -2,95 -0,64 pauB3 hypothetical protein
PA2805 -0,58 -1,14 -0,56 NA hypothetical protein
PA2815 -0,67 -1,07 -0,39 yafH acyl-CoA dehydrogenase
PA2817 1,07 1,67 0,60 NA hypothetical protein
PA2825 -0,97 -1,93 -0,97 ospR transcriptional regulator
PA2826 -0,84 -1,67 -0,83 NA glutathione peroxidase
PA2830 -0,67 -1,23 -0,55 htpX protease HtpX
PA2832 -0,79 -1,60 -0,82 tpm thiopurine S-methyltransferase
PA2835 0,70 2,21 1,51 NA major facilitator superfamily transporter
PA2840 2,00 3,23 1,23 deaD ATP-dependent RNA helicase
PA2851 0,55 1,14 0,59 efp elongation factor P
PA2853 -0,14 -1,87 -1,73 oprI outer membrane lipoprotein OprI
PA2862 -1,83 -2,83 -1,00 lipA lactonizing lipase
PA2863 -1,46 -1,84 -0,38 lipH lipase chaperone
PA2870 0,37 1,41 1,04 NA hypothetical protein
PA2883 -1,18 -1,48 -0,30 NA hypothetical protein
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PA2885 -0,57 -1,13 -0,55 atuR atu genes repressor
PA2886 -1,36 -1,90 -0,53 atuA hypothetical protein
PA2887 -1,29 -1,94 -0,65 atuB citronellol catabolism dehydrogenase
PA2888 -1,75 -2,03 -0,28 atuC geranyl-CoA carboxylase subunit beta
PA2889 -1,34 -2,13 -0,80 atuD citronellyl-CoA dehydrogenase
PA2890 -1,75 -1,91 -0,15 atuE isohexenylglutaconyl-CoA hydratase
PA2891 -1,33 -1,45 -0,12 atuF geranyl-CoA carboxylase subunit alpha
PA2892 -1,21 -1,42 -0,21 atuG short-chain dehydrogenase
PA2897 -0,65 -1,03 -0,39 NA transcriptional regulator
PA2905 0,77 1,44 0,67 cobH precorrin-8X methylmutase
PA2912 0,42 1,19 0,77 NA ABC transporter ATP-binding protein
PA2937 0,88 1,37 0,49 NA hypothetical protein
PA2939 1,67 1,62 -0,05 pepB aminopeptidase
PA2950 1,43 1,56 0,12 pfm proton motive force protein 
PA2957 0,92 1,55 0,63 NA transcriptional regulator
PA2967 2,21 2,53 0,32 fabG 3-oxoacyl-[acyl-carrier-protein] reductase FabG
PA2968 2,16 2,28 0,11 fabD malonyl CoA-ACP transacylase
PA2971 1,14 1,79 0,66 yceD hypothetical protein
PA2976 0,51 1,30 0,79 rne ribonuclease E
PA3000 1,13 1,00 -0,13 aroP1 aromatic amino acid transporter AroP
PA3006 -0,57 -1,11 -0,55 psrA transcriptional regulator PsrA
PA3015 -0,90 -1,32 -0,42 NA hypothetical protein
PA3017 -0,49 -1,40 -0,90 NA hypothetical protein
PA3023 -0,76 -1,26 -0,50 yegS lipid kinase
PA3031 -0,75 -1,05 -0,30 NA hypothetical protein
PA3032 0,89 1,49 0,61 snr1 cytochrome C Snr1
PA3038 -2,82 -4,34 -1,52 opdQ porin
PA3043 -0,99 -1,24 -0,25 NA deoxyguanosinetriphosphate triphosphohydrolase
PA3048 1,04 0,91 -0,13 ycbY ribosomal RNA large subunit methyltransferase K/L
PA3058 0,69 1,54 0,85 pelG pellicle/biofilm biosynthesis Wzx-like polysaccharide transporter PelG
PA3059 0,67 1,16 0,49 pelF pellicle/biofilm biosynthesis glycosyltransferase PelF
PA3067 -0,13 0,88 1,00 NA transcriptional regulator
PA3068 -1,26 -0,92 0,35 gdhB NAD-specific glutamate dehydrogenase
PA3079 -1,79 -2,53 -0,74 NA hypothetical protein
PA3080 -1,35 -2,09 -0,74 NA hypothetical protein
PA3112 1,26 1,66 0,41 accD acetyl-CoA carboxylase carboxyltransferase subunit beta
PA3124 -0,61 -1,10 -0,49 NA transcriptional regulator
PA3126 -0,18 -1,62 -1,45 ibpA heat-shock protein IbpA
PA3161 -0,70 -1,26 -0,56 himD integration host factor subunit beta
PA3162 1,02 1,65 0,63 rpsA 30S ribosomal protein S1
PA3171 0,50 1,05 0,55 ubiG ubiquinone biosynthesis O-methyltransferase
PA3179 1,90 2,61 0,71 yciL ribosomal large subunit pseudouridine synthase B
PA3181 -4,57 -3,14 1,43 edaA 2-dehydro-3-deoxy-phosphogluconate aldolase
PA3182 -4,85 -2,99 1,86 pgl 6-phosphogluconolactonase
PA3183 -5,07 -3,48 1,59 zwf glucose-6-phosphate 1-dehydrogenase
PA3186 -1,82 4,17 5,99 oprB porin B
PA3187 -3,66 2,18 5,83 gltK ABC transporter ATP-binding protein
PA3188 -7,23 -1,47 5,76 gltG sugar ABC transporter permease
PA3189 -6,82 -1,80 5,02 gltF sugar ABC transporter permease
PA3190 -0,73 4,38 5,10 gltB sugar ABC transporter substrate-binding protein
PA3191 -2,16 -1,40 0,76 gtrS two-component sensor
PA3192 -2,47 -1,71 0,76 gltR two-component response regulator GltR
PA3193 -2,66 -2,03 0,63 glk glucokinase
PA3194 -3,69 -2,80 0,89 edd phosphogluconate dehydratase
PA3195 -4,67 -3,04 1,62 gapA glyceraldehyde 3-phosphate dehydrogenase
PA3229 -0,97 -1,96 -0,99 NA hypothetical protein
PA3232 0,21 -1,33 -1,54 NA DNA polymerase III subunit epsilon
PA3233 -0,71 -2,48 -1,77 NA hypothetical protein
PA3234 -1,30 -3,89 -2,58 yjcG acetate permease
PA3235 -1,36 -4,23 -2,87 yjcH hypothetical protein
PA3263 -0,13 1,19 1,32 yaiD recombination associated protein RdgC
PA3266 -0,36 -1,62 -1,26 capB major cold shock protein CspA
PA3268 1,75 2,32 0,57 NA TonB-dependent receptor
PA3272 -0,76 -1,33 -0,57 lhr ATP-dependent DNA helicase
PA3286 0,94 1,26 0,31 NA 3-oxoacyl-ACP synthase
PA3296 1,55 2,05 0,51 phoA alkaline phosphatase
PA3300 -1,38 -1,83 -0,45 fadD2 long-chain-fatty-acid--CoA ligase
PA3308 0,53 1,31 0,78 hepA RNA polymerase-associated protein RapA
PA3309 1,45 0,98 -0,47 uspK hypothetical protein
PA3321 -1,57 -1,54 0,03 NA transcriptional regulator
PA3326 1,68 1,51 -0,16 clpP2 ATP-dependent Clp protease proteolytic subunit
PA3327 1,99 2,09 0,10 NA non-ribosomal peptide synthetase
PA3328 2,53 2,62 0,09 NA FAD-dependent monooxygenase
PA3329 2,22 2,52 0,29 NA hypothetical protein
PA3330 3,00 3,33 0,34 NA short-chain dehydrogenase
PA3331 3,07 3,18 0,11 NA cytochrome P450
PA3332 3,01 3,10 0,09 NA hypothetical protein
PA3333 3,18 3,39 0,21 fabH2 3-oxoacyl-ACP synthase III
PA3334 2,92 3,26 0,34 NA acyl carrier protein
PA3335 2,48 2,81 0,33 NA hypothetical protein
PA3336 2,28 2,00 -0,28 NA major facilitator superfamily transporter
PA3342 -1,19 -1,83 -0,64 NA hypothetical protein
PA3343 -0,53 -1,00 -0,47 hsbD hypothetical protein
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PA3354 -0,65 -1,37 -0,72 NA hypothetical protein
PA3355 -1,35 -1,56 -0,21 NA hypothetical protein
PA3356 -1,97 -1,95 0,02 pauA5 hypothetical protein
PA3359 1,12 1,52 0,40 NA hypothetical protein
PA3360 1,11 1,79 0,67 NA secretion protein
PA3361 1,75 1,64 -0,11 lecB fucose-binding lectin PA-IIL
PA3369 -1,68 -2,44 -0,76 NA hypothetical protein
PA3370 -0,80 -1,83 -1,03 NA hypothetical protein
PA3383 0,26 1,68 1,42 phnD phosphonate ABC transporter substrate-binding protein
PA3391 0,35 1,71 1,36 nosR regulatory protein NosR
PA3397 1,59 2,19 0,61 fprA ferredoxin-NADP reductase
PA3399 -0,96 -1,77 -0,82 NA hypothetical protein
PA3408 0,52 1,53 1,01 hasR heme uptake outer membrane receptor HasR
PA3410 0,96 1,36 0,40 hasI ECF subfamily sigma-70 factor
PA3424 0,55 1,47 0,91 NA hypothetical protein
PA3425 0,45 1,63 1,18 NA hypothetical protein
PA3427 -0,63 -1,09 -0,46 NA short-chain dehydrogenase
PA3452 0,17 1,82 1,65 mqoA malate:quinone oxidoreductase
PA3455 -0,70 -1,06 -0,36 NA hypothetical protein
PA3459 -1,56 -1,51 0,05 asnB glutamine amidotransferase
PA3460 -1,45 -1,27 0,18 NA acetyltransferase
PA3461 -1,10 -0,90 0,20 yhfE hypothetical protein
PA3471 -0,95 -1,04 -0,09 sfcA NAD-dependent malic enzyme
PA3478 2,12 3,02 0,90 rhlB rhamnosyltransferase subunit B
PA3479 2,50 3,06 0,56 rhlA rhamnosyltransferase subunit A
PA3491 0,79 1,10 0,30 rnfC electron transport complex subunit C
PA3495 0,58 1,11 0,52 nth endonuclease III
PA3496 -0,98 -2,58 -1,60 NA hypothetical protein
PA3499 -1,39 -1,29 0,09 NA hypothetical protein
PA3500 -1,63 -1,47 0,16 NA hypothetical protein
PA3503 -1,49 -1,47 0,02 NA NA
PA3504 -1,52 -1,53 0,00 NA aldehyde dehydrogenase
PA3506 -1,38 -1,49 -0,11 NA hypothetical protein
PA3508 -1,16 -2,04 -0,88 NA transcriptional regulator
PA3509 -1,62 -1,95 -0,33 NA hydrolase
PA3510 -1,94 -2,40 -0,46 NA hypothetical protein
PA3511 -1,71 -1,52 0,19 NA short-chain dehydrogenase
PA3514 -1,64 -2,62 -0,98 NA ABC transporter ATP-binding protein
PA3531 -0,87 0,29 1,16 bfrB bacterioferritin
PA3560 -0,04 4,09 4,13 fruA PTS system fructose-specific transporter subunit IIBC
PA3561 -0,34 3,07 3,41 fruK 1-phosphofructokinase
PA3562 -0,17 3,95 4,12 fruI PTS system fructose-specific transporter subunit FruI
PA3567 -1,07 -1,11 -0,04 NA oxidoreductase
PA3568 -1,14 -1,55 -0,41 ymmS propionyl-CoA synthetase
PA3581 -2,59 -2,66 -0,08 glpF glycerol uptake facilitator protein
PA3582 -2,62 -3,25 -0,64 glpK glycerol kinase
PA3601 0,72 1,31 0,59 ykgM 50S ribosomal protein L31 type B
PA3607 1,73 1,67 -0,06 potA polyamine transporter ATP-binding protein PotA
PA3608 1,25 2,24 0,99 potB polyamine ABC transporter permease PotB
PA3609 0,96 2,41 1,45 potC polyamine ABC transporter permease PotC
PA3610 0,61 1,93 1,31 potD polyamine ABC transporter substrate-binding protein PotD
PA3613 0,99 1,16 0,17 NA hypothetical protein
PA3615 -0,69 -1,41 -0,72 NA hypothetical protein
PA3621 0,51 1,35 0,84 fdxA ferredoxin I
PA3622 -0,81 -1,44 -0,63 rpoS RNA polymerase sigma factor RpoS
PA3623 -0,81 -1,76 -0,95 NA hypothetical protein
PA3629 -1,06 -1,07 -0,01 adhC alcohol dehydrogenase
PA3633 0,57 1,15 0,58 ygbP 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
PA3639 0,79 1,07 0,29 accA acetyl-CoA carboxylase carboxyltransferase subunit alpha
PA3641 1,28 1,81 0,53 NA amino acid permease
PA3645 0,84 1,48 0,64 fabZ 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
PA3652 1,02 1,11 0,09 uppS ditrans,polycis-undecaprenyl-diphosphate synthase
PA3653 1,11 1,43 0,32 frr ribosome recycling factor
PA3654 0,96 1,18 0,22 pyrH uridylate kinase
PA3655 1,15 1,54 0,38 tsf elongation factor Ts
PA3656 1,16 1,95 0,79 rpsB 30S ribosomal protein S2
PA3659 0,38 1,23 0,85 dapC succinyldiaminopimelate transaminase
PA3662 -0,71 -1,63 -0,92 NA hypothetical protein
PA3687 -0,74 -1,09 -0,35 ppc phosphoenolpyruvate carboxylase
PA3689 -0,76 -1,65 -0,89 yhdM transcriptional regulator
PA3691 -1,50 -1,63 -0,13 NA hypothetical protein
PA3692 -1,16 -0,62 0,54 lptF outer membrane porin F
PA3698 -0,67 -1,03 -0,35 NA hypothetical protein
PA3700 0,69 1,46 0,77 lysS lysine--tRNA ligase
PA3709 -1,46 -2,65 -1,19 NA major facilitator superfamily transporter
PA3710 -1,08 -1,53 -0,45 NA GMC-type oxidoreductase
PA3712 -1,05 -1,54 -0,49 NA hypothetical protein
PA3713 0,44 1,28 0,84 spdH spermidine dehydrogenase SpdH
PA3721 0,69 1,13 0,44 nalC transcriptional regulator
PA3724 1,70 1,74 0,05 lasB elastase LasB
PA3741 1,03 1,83 0,80 NA acyl-CoA thioesterase
PA3743 1,26 2,23 0,97 trmD tRNA (guanine-N(1)-)-methyltransferase
PA3744 1,03 1,60 0,56 rimM ribosome maturation factor RimM
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PA3745 0,99 1,80 0,81 rpsP 30S ribosomal protein S16
PA3754 -0,74 -1,50 -0,76 yeaB hypothetical protein
PA3757 -0,98 -1,22 -0,24 nagR transcriptional regulator
PA3758 -1,09 -1,17 -0,08 nagA N-acetylglucosamine-6-phosphate deacetylase
PA3760 -1,35 -1,42 -0,08 nagF N-acetyl-D-glucosamine phosphotransferase system transporter
PA3761 -0,56 -1,38 -0,82 nagE N-acetyl-D-glucosamine phosphotransferase system transporter
PA3766 -0,20 -1,71 -1,50 NA aromatic amino acid transporter
PA3769 0,98 1,46 0,47 guaA GMP synthase
PA3770 0,83 1,40 0,58 guaB inosine 5'-monophosphate dehydrogenase
PA3795 -0,87 -1,16 -0,28 NA oxidoreductase
PA3807 0,80 1,05 0,25 ndk nucleoside diphosphate kinase
PA3809 0,80 1,23 0,42 fdx2 (2Fe-2S) ferredoxin
PA3810 0,77 1,30 0,53 hscA chaperone protein HscA
PA3814 0,50 1,03 0,53 iscS cysteine desulfurase
PA3815 0,61 1,34 0,73 iscR HTH-type transcriptional regulator
PA3818 1,64 2,88 1,24 suhB type III secretion system regulator SuhB
PA3819 -0,61 -1,62 -1,02 ycfJ hypothetical protein
PA3823 0,39 1,01 0,62 tgt queuine tRNA-ribosyltransferase
PA3824 0,76 1,20 0,44 queA S-adenosylmethionine--tRNA ribosyltransferase-isomerase
PA3836 -1,25 -1,76 -0,51 NA hypothetical protein
PA3837 -1,02 -1,10 -0,08 NA ABC transporter permease
PA3838 -0,73 -1,08 -0,35 NA ABC transporter ATP-binding protein
PA3844 -0,76 -1,22 -0,46 NA hypothetical protein
PA3846 -0,89 -1,28 -0,39 NA hypothetical protein
PA3851 -0,42 -1,22 -0,79 NA hypothetical protein
PA3852 -0,51 -1,30 -0,79 NA hypothetical protein
PA3860 -1,55 -2,36 -0,81 NA acyl-CoA synthetase
PA3865 -1,14 -1,57 -0,43 NA amino acid binding protein
PA3875 0,85 1,37 0,52 narG respiratory nitrate reductase subunit alpha
PA3888 -1,71 -1,10 0,61 opuCD ABC transporter permease
PA3890 -1,19 -0,18 1,01 opuCB ABC transporter permease
PA3891 -1,44 -0,95 0,49 opuCA ABC transporter ATP-binding protein
PA3892 1,88 2,70 0,82 NA hypothetical protein
PA3893 1,71 2,95 1,24 NA hypothetical protein
PA3894 1,67 2,74 1,07 opmI hypothetical protein
PA3901 0,60 1,77 1,17 fecA Fe(III) dicitrate transporter FecA
PA3909 0,40 1,47 1,08 eddB extracelullar DNA degradation protein EddB
PA3919 -1,14 -1,74 -0,60 ylaK hypothetical protein
PA3921 -0,93 -1,01 -0,08 NA transcriptional regulator
PA3922 -2,66 -3,72 -1,06 NA hypothetical protein
PA3923 -2,43 -3,51 -1,08 NA hypothetical protein
PA3924 -1,17 -2,16 -0,99 NA long-chain-fatty-acid--CoA ligase
PA3927 -1,40 -1,43 -0,03 NA transcriptional regulator
PA3934 -1,01 -1,42 -0,42 NA hypothetical protein
PA3952 -0,68 -1,88 -1,21 NA hypothetical protein
PA3959 -1,18 -0,84 0,34 NA hypothetical protein
PA3962 -0,61 -1,40 -0,79 NA hypothetical protein
PA3967 1,18 1,34 0,16 NA hypothetical protein
PA3972 -0,55 -1,50 -0,95 aidB acyl-CoA dehydrogenase
PA3973 -0,69 -1,73 -1,04 NA transcriptional regulator
PA3979 0,71 1,42 0,72 NA hypothetical protein
PA3980 0,55 1,30 0,75 miaB (dimethylallyl)adenosine tRNA methylthiotransferase
PA3986 -0,38 -1,43 -1,06 NA hypothetical protein
PA4021 -1,23 -1,38 -0,15 NA transcriptional regulator
PA4022 -2,02 -1,92 0,11 hdhA aldehyde dehydrogenase
PA4023 -2,43 -2,62 -0,19 eutP transporter
PA4024 -2,35 -2,33 0,02 eutB ethanolamine ammonia-lyase large subunit
PA4025 -2,35 -2,58 -0,23 eutC ethanolamine ammonia-lyase small subunit
PA4026 -0,98 -1,39 -0,41 NA acetyltransferase
PA4061 -0,56 -1,10 -0,54 ybbN thioredoxin
PA4067 2,26 2,55 0,28 oprG outer membrane protein OprG
PA4082 0,15 1,08 0,93 cupB5 adhesive protein CupB5
PA4094 -0,86 -1,47 -0,61 NA transcriptional regulator
PA4099 0,64 2,34 1,70 NA hypothetical protein
PA4103 0,92 1,65 0,73 NA hypothetical protein
PA4113 1,27 1,50 0,23 ydeA sugar efflux transporter
PA4115 -0,79 -1,09 -0,30 NA hypothetical protein
PA4131 2,27 2,54 0,27 NA iron-sulfur protein
PA4132 1,94 1,80 -0,13 NA hypothetical protein
PA4133 2,10 2,68 0,59 ccoN cbb3-type cytochrome C oxidase subunit I
PA4139 1,78 1,46 -0,32 NA hypothetical protein
PA4140 1,47 1,58 0,11 NA hypothetical protein
PA4141 1,93 1,14 -0,79 NA hypothetical protein
PA4142 1,66 1,92 0,26 NA secretion protein
PA4143 1,17 1,39 0,22 cyaB toxin transporter
PA4147 -1,22 -2,03 -0,81 acoR transcriptional regulator AcoR
PA4156 0,08 1,25 1,16 fvbA TonB-dependent receptor
PA4164 -0,31 -1,02 -0,71 NA hypothetical protein
PA4178 0,46 1,97 1,51 eftM hypothetical protein
PA4180 -0,76 -1,22 -0,46 NA acetolactate synthase
PA4198 -1,15 -1,81 -0,66 NA acyl-CoA synthetase
PA4199 -0,75 -1,35 -0,60 NA acyl-CoA dehydrogenase
PA4201 -0,85 -1,22 -0,36 ddlA D-alanine--D-alanine ligase
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PA4204 -0,83 -1,03 -0,20 ppgL gluconolactonase PpgL
PA4206 0,69 1,10 0,41 mexH resistance-nodulation-cell division (RND) efflux membrane fusion protein
PA4209 3,31 3,00 -0,31 phzM phenazine-specific methyltransferase
PA4210 4,07 4,11 0,04 phzA1 phenazine biosynthesis protein
PA4211 4,71 4,77 0,06 phzB1 phenazine biosynthesis protein
PA4212 2,46 3,03 0,57 phzC1 phenazine biosynthesis protein PhzC
PA4217 4,42 5,22 0,80 phzS hypothetical protein
PA4221 1,01 0,98 -0,03 fptA Fe(III)-pyochelin outer membrane receptor
PA4238 0,74 1,20 0,46 rpoA DNA-directed RNA polymerase subunit alpha
PA4239 0,91 1,33 0,42 rpsD 30S ribosomal protein S4
PA4240 0,96 1,44 0,48 rpsK 30S ribosomal protein S11
PA4241 0,94 1,33 0,39 rpsM 30S ribosomal protein S13
PA4242 1,21 1,73 0,52 rpmJ 50S ribosomal protein L36
PA4243 1,09 1,55 0,45 secY preprotein translocase subunit SecY
PA4244 0,90 1,16 0,26 rplO 50S ribosomal protein L15
PA4245 0,90 1,43 0,53 rpmD 50S ribosomal protein L30
PA4247 1,03 1,58 0,55 rplR 50S ribosomal protein L18
PA4248 0,83 1,53 0,70 rplF 50S ribosomal protein L6
PA4249 0,91 1,43 0,52 rpsH 30S ribosomal protein S8
PA4251 1,07 1,14 0,07 rplE 50S ribosomal protein L5
PA4252 1,37 1,75 0,38 rplX 50S ribosomal protein L24
PA4253 1,03 1,35 0,32 rplN 50S ribosomal protein L14
PA4254 1,26 1,77 0,51 rpsQ 30S ribosomal protein S17
PA4255 1,06 1,23 0,18 rpmC 50S ribosomal protein L29
PA4256 1,12 1,26 0,14 rplP 50S ribosomal protein L16
PA4257 1,09 1,49 0,39 rpsC 30S ribosomal protein S3
PA4258 1,26 1,62 0,37 rplV 50S ribosomal protein L22
PA4259 1,13 1,97 0,83 rpsS 30S ribosomal protein S19
PA4260 1,05 1,76 0,71 rplB 50S ribosomal protein L2
PA4261 1,14 1,96 0,82 rplW 50S ribosomal protein L23
PA4262 1,09 1,83 0,74 rplD 50S ribosomal protein L4
PA4263 1,01 1,82 0,82 rplC 50S ribosomal protein L3
PA4264 0,96 1,65 0,69 rpsJ 30S ribosomal protein S10
PA4266 0,76 1,21 0,45 fusA1 elongation factor G
PA4268 0,81 1,45 0,65 rpsL 30S ribosomal protein S12
PA4269 1,07 1,28 0,21 rpoC DNA-directed RNA polymerase subunit beta'
PA4270 0,94 1,29 0,35 rpoB DNA-directed RNA polymerase subunit beta
PA4271 0,98 1,05 0,06 rplL 50S ribosomal protein L7/L12
PA4272 1,25 1,56 0,31 rplJ 50S ribosomal protein L10
PA4273 1,30 1,74 0,44 rplA 50S ribosomal protein L1
PA4274 1,24 1,78 0,54 rplK 50S ribosomal protein L11
PA4275 0,79 1,08 0,29 nusG transcription antitermination protein NusG
PA4276 0,70 1,41 0,71 secE preprotein translocase subunit SecE
PA4277 0,76 1,31 0,55 tufB elongation factor Tu
PA4280 0,29 1,12 0,83 birA biotin--protein ligase
PA4290 -0,13 -1,97 -1,84 NA chemotaxis transducer
PA4292 0,86 1,53 0,67 NA phosphate transporter
PA4296 -0,31 -1,02 -0,72 pprB two-component response regulator PprB
PA4311 -0,92 -1,29 -0,37 NA hypothetical protein
PA4317 -0,15 -1,00 -0,85 NA hypothetical protein
PA4326 -0,31 -1,22 -0,90 NA hypothetical protein
PA4328 1,06 1,21 0,15 NA hypothetical protein
PA4333 0,49 1,00 0,51 fumA fumarase
PA4341 -1,36 -1,55 -0,19 NA transcriptional regulator
PA4345 -1,08 -1,45 -0,38 NA hypothetical protein
PA4346 -1,25 -1,12 0,13 NA hypothetical protein
PA4348 0,96 1,17 0,21 NA hypothetical protein
PA4352 1,63 1,65 0,02 NA hypothetical protein
PA4363 -0,72 -1,47 -0,75 iciA chromosome replication initiation inhibitor protein
PA4385 -1,02 -1,65 -0,64 groEL molecular chaperone GroEL
PA4386 -0,80 -1,68 -0,88 groES co-chaperonin GroES
PA4428 1,03 1,02 -0,01 sspA stringent starvation protein A
PA4433 0,90 1,26 0,36 rplM 50S ribosomal protein L13
PA4435 -0,64 -1,69 -1,05 NA acyl-CoA dehydrogenase
PA4438 0,88 2,22 1,34 yhcM hypothetical protein
PA4440 -0,97 -1,18 -0,21 NA hypothetical protein
PA4472 -0,59 -1,49 -0,90 pmbA PmbA protein
PA4474 -0,46 -1,17 -0,72 tldD hypothetical protein
PA4481 0,59 1,21 0,62 mreB rod shape-determining protein MreB
PA4494 0,88 1,37 0,49 roxS sensor histidine kinase RoxS
PA4496 -2,14 -2,73 -0,59 dppA1 ABC transporter
PA4497 -1,48 -1,71 -0,23 dppA2 ABC transporter
PA4500 -1,15 -1,46 -0,31 dppA3 ABC transporter
PA4501 -1,79 -2,27 -0,48 opdD,opdP glycine-glutamate dipeptide porin OpdP
PA4502 -1,64 -1,98 -0,33 dppA4 ABC transporter
PA4503 -1,57 -1,83 -0,26 dppB ABC transporter permease
PA4504 -1,49 -1,23 0,26 dppC ABC transporter permease
PA4505 -1,65 -1,61 0,04 dppD ABC transporter ATP-binding protein
PA4506 -1,53 -1,74 -0,20 dppF peptide ABC transporter ATP-binding protein
PA4514 1,36 1,97 0,61 piuA iron transport outer membrane receptor
PA4519 1,43 1,76 0,32 speC ornithine decarboxylase
PA4520 -1,00 -1,43 -0,42 NA chemotaxis transducer
PA4522 -0,55 -1,27 -0,71 ampD N-acetyl-anhydromuranmyl-L-alanine amidase
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PA4530 -0,71 -1,33 -0,62 NA zinc-binding protein
PA4536 -0,61 -1,13 -0,51 NA hypothetical protein
PA4540 0,41 1,44 1,03 lepB hypothetical protein
PA4542 -0,61 -1,85 -1,25 clpB chaperone protein ClpB
PA4556 -0,77 -1,15 -0,38 pilE type 4 fimbrial biogenesis protein PilE
PA4563 0,86 1,75 0,88 rpsT 30S ribosomal protein S20
PA4568 1,09 1,55 0,46 rplU 50S ribosomal protein L21
PA4571 1,10 1,79 0,69 NA cytochrome C
PA4572 0,49 1,35 0,86 fklB peptidyl-prolyl cis-trans isomerase FklB
PA4579 -1,44 -1,52 -0,08 NA hypothetical protein
PA4587 1,69 1,88 0,19 ccpR cytochrome C551 peroxidase
PA4598 0,56 1,24 0,68 mexD resistance-nodulation-cell division (RND) multidrug efflux transporter MexD
PA4602 0,51 1,13 0,63 glyA3 serine hydroxymethyltransferase
PA4605 -0,83 -1,59 -0,77 ybdD hypothetical protein
PA4606 -0,80 -1,84 -1,03 cstA hypothetical protein
PA4613 0,36 1,13 0,77 katB catalase
PA4615 -0,86 -1,18 -0,32 fprB oxidoreductase
PA4616 0,84 1,81 0,97 NA C4-dicarboxylate-binding protein
PA4624 1,02 0,53 -0,48 cdrB hypothetical protein
PA4627 0,60 1,41 0,81 yjjT 16S rRNA methyltransferase
PA4628 0,80 1,07 0,27 lysP lysine-specific permease
PA4644 1,38 1,76 0,38 NA hypothetical protein
PA4645 1,16 1,80 0,64 hprT hypoxanthine-guanine phosphoribosyltransferase
PA4646 0,72 1,28 0,56 upp uracil phosphoribosyltransferase
PA4647 0,57 1,12 0,56 uraA uracil permease
PA4661 -0,49 -1,31 -0,83 pagL lipid A 3-O-deacylase
PA4665 0,41 1,08 0,66 prfA peptide chain release factor 1
PA4670 0,89 1,51 0,62 prs ribose-phosphate pyrophosphokinase
PA4671 0,97 1,20 0,23 rplY 50S ribosomal protein L25/general stress protein Ctc
PA4672 1,11 1,63 0,52 pth peptidyl-tRNA hydrolase
PA4673 1,41 2,15 0,74 ychF GTP-dependent nucleic acid-binding protein EngD
PA4684 0,50 1,21 0,71 NA hypothetical protein
PA4710 0,56 1,76 1,20 phuR heme/hemoglobin uptake outer membrane receptor PhuR
PA4714 -0,74 -1,46 -0,73 NA hypothetical protein
PA4719 1,01 1,95 0,94 NA transporter
PA4720 0,99 1,65 0,66 trmA tRNA (uracil-5-)-methyltransferase
PA4724.1 -0,87 -1,28 -0,41 NA hypothetical protein
PA4726 -0,75 -1,09 -0,34 cbrB two-component response regulator CbrB
PA4733 -1,27 -1,79 -0,52 acsB acetyl-CoA synthetase
PA4736 -0,54 -1,16 -0,63 NA hypothetical protein
PA4738 -1,09 -1,54 -0,45 yjbJ hypothetical protein
PA4739 -1,11 -0,84 0,27 NA hypothetical protein
PA4740 0,61 1,08 0,47 pnp polynucleotide phosphorylase
PA4742 0,57 1,53 0,96 truB tRNA pseudouridine synthase B
PA4743 0,74 1,08 0,34 rbfA ribosome-binding factor A
PA4744 0,84 1,27 0,43 infB translation initiation factor IF-2
PA4745 0,78 1,25 0,47 nusA transcription elongation factor NusA
PA4746 0,70 1,64 0,94 yhbC hypothetical protein
PA4748 0,52 1,03 0,51 tpiA triosephosphate isomerase
PA4751 -0,57 -1,23 -0,66 ftsH cell division protein FtsH
PA4757 1,04 1,83 0,79 yeaS leucine export protein LeuE
PA4758 0,94 1,03 0,09 carA carbamoyl phosphate synthase small subunit
PA4759 -0,22 -1,48 -1,26 dapB 4-hydroxy-tetrahydrodipicolinate reductase
PA4761 -0,56 -1,65 -1,08 dnaK molecular chaperone DnaK
PA4762 -0,37 -1,53 -1,16 grpE heat shock protein GrpE
PA4765 0,13 1,03 0,90 omlA outer membrane lipoprotein OmlA
PA4782 -0,48 -1,45 -0,96 NA hypothetical protein
PA4786 -0,74 -1,58 -0,84 NA 3-ketoacyl-ACP reductase
PA4787 -1,09 -1,39 -0,30 NA transcriptional regulator
PA4811 -0,39 -1,35 -0,96 fdnH nitrate-inducible formate dehydrogenase subunit beta
PA4812 -0,55 -1,31 -0,76 fdnG formate dehydrogenase-O major subunit
PA4817 1,39 1,64 0,25 NA hypothetical protein
PA4825 0,13 1,30 1,16 mgtA Mg(2+) transport ATPase
PA4833 -0,52 -1,60 -1,08 NA hypothetical protein
PA4837 0,27 1,75 1,49 NA hypothetical protein
PA4842 -0,65 -1,44 -0,79 NA hypothetical protein
PA4846 0,40 1,16 0,76 aroQ1 3-dehydroquinate dehydratase
PA4847 0,86 1,07 0,20 accB acetyl-CoA carboxylase biotin carboxyl carrier protein subunit
PA4852 0,85 1,31 0,46 yhdG hypothetical protein
PA4853 0,80 1,30 0,50 fis Fis family transcriptional regulator
PA4854 0,70 1,41 0,71 purH bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase
PA4855 0,90 1,52 0,62 purD phosphoribosylamine--glycine ligase
PA4861 0,69 1,49 0,80 NA ABC transporter ATP-binding protein
PA4873 0,82 1,48 0,66 NA heat-shock protein
PA4876 -1,38 -2,00 -0,62 osmE OsmE family transcriptional regulator
PA4877 -1,08 -1,28 -0,20 NA hypothetical protein
PA4880 -2,20 -1,86 0,34 NA bacterioferritin
PA4888 0,19 1,66 1,48 desB acyl-CoA desaturase
PA4909 -0,91 -1,57 -0,66 NA ABC transporter ATP-binding protein
PA4910 -0,86 -1,49 -0,63 NA ABC transporter ATP-binding protein
PA4912 -0,71 -1,37 -0,66 NA branched-chain amino acid ABC transporter
PA4913 -1,50 -2,70 -1,20 NA ABC transporter
PA4914 -0,90 -1,40 -0,50 amaR transcriptional regulator
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PA4918 -1,21 -1,09 0,12 pcnA hypothetical protein
PA4919 -0,96 -1,09 -0,13 pncB1 nicotinate phosphoribosyltransferase
PA4920 -1,12 -0,91 0,22 nadE NAD synthetase
PA4921 -1,01 -1,16 -0,15 choE hypothetical protein
PA4928 0,94 1,87 0,93 ygiR hypothetical protein
PA4933 1,16 1,78 0,62 NA hypothetical protein
PA4934 1,26 2,18 0,92 rpsR 30S ribosomal protein S18
PA4935 1,12 2,06 0,94 rpsF 30S ribosomal protein S6
PA4936 -0,89 -1,50 -0,61 spoU 23S rRNA (guanosine(2251)-2'-O)-methyltransferase RlmB
PA4971 -0,80 -1,10 -0,31 aspP adenosine diphosphate sugar pyrophosphatase
PA4976 -1,20 -1,27 -0,07 aruH arginine:pyruvate transaminase AruH
PA4977 -0,93 -1,65 -0,72 aruI hypothetical protein
PA4978 -1,30 -2,15 -0,85 NA hypothetical protein
PA4979 -1,19 -1,55 -0,36 NA acyl-CoA dehydrogenase
PA4980 -0,77 -1,59 -0,82 NA enoyl-CoA hydratase
PA4982 -1,71 -2,05 -0,34 NA two-component sensor
PA4983 -1,28 -1,89 -0,60 dmsR two-component response regulator
PA4985 -1,11 -1,39 -0,28 NA hypothetical protein
PA4986 -1,32 -1,73 -0,41 NA oxidoreductase
PA5016 -1,08 -1,08 0,00 aceF dihydrolipoamide acetyltransferase
PA5027 1,87 1,68 -0,19 NA hypothetical protein
PA5029 -0,54 -1,15 -0,61 ynfL transcriptional regulator
PA5030 1,43 2,64 1,20 ynfM major facilitator superfamily transporter
PA5034 0,72 1,17 0,45 hemE uroporphyrinogen decarboxylase
PA5052 0,50 1,50 1,00 NA hypothetical protein
PA5053 -0,34 -1,54 -1,20 hslV ATP-dependent protease peptidase subunit
PA5054 -0,44 -1,80 -1,36 hslU ATP-dependent protease ATP-binding subunit HslU
PA5055 -0,27 -1,57 -1,30 NA hypothetical protein
PA5056 -0,75 -1,10 -0,34 phaC1 poly(3-hydroxyalkanoic acid) synthase
PA5060 -0,62 -1,06 -0,44 phaF polyhydroxyalkanoate synthesis protein PhaF
PA5061 -0,95 -1,22 -0,27 phaI hypothetical protein
PA5062 -0,40 0,73 1,13 NA hypothetical protein
PA5072 1,25 1,78 0,53 NA chemotaxis transducer
PA5112 -0,75 -1,25 -0,49 estA esterase
PA5117 1,14 1,77 0,63 typA regulatory protein TypA
PA5118 1,32 2,22 0,90 thiI thiamine biosynthesis protein ThiI
PA5129 0,43 1,42 1,00 grxC glutaredoxin
PA5137 -0,82 -1,09 -0,27 NA hypothetical protein
PA5139 0,65 1,98 1,33 NA hypothetical protein
PA5150 -1,06 -1,51 -0,45 NA short-chain dehydrogenase
PA5152 -1,46 -1,82 -0,36 NA ABC transporter ATP-binding protein
PA5153 -1,97 -3,04 -1,06 NA amino acid ABC transporter substrate-binding protein
PA5154 -1,84 -2,11 -0,26 NA ABC transporter permease
PA5155 -1,65 -2,14 -0,48 NA amino acid ABC transporter permease
PA5158 0,40 1,30 0,90 opmG hypothetical protein
PA5160 0,60 1,24 0,65 emrB; pmrB drug efflux transporter
PA5167 -1,69 -2,68 -0,99 dctP C4-dicarboxylate-binding protein
PA5168 -1,26 -2,02 -0,77 dctQ dicarboxylate transporter
PA5169 -1,37 -2,18 -0,81 dctM C4-dicarboxylate transporter
PA5170 1,50 1,68 0,18 arcD arginine/ornithine antiporter
PA5171 1,75 1,71 -0,05 arcA arginine deiminase
PA5172 2,03 2,07 0,04 arcB ornithine carbamoyltransferase
PA5173 1,60 1,45 -0,15 arcC carbamate kinase
PA5174 1,61 1,70 0,09 NA beta-ketoacyl synthase
PA5178 -0,36 -1,08 -0,72 NA hypothetical protein
PA5180 1,53 1,23 -0,30 fdhD hypothetical protein
PA5181 1,44 1,09 -0,34 NA oxidoreductase
PA5183.1 -0,29 -1,71 -1,43 rsmN hypothetical protein
PA5184 -0,97 -1,32 -0,35 NA chorismate mutase
PA5191 -0,69 -1,65 -0,96 NA hypothetical protein
PA5201 0,47 1,10 0,63 yhgF hypothetical protein
PA5212 -1,56 -2,11 -0,55 NA hypothetical protein
PA5219 1,51 2,22 0,71 NA hypothetical protein
PA5220 1,64 1,45 -0,20 NA hypothetical protein
PA5227 -0,87 -1,16 -0,29 ygfE hypothetical protein
PA5239 0,51 1,05 0,55 rho transcription termination factor Rho
PA5240 -0,35 -1,31 -0,96 trxA thioredoxin
PA5253 -0,83 -1,38 -0,54 algP alginate regulatory protein AlgP
PA5254 -0,83 -1,26 -0,42 fkbZ FkbP-type peptidyl-prolyl cis-trans isomerase
PA5255 -1,11 -1,47 -0,36 algQ anti-RNA polymerase sigma 70 factor
PA5258 -0,49 -1,02 -0,54 hemX hypothetical protein
PA5261 -1,03 -1,66 -0,63 algR alginate biosynthesis regulatory protein AlgR
PA5262 -0,75 -1,40 -0,65 fimS alginate biosynthesis protein AlgZ/FimS
PA5268 -0,90 -1,23 -0,33 corA magnesium/cobalt transporter
PA5269 -0,61 -1,41 -0,80 NA hypothetical protein
PA5284 0,29 1,63 1,34 NA hypothetical protein
PA5286 0,65 1,21 0,56 yjbQ hypothetical protein
PA5298 0,70 1,16 0,46 xpt xanthine phosphoribosyltransferase
PA5301 -1,19 -1,46 -0,28 pauR transcriptional regulator
PA5302 -0,47 -1,88 -1,41 dadX alanine racemase
PA5303 -0,36 -1,89 -1,53 NA hypothetical protein
PA5304 -0,93 -2,14 -1,21 dadA D-amino acid dehydrogenase small subunit
PA5309 -1,38 -1,70 -0,31 pauB4 oxidoreductase
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PA5312 -3,10 -3,72 -0,63 pauC aldehyde dehydrogenase
PA5313 -3,00 -3,58 -0,58 gabT2 omega amino acid--pyruvate transaminase
PA5314 -3,30 -4,04 -0,74 NA hypothetical protein
PA5316 1,17 1,89 0,72 rpmB 50S ribosomal protein L28
PA5324 -0,95 -1,35 -0,40 sphR transcriptional regulator
PA5348 -2,21 -3,42 -1,21 NA DNA-binding protein
PA5364 -0,61 -1,07 -0,46 NA two-component response regulator
PA5371 -0,72 -1,48 -0,76 yciA acyl-CoA thioesterase
PA5376 -0,63 -1,16 -0,53 cbcV ABC transporter ATP-binding protein
PA5377 -0,53 -1,12 -0,59 cbcW ABC transporter permease
PA5378 -0,76 -1,10 -0,34 cbcX hypothetical protein
PA5380 -0,76 -1,44 -0,68 gbdR protein GbdR
PA5383 1,77 1,25 -0,53 yeiH hypothetical protein
PA5387 0,68 1,96 1,28 cdhC carnitine dehydrogenase
PA5388 0,49 1,37 0,88 caiX hypothetical protein
PA5394 -0,38 -1,29 -0,91 cls cardiolipin synthetase
PA5396 -0,59 -1,18 -0,60 NA hypothetical protein
PA5398 -0,64 -1,34 -0,70 dgcA dimethylglycine catabolism protein DgcA
PA5404 0,74 2,04 1,29 NA hypothetical protein
PA5409 -0,79 -1,62 -0,83 NA hypothetical protein
PA5411 -0,84 -1,17 -0,33 gbcB protein GbcB
PA5415 -0,27 -2,15 -1,87 glyA1 serine hydroxymethyltransferase
PA5424 -0,85 -1,48 -0,63 yeaQ hypothetical protein
PA5427 1,80 1,81 0,01 adhA alcohol dehydrogenase
PA5428 1,34 1,02 -0,33 NA transcriptional regulator
PA5429 3,77 3,82 0,05 aspA aspartate ammonia-lyase
PA5435 -1,24 -1,15 0,09 oadA pyruvate carboxylase subunit B
PA5436 -1,22 -0,96 0,26 NA acetyl-CoA carboxylase subunit alpha
PA5440 1,27 1,76 0,49 yegQ peptidase
PA5442 -1,14 -1,86 -0,72 NA hypothetical protein
PA5445 -0,19 -1,57 -1,37 psecoA coenzyme A transferase
PA5446 1,48 1,58 0,09 NA hypothetical protein
PA5447 -0,82 -1,30 -0,48 wbpZ glycosyltransferase WbpZ
PA5448 -1,07 -1,74 -0,67 wbpY glycosyltransferase WbpY
PA5449 -1,13 -1,37 -0,24 wbpX glycosyltransferase WbpX
PA5450 -0,98 -1,40 -0,42 wzt ABC transporter
PA5451 -1,01 -1,28 -0,27 wzm LPS efflux transporter membrane protein
PA5452 -1,18 -1,53 -0,35 wbpW phosphomannose isomerase/mannose-1-phosphate guanylyl transferase
PA5453 -1,14 -1,75 -0,61 gmd GDP-mannose 4,6-dehydratase
PA5454 -1,05 -1,74 -0,69 rmd oxidoreductase Rmd
PA5455 -0,98 -1,31 -0,32 NA hypothetical protein
PA5470 1,56 1,23 -0,33 prfH peptide chain release factor-like protein
PA5471 1,53 1,56 0,04 armZ hypothetical protein
PA5471.1 1,49 1,51 0,02 NA NA
PA5473 -0,55 -1,06 -0,52 yjbB hypothetical protein
PA5475 1,84 2,31 0,47 NA hypothetical protein
PA5479 1,89 2,72 0,83 gltP glutamate/aspartate:proton symporter
PA5481 -1,86 -2,40 -0,54 NA hypothetical protein
PA5482 -1,95 -2,48 -0,52 NA hypothetical protein
PA5484 -1,05 -1,10 -0,05 kinB two-component sensor
PA5487 -1,05 -1,39 -0,34 NA hypothetical protein
PA5490 0,81 1,24 0,43 cc4 cytochrome C4
PA5502 0,76 1,52 0,76 NA hypothetical protein
PA5503 0,99 1,71 0,72 NA ABC transporter ATP-binding protein
PA5504 1,14 2,25 1,11 NA D-methionine ABC transporter
PA5507 -1,04 -1,04 0,00 NA hypothetical protein
PA5508 -1,06 -1,32 -0,26 pauA7 glutamine synthetase
PA5521 -1,67 -2,36 -0,69 NA short-chain dehydrogenase
PA5522 -1,25 -1,59 -0,34 pauA6 glutamine synthetase
PA5523 -1,36 -2,23 -0,87 NA aminotransferase
PA5526 -0,56 -1,90 -1,34 NA hypothetical protein
PA5530 -0,21 -1,01 -0,80 NA MFS dicarboxylate transporter
PA5541 0,65 1,74 1,10 pyrQ dihydroorotase
PA5542 -0,73 -1,16 -0,43 NA hypothetical protein
PA5544 -1,07 -1,67 -0,60 NA hypothetical protein
PA5545 -0,93 -1,49 -0,57 NA hypothetical protein
PA5547 -0,51 -1,37 -0,86 NA hypothetical protein
PA5553 1,66 1,28 -0,38 atpC ATP synthase subunit epsilon
PA5554 1,89 1,97 0,07 atpD ATP synthase subunit beta
PA5555 1,99 2,19 0,20 atpG ATP synthase subunit gamma
PA5556 1,80 2,19 0,38 atpA ATP synthase subunit alpha
PA5557 1,92 2,33 0,41 atpH ATP synthase subunit delta
PA5558 1,84 2,09 0,24 atpF ATP synthase subunit B
PA5559 1,85 1,91 0,06 atpE ATP synthase subunit C
PA5560 1,52 1,67 0,15 atpB ATP synthase subunit A
PA5561 1,09 0,97 -0,12 atpI ATP synthase subunit I
2. Boldface characters, deleted genes
1. Red figures, significant difference (Padj < 0.05)
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Table S6. Glucose responsive genes in PAO1 (10 min after glucose addition) 
Locus Log2 FC1 Name Description 
 
PAO1+ 
vs. 
PAO1 
GUN+ 
vs. 
PAO1+ 
GUN+ 
vs. 
PAO1 
  
PA0039 -1.27 0.64 -0.63  hypothetical protein 
PA0085 -1.55 0.21 -1.34 hcpI 
protein secretion apparatus 
assembly protein 
PA0329 -1.25 -0.51 -1.76  hypothetical protein 
PA0425 1.02 0.62 1.64 mexA multidrug resistance protein 
PA0427 1.05 0.92 1.97 oprM outer membrane protein 
PA0446 1.31 -0.38 0.93  hypothetical protein 
PA0447 1.13 -0.60 0.53 gcdH glutaryl-CoA dehydrogenase 
PA0654 1.06 1.13 2.19 speD 
S-adenosylmethionine 
decarboxylase 
PA0779 -1.26 -0.87 -2.13 asrA ATP-dependent protease 
PA0887 -2.37 -1.62 -4.00 acsA acetyl-CoA synthetase 
PA1159 -1.28 -0.88 -2.16  cold-shock protein 
PA1302 1.55 0.65 2.16 hxuC heme utilization protein 
PA1317 1.70 4.64 6.34 cyoA 
cytochrome o ubiquinol 
oxidase subunit II 
PA1318 1.42 4.55 5.97 cyoB 
cytochrome o ubiquinol 
oxidase subunit I 
PA1338 -1.69 -0.68 -2.37 ggt γ-glutamyltranspeptidase 
PA1339 -1.14 -0.37 -1.52 aatP 
amino acids ABC transporter 
ATP binding protein 
PA1340 -1.25 -0.32 -1.57 aatM 
amino acids ABC transporter 
permease 
PA1341 -1.47 -0.07 -1.53 aatQ 
amino acids ABC transporter 
permease 
PA1596 -1.15 -0.45 -1.61 htpG chaperone protein 
PA1617 -1.56 -1.75 -3.31  AMP-binding protein 
PA1974 2.15 0.47 2.62  hypothetical protein 
PA2262 1.98 -3.25 -1.27 kguT 
2 2-ketogluconate transporter 
PA2264 1.65 -0.12 1.53  hypothetical protein 
PA2265 1.60 0.04 1.64 gad gluconate dehydrogenase 
PA2266 1.62 -0.20 1.42  cytochrome C precursor 
PA2289 2.41 1.39 3.80  hypothetical protein 
PA2290 1.52 1.27 2.80 gcd glucose dehydrogenase 
PA2291 1.53 0.98 2.52 oprB2 glucose-sensitive porin 
PA2320 2.35 -3.17 -0.81 gntR transcriptional regulator 
PA2321 7.11 -8.47 -1.37 gntK gluconokinase 
PA2322 5.96 -7.69 -1.73 gntP 
2 gluconate permease 
PA2323 5.68 -2.94 2.73 gapN 
glyceraldehyde-3-phosphate 
dehydrogenase 
PA2629 1.17 1.32 2.49 purB adenylosuccinate lyase 
PA2774 -1.27 0.27 -1.00 tse4 hypothetical protein 
PA2853 -1.73 0.14 -1.87 oprI outer membrane lipoprotein 
PA2862 -1.00 -1.83 -2.83 lipA lactonizing lipase 
PA3038 -1.52 -2.82 -4.34 opdQ porin 
PA3067 1.00 -0.13 0.88  transcriptional regulator 
PA3126 -1.45 -0.18 -1.62 ibpA heat-shock protein 
PA3181 1.43 -4.57 -3.14 edaA 
2-dehydro-3-deoxy-
phosphogluconate aldolase 
PA3182 1.86 -4.85 -2.99 pgl 6-phospho-gluconolactonase 
PA3183 1.59 -5.07 -3.48 zwf 
glucose-6-phosphate 1-
dehydrogenase 
PA3186 5.99 -1.82 4.17 oprB porin B 
PA3187 5.83 -3.66 2.18 gltK 
2 sugar ABC transporter ATP-
binding protein 
PA3188 5.76 -7.23 -1.47 gltG 
2 sugar ABC transporter 
permease 
PA3189 5.02 -6.82 -1.80 gltF 
2 sugar ABC transporter 
permease 
PA3190 5.10 -0.73 4.38 gltB 
sugar ABC transporter 
substrate-binding protein 
PA3195 1.62 -4.67 -3.04 gapA 
glyceraldehyde 3-phosphate 
dehydrogenase 
PA3234 -2.58 -1.30 -3.89 yjcG acetate permease 
PA3235 -2.87 -1.36 -4.23 yjcH hypothetical protein 
PA3263 1.32 -0.13 1.19 yaiD 
recombination associated 
protein 
PA3452 1.65 0.17 1.82 mqoA 
malate:quinone 
oxidoreductase 
PA3496 -1.60 -0.98 -2.58  hypothetical protein 
PA3531 1.16 -0.87 0.29 bfrB bacterioferritin 
PA3560 4.13 -0.04 4.09 fruA 
PTS system fructose-specific 
transporter subunit 
PA3561 3.41 -0.34 3.07 fruK 1-phosphofructokinase 
PA3562 4.12 -0.17 3.95 fruI 
PTS system fructose-specific 
transporter subunit 
PA3766 -1.50 -0.20 -1.71  
aromatic amino acids 
transporter 
PA3818 1.24 1.64 2.88 suhB 
type III secretion system 
regulator SuhB 
PA3819 -1.02 -0.61 -1.62 ycfJ hypothetical protein 
PA3890 1.01 -1.19 -0.18 opuCB ABC transporter permease 
PA3922 -1.06 -2.66 -3.72  hypothetical protein 
PA3923 -1.08 -2.43 -3.51  hypothetical protein 
PA4290 -1.84 -0.13 -1.97  chemotaxis transducer 
PA4435 -1.05 -0.64 -1.69  acyl-CoA dehydrogenase 
PA4438 1.34 0.88 2.22 yhcM hypothetical protein 
PA4542 -1.25 -0.61 -1.85 clpB chaperone protein 
PA4606 -1.03 -0.80 -1.84 cstA hypothetical protein 
PA4759 -1.26 -0.22 -1.48 dapB 
tetrahydrodipicolinate 
reductase 
PA4761 -1.08 -0.56 -1.65 dnaK molecular chaperone 
1Red figures indicate statistically significant difference (Padj < 0.05). 
2Genes deleted in GUN. 
 
 
 
 
 
 
 
 
 
 
 
 
PA4762 -1.16 -0.37 -1.53 grpE heat shock protein 
PA4888 1.48 0.19 1.66 desB acyl-CoA desaturase 
PA4913 -1.20 -1.50 -2.70  ABC transporter 
PA5052 1.00 0.50 1.50  hypothetical protein 
PA5053 -1.20 -0.34 -1.54 hslV heat-shock protein 
PA5054 -1.36 -0.44 -1.80 hslU heat-shock protein 
PA5062 1.13 -0.40 0.73  hypothetical protein 
PA5153 -1.06 -1.97 -3.04  
amino acids ABC transporter 
substrate-binding protein 
PA5183.1 -1.43 -0.29 -1.71 rsmN hypothetical protein 
PA5302 -1.41 -0.47 -1.88 dadX alanine racemase 
PA5303 -1.53 -0.36 -1.89  hypothetical protein 
PA5304 -1.21 -0.93 -2.14 dadA 
D-amino acids dehydrogenase 
small subunit 
PA5348 -1.21 -2.21 -3.42  DNA-binding protein 
PA5415 -1.87 -0.27 -2.15 glyA1 
serine 
hydroxymethyltransferase 
PA5445 -1.37 -0.19 -1.57 psecoA coenzyme A transferase 
PA5504 1.11 1.14 2.25  
D-methionine ABC 
transporter 
PA5526 -1.34 -0.56 -1.90  hypothetical protein 
Table S7. DEGs encoding putative/known transcription factors (10 min after 
glucose addition) 
Locus Log2 FC1 Name Description2 
 
PAO1+ 
vs. 
PAO1 
GUN+ 
vs. 
PAO1+ 
GUN+ 
vs. 
PAO1 
  
PA0048 -0.21 -0.99 -1.20  transcriptional regulator 
PA0120 -0.22 -0.80 -1.01  transcriptional regulator 
PA0248 -0.96 -0.60 -1.56 pobR PHBA metabolism regulator 
PA0475 -0.96 -0.55 -1.50  transcriptional regulator 
PA0527 0.82 1.04 1.86 dnr denitrifaction regulator 
PA0547 0.56 1.29 1.85  transcriptional regulator 
PA0708 -1.34 -1.22 -2.56  transcriptional regulator 
PA0797 0.18 -1.95 -1.77  transcriptional regulator 
PA0815 -0.61 -0.82 -1.42  transcriptional regulator 
PA0831 -0.33 -1.01 -1.34 oruR ornithine metabolism regulator 
PA0839 -0.21 -0.88 -1.09  transcriptional regulator 
PA0906 -0.41 -0.83 -1.24 alpR lysis phenotype repressor 
PA1663 0.38 1.01 1.39 sfa2 RpoN sigma factor activator 
PA1759 -0.75 -1.16 -1.91  transcriptional regulator 
PA1760 -0.14 -1.25 -1.39  transcriptional regulator 
PA2016 -0.28 -1.61 -1.89 liuR leucine metabolism regulator 
PA2076 0.65 0.71 1.36  transcriptional regulator 
PA2082 -0.54 -0.84 -1.38 kynR tryptophan metabolism regulator 
PA2196 0.29 1.10 1.39  transcriptional regulator 
PA2246 0.06 -1.43 -1.37 bkdR 
branched-chain amino acids 
metabolism regulator 
PA2259 0.97 -2.31 -1.34 ptxS 
2-ketogluconate metabolism 
regulator 
PA2320 2.35 -3.17 -0.81 gntR gluconate metabolism regulator 
PA2556 -0.67 -1.79 -2.46  transcriptional regulator 
PA2686 0.69 0.94 1.62 pfeR enterobactin receptor regulator 
PA2825 -0.97 -0.97 -1.93 ospR oxidative stress response regulator 
PA2897 -0.39 -0.65 -1.03  transcriptional regulator 
PA2957 0.63 0.92 1.55  transcriptional regulator 
PA3006 -0.55 -0.57 -1.11 psrA fatty acid β-oxidation regulator 
PA3067 1.00 -0.13 0.88  transcriptional regulator 
PA3124 -0.49 -0.61 -1.10  transcriptional regulator 
PA3192 0.76 -2.47 -1.71 gltR TC response regulator 
PA3321 0.03 -1.57 -1.54  transcriptional regulator 
PA3410 0.40 0.96 1.36 hasI ECF sigma factor HasI 
PA3508 -0.88 -1.16 -2.04  transcriptional regulator 
PA3622 -0.63 -0.81 -1.44 rpoS sigma factor RpoS 
PA3689 -0.89 -0.76 -1.65 yhdM transcriptional regulator 
PA3721 0.44 0.69 1.13 nalC TetR family repressor 
PA3757 -0.24 -0.98 -1.22 nagR GlcNAc metabolism regulator 
PA3815 0.73 0.61 1.34 iscR 
iron-sulphur cluster biosynthesis 
regulator 
PA3921 -0.08 -0.93 -1.01  transcriptional regulator 
PA3927 -0.03 -1.40 -1.43  transcriptional regulator 
PA3973 -1.04 -0.69 -1.73  transcriptional regulator 
PA4021 -0.15 -1.23 -1.38  transcriptional regulator 
PA4094 -0.61 -0.86 -1.47  transcriptional regulator 
PA4147 -0.81 -1.22 -2.03 acoR 2.3-butanediol metabolism regulator 
PA4296 -0.72 -0.31 -1.02 pprB TC response regulator 
PA4341 -0.19 -1.36 -1.55  transcriptional regulator 
PA4726 -0.34 -0.75 -1.09 cbrB TC response regulator 
PA4787 -0.30 -1.09 -1.39  transcriptional regulator 
PA4853 0.50 0.80 1.30 fis Fis family regulator 
PA4914 -0.50 -0.90 -1.40 amaR lysine metabolism regulator 
PA4983 -0.60 -1.28 -1.89 dsmR TC response regulator 
PA5029 -0.61 -0.54 -1.15 ynfL transcriptional regulator 
PA5261 -0.63 -1.03 -1.66 algR transcriptional regulator 
PA5301 -0.28 -1.19 -1.46 pauR polyamine metabolism regulator 
PA5324 -0.40 -0.95 -1.35 sphR sphingosine-responsive regulator 
PA5364 -0.46 -0.61 -1.07  TC response regulator 
PA5380 -0.68 -0.76 -1.44 gbdR protein GbdR 
PA5428 -0.33 1.34 1.02  transcriptional regulator 
1Red figures indicate statistically significant difference (Padj < 0.05). 
2PHBA, p-hydroxybenzoic acid; TC, Two-Component; GlcNAc, N-acetylglucosamine. 
